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Abstract 
Adenoviruses are disease-causing agents, but are also explored as a model system to 
decipher mechanisms of molecular biology and used as vectors for gene and cancer therapy 
trials. Vectors wholly or partially based on animal adenoviruses may be interesting in this 
respect, both for avoiding pre-existing immunity in humans and the possibility of having novel 
cell-targeting properties. The capsid of the icosahedral, double-stranded DNA-containing 
adenovirus maintains the integrity of virus particle, but also has proteins involved in virus 
entry. The fibre is one such protein and is responsible for primary virus-host interaction. 
Hence, the homo-trimeric fibre protein is an important factor in adenoviral biology and to 
successfully exploit these viruses for medical applications.  
In this thesis work, X-ray crystallographic structures of four animal adenovirus fibre heads 
have been determined, three of which belong to recently established genera of Adenoviridae, 
namely Siadenovirus and Atadenovirus. Despite being members of distinct genera and 
targeting various organisms, the structures revealed overall conserved topology of the central 
beta-sandwich in their head domains. However, other features of these fibre heads, such as 
their size, shape and the length of connecting loops show more diversity, which may, in turn, 
have an impact on their tropism.  
Structures determined from two atadenoviruses have established their fibre heads as the 
smallest among all known adenovirus fibre head structures. Both the snake adenovirus 1 fibre 
head and the lizard adenovirus 2 short fibre heads are compact, with relatively short loops 
connecting their beta-strands. The presence of a prominent alpha-helix in their structures is 
also interesting. 
Turkey adenovirus-3, which exists in avirulent and virulent forms, has a fibre head more 
similar to reovirus fibre heads than to those of other adenoviruses. The presence of a beta-
hairpin insertion is unique to the structure. Moreover, the striking similarity of turkey 
adenovirus-3 fibre head with reovirus attachment proteins has strengthened the theory of an 
evolutionary link between adenoviruses and reoviruses. Sialic acid-containing carbohydrates 
were identified as in vitro ligands by NMR spectroscopy and calorimetry and co-crystal 
structures were successfully determined. The structure of ligand-bound turkey adenovirus 3 
fibre head revealed the sialic acid binding site located on the side of the trimer.  
Murine adenovirus 2, like most mammalian adenoviruses and all known human 
adenoviruses, belongs to the Mastadenovirus genus and could potentially be developed into a 
model system to study adenovirus pathogenicity. I have determined the high-resolution crystal 
 XVI 
structure of the fibre head domain of murine adenovirus 2, along with the two directly 
preceding shaft domain repeats, which shows an overall resemblance to other adenovirus fibre 
heads of Mastadenovirus genus. Structural comparison with other fibre head structures, 
however, clearly shows variations that may have functional implications. N-
acetylglucosamine, which is common component of glycosaminoglycans such as heparan 
sulfate and has a wide tissue distribution, has been identified as a ligand for murine adenovirus 
2 fibre head in this thesis. 
In summary, I present new structural and functional findings on distinct adenovirus fibre 
heads that will be useful in elucidating their tropism and biology. The new structures may also 
be useful in the design and development of animal adenovirus-based applications. 
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1. Introduction 
1.1 History and significance of adenovirus research 
Adenoviruses were first isolated in 1953 from human pharyngeal tonsils (Rowe et al., 
1953). The isolated agent was able to cause cytopathic changes and degradation of the 
adenoidal cells. Hilleman isolated a similar agent associated with acute respiratory illness 
from the tracheal phlegm and called it "adenoid degenerating agent" (Hilleman and Werner, 
1954); later Huebner named them "adenoid-pharyngeal conjunctival and acute respiratory 
disease agents" (Huebner et al., 1954). Based on the observations of a common origin and 
close relatedness of the isolated agents, they were collectively named adenovirus (Enders, 
1956). Further studies by different research groups firmly established the linkage of 
adenoviruses with acute respiratory illness and their frequent existence in a latent state in 
human tonsils and adenoids (Sohier et al., 1965). Furthermore, some adenovirus serotypes 
were found associated with infections of ocular tissues, such as adenovirus serotype 8 causing 
epidemic keratoconjunctivitis (Jawetz et al., 1957; Jawetz et al., 1955). Following the 
identification in humans, the first detection of adenovirus from non-human species was 
realized in cow (Klein, 1959) and in mouse (Hartley and Rowe, 1960). Later, they were 
isolated from and characterized in a number of further vertebrates species. 
Due to their diverse occurrence and disease causing ability, several research groups 
focussed on adenovirus in the 1960s. During one such study, tissue culture fluid of human 
adenovirus serotype 12 (HAdV-12) was observed to successfully transform hamster cells 
(Trentin et al., 1962). Furthermore, it was shown that the HAdV-12 virus can also transform 
mice cells (Yabe et al., 1964). These two observations temporarily attributed adenovirus with 
a role in cancer progression. Subsequent research refuted this idea, but the intrinsic 
transformation ability of adenoviruses made them excellent tools to study the process of 
carcinogenesis. Splicing of introns was also observed for the first time in mRNAs of 
adenovirus serotype 2 (HAdV-2), during the late infection stage (Chow et al., 1977). This 
helped in establishing adenovirus as a model system to study gene expression in eukaryotes 
(Philipson, 1995). 
During the past two decades, adenoviruses have been explored with two major objectives: 
to develop effective anti-virals against them and to adapt the virus into vector to be used in 
gene and cancer therapy. Additionally, some human adenovirus types have been used as oral 
vaccines against respiratory illnesses such as febrile acute respiratory disease. A vaccine 
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containing the avirulent form of turkey adenovirus 3 (TAdV-3) is widely used to prevent 
hemorrhagic enteritis in young turkeys. 
Adenoviruses are associated with a number of pathogenic conditions such as epidemic 
keratoconjunctivitis, a severe ocular infection caused by some group D human adenoviruses 
(Martin et al., 2007). These viruses use cell surface sialic acid molecules as their attachment 
receptors and hence, inhibitors based on sialic acid are currently being developed against these 
viruses (Spjut et al., 2011). Although these conditions are usually self-limiting and infection 
generally induces sufficiently strong adaptive and protective immunity, patients have to suffer 
due to associated clinical manifestations. Moreover, in the case of immunosuppressed patients, 
infection can lead to severe clinical complications such as organ failure (Kinchington et al., 
2005). Despite all efforts, there are currently no anti-viral agents against adenovirus for 
systemic or topical administration (Kinchington et al., 2005).  
As far as vector development is concerned, the decade of the 90s has seen significant 
efforts in designing vector systems based on adenoviruses, thanks to their distinctive features 
such as a high potential trans-gene capacity, possibility of recombinant growth up to high titer 
and efficient transduction (McConnell and Imperiale, 2004; Bachtarzi et al., 2008). Patients 
may have pre-established immunity against human adenoviruses, so use of non-human 
adenoviruses might be advantageous, as they may be less immunogenic and may have novel 
receptor-binding properties (Loser et al., 2002). 
1.2 Genome organisation 
The adenovirus genome is a linear, non-segmented, double stranded DNA with 
characteristic inverted terminal repeats (ITR) and a covalently attached terminal protein at the 
5'-end of each strand. Depending on genus and adenovirus type, the genome is between 26 and 
48 kb in length, along with variations in features such as length of the ITR and degree of 
sequence conservation, however, these variations are mainly observed in the terminal regions 
and the central part of the genome is generally conserved (Figure 1; (Mautner et al., 1995; 
Harrach, 2011)). Variations in total G+C content of genomes have also been observed among 
different adenovirus types. 
Many of the adenoviral RNA polymerase II transcription units are poly-cistronic. The 
products of these units undergo alternative splicing to yield different products (Berget et al., 
1977). The transcriptional units were named according to whether their mRNA products 
accumulate in the early (E1A, E1B, E2A, E2B, E3, and E4) or late phase (L1 to L5) of 
infection (Flint et al., 1975; Russell, 2000). Furthermore, the gene products expressed in the 
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early phase are associated with viral DNA replication, while the production of virus structural 
components and the encapsulation and maturation of virus particles takes place in the late 
phase (Russell, 2000). 
Figure 1: Genome organization of representative species of four adenovirus genera. Black arrows 
show conserved genes; grey arrow indicates genes that are present in more than one genus; colored 
arrows show genus-specific genes. Genome map for the fifth genus Ichtadenovirus is not yet available. 
Modified from (Harrach, 2011). 
1.3 Adenovirus virion architecture 
The adenovirus virion is around 90 nm in diameter and displays icosahedral symmetry with 
a triangulation number of 25 (T=25). Each non-enveloped, mature particle has an outer capsid 
and an inner DNA containing central core that accounts for a combined mass of approximately 
150 x 106 Da (Vellinga et al., 2005; Shenk, 1996). Proteins account for 87% of the total mass 
whereas a single DNA molecule contributes the remaining 13%. Trace amount of N-acetyl-
glucosamine is also present as an added moiety to the fibre protein, which is the only 
adenoviral protein undergoing glycosylation (Beach et al., 2009a).  
The faces of adenovirus capsid are made up of the hexon protein, while the penton base 
forms the vertices. Into each vertex, a trimeric fibre is inserted. Besides these, there are some 
minor structural proteins, which are necessary for assembly and function as capsid stabilizers 
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(San Martin, 2012). In atadenoviruses, the capsid additionally contains two genus specific 
proteins, p32 and LH3 (Löser, 1999). Figure 2 shows a schematic representation of different 
polypeptides and their location in the viral capsid. Capsid associated proteins of adenoviruses 
can be divided in two categories: 
 
1 Major capsid proteins 
2 Minor capsid proteins 
Figure 2: Location of adenovirus proteins (A) Schematic diagram of human adenovirus (HAdV) 
showing the eleven capsid and core proteins alongwith the viral DNA. Modified from Stewart and 
Burnett (1993). (B) Cryo-EM reconstruction of ovine adenovirus, a member of Atadenovirus genus. 
The genus specific LH3 protein is shown in blue and pentons are highlighted in yellow (Pantelic et al., 
2008). 
1.3.1 Major capsid proteins  
Hexon: The hexon or polypeptide II is the most abundant and primary constituting unit of 
the adenovirus capsid. Twelve copies of the hexon trimer form each of the 20 icosahedral 
facets of the virion; the 720 total copies of the hexon monomer account for 63% of the virion 
protein mass (van Oostrum and Burnett, 1985; Rux and Burnett, 2004). It is worth mentioning 
that the hexon was the first animal virus protein to be crystallized (Pereira et al., 1968). 
A single hexon subunit is composed of two anti-parallel, eight stranded beta-barrels, which 
are localized towards the bottom of the structure. In the trimeric assembly, the 3-fold 
repetition of these beta-barrels gives the pseudo-hexagonal appearance to isolated hexons 
(Rux and Burnett, 2004). Some of the loops connecting the strands reach out to the top of the 
trimer and interact with loops of adjoining subunits. These inter-monomeric interactions 
confer remarkable stability to the trimer.  
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Apart from inter-monomeric interactions within a hexon, the terminal regions of the hexon 
monomer have also been implicated in facilitating interactions between two hexons and 
between a hexon and minor coat proteins IIIa and VIII (San Martin, 2012). These interactions 
further contribute towards capsid integrity. Some studies have also shown that the outer 
regions of hexon are involved in receptor binding and virus internalization (Waddington et al., 
2008; Kalyuzhniy et al., 2008). 
Penton base: The penton base is a pentameric assembly of polypeptide III. Together with 
the trimeric fibre protein it constitutes the vertex capsomers or pentons of adenoviruses. The 
penton base exhibits a high level of amino acid sequence conservation even among human and 
non-human adenoviruses, with only the exposed hypervariable regions showing high sequence 
divergence (Zubieta et al., 2005). The atomic structure of the penton base revealed a 30 Å 
hollow central core. The N-terminal region of each monomer is directed towards the viral 
core, while interacting with the minor capsid stabilizing protein IIIa (Liu et al., 2010). An 
alteration in the interacting region of IIIa results in premature loss of pentons from the capsid 
(San Martin et al., 2008). At the capsid surface, the jellyroll arrangement of each monomer 
provides five equivalent interfaces that can accommodate incoming fibre tail monomers 
(Zubieta et al., 2005). 
The vertex capsomers are responsible for the crucial cell entry process. The distal C-
terminal part of the fibre recognizes specific cell surface receptors and attaches the virus to 
host cell in a convenient orientation (Bergelson et al., 1997; Arnberg et al., 2000). This is then 
followed by a secondary interaction between the penton base and cell surface integrins, 
promoting viral internalization via endocytosis (Wickham et al., 1993; Li et al., 2001; Soudais 
et al., 2000; Bangari and Mittal, 2005). Although the secondary interaction of integrins with 
the penton RGD motifs greatly enhances the efficiency of cellular entry, absence of RGD 
motifs doesn’t prevent viral infection (Albinsson and Kidd, 1999; Hidaka et al., 1999). In the 
absence of other virion components, pentons can assemble as dodecamers and enter into the 
cell by endocytosis (Fender et al., 1997; Zubieta et al., 2005). 
Fibre: The adenovirus fibre is a homo-trimeric, long, surface exposed protein that is 
attached to the penton base at each of the capsid vertices and protrudes away from the viral 
surface (Figure 3A). Its primary function is to mediate virus-host attachment through 
interactions with cell surface receptors such as CAR, sialic acid, desmoglein 2 or CD46/80/86 
(Bergelson et al., 1997; Arnberg et al., 2000; Wang et al., 2011; Segerman et al., 2003; Short 
et al., 2006). The fibre is one of the major contributors to viral antigenecity, along with the 
hexon and the penton base. It has also been linked to viral maturation and intracellular 
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trafficking (Legrand et al., 1999; Harrach, 2011). Generally, the number of fibres per vertex is 
one, however, there are exceptions (Hess et al., 1995). Historically, the fibre was the second 
adenovirus structural protein to be crystallized (Mautner and Pereira, 1971), however, 
successful structure determination took another 23 years (Xia et al., 1994).  
Structurally, the fibre can be divided into three domains; an N-terminal virus attachment or 
tail domain, a central shaft domain and a distal C-terminal globular head or knob domain 
(Figure 3A). The tail domain contains well-conserved motifs (Chroboczek J, 1995), of which 
one (ENPVYPY) anchors the tail to the penton base (Zubieta et al., 2005). The central shaft 
domain contains triple beta-spiral repeats with the consensus sequence XXϕXϕXϕX-T-
X#ϕXϕXX-L (X is any amino acid, # is typically a proline or glycine, ϕ is a hydrophobic 
residue, T is a turn region and L a loop region). Amino acid insertions are tolerated in the loop 
region and, to a lesser extent, in the turn (Figure 3B; van Raaij et al. (1999b)). The length of 
the shaft domain is quite variable between adenovirus types, depending upon the number of 
triple beta-spiral repeats present (Nicklin et al., 2005). For example, the human adenovirus 
serotype 3 (HAdV-3) fibre shaft has only six triple beta-spiral repeats whereas serotypes 2 and 
5 contain 23 (Signas et al., 1985; Green et al., 1983). This variation may affect viral infectivity 
and receptor specificity (Shayakhmetov and Lieber, 2000). Among different adenoviruses, the 
fibre head domain varies significantly in sequence. In contrast, their structures show 
conservation of topology, while major variations are restricted to connecting loops (Figure 3B; 
(Xia et al., 1994; van Raaij et al., 1999b; Guardado-Calvo et al., 2007; El Bakkouri et al., 
2008; Guardado-Calvo et al., 2010)). This conservation extends to reovirus fibres and certain 
bacteriophage receptor-binding proteins as well (Chappell et al., 2002; Spinelli et al., 2006). 
Each monomer of the adenovirus fibre head trimer has a central eight-stranded beta-sandwich, 
the strands of which are connected through loops of varying lengths (Xia et al., 1994).  
The globular nature of the fibre head allows its sides and top surface for engaging host 
receptors and, at the same time, the shaft domain provides reach and flexibility (Nicklin et al., 
2005). Given its crucial role in receptor recognition process, the fibre is regarded as an 
important determinant of adenoviral tropism, which makes it an object of study in adenovirus-
based gene vector systems (Nicklin et al., 2005; Noureddini and Curiel, 2005). 
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Figure 3:  Adenovirus fibre (A) Schematic representation highlighting the N-terminal tail, the central 
beta-spiral repeat-containing shaft and the C-terminal receptor-binding head domain. (B) Crystal 
structure of the HAdV-2 fibre head domain with a portion of the shaft region. Monomers are shown in 
different colours (van Raaij et al., 1999b). 
LH3: LH3 is a trimeric protein, of which each monomer weighs 42 kDa, and is present in 
members of Atadenovirus genus only. It is one of the two genus-specific proteins of 
atadenoviruses, the other being p32. Initially it was thought to be a homologue of the E1B55 
kDa protein, which is a non-structural regulatory in protein human adenoviruses (Vrati et al., 
1996). LH3 is a capsid component in ovine adenovirus, with approximately 1500 copies (i.e. 
500 trimers) per virion (Gorman et al., 2005). Later, a cryo-EM reconstruction at 10 Å 
revealed the location of LH3 on the outside of the capsid, forming prominent surface 
protrusions (Figure 2B). It occupies a position equivalent to that of human adenovirus capsid 
protein IX (Ghosh-Choudhury et al., 1987; Pantelic et al., 2008) and may be involved in 
capsid stabilization and/or receptor interaction (Löser, 1999; Pantelic et al., 2008). 
1.3.2 Minor capsid proteins  
Proteins IIIa, VI, VIII and IX are four minor capsid components in human adenoviruses. 
Their contributions towards virus structure and function is not completely understood 
(Vellinga et al., 2005). Protein IIIa is a 63.5 kDa protein and is generated by the N-terminal 
cleavage of a 67 kDa precursor molecule (Vellinga et al., 2005). Protein IIIa acts like a 
cementing material below the vertex to hold adjoining hexons together and thus maintains the 
stability of capsid facets (Liu et al., 2010). This crucial aspect is reflected in assembly 
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malfunctions of virons in case of a defective or non-functional protein IIIa (Chroboczek et al., 
1986).  
Protein VI is a 22 kDa protein. It holds peripentonal hexons together and connects 
individual hexons trimers to the double stranded DNA (Figure 2A; (Wodrich et al., 2003; 
Russell and Precious, 1982; Stewart et al., 1993)). Free protein VI, released during pH-
dependent viral disassembly, destabilizes the endosomal membrane, facilitating viral escape 
(Wiethoff et al., 2005; Maier et al., 2010). Newly synthesized hexons, which are bound to 
protein VI, are transported to the nucleus through the interaction of a C-terminal nuclear 
localization signal sequence of protein VI with the importin protein (Wodrich et al., 2003).  
Protein VIII is the least characterised of all minor capsid proteins and exist in a dimeric 
form inside the viral capsid (Figure 2A; Vellinga et al. (2005)). Mutational analysis has shown 
its contribution in maintaining virion stability and integrity (Liu et al., 1985). In case of 
porcine adenovirus 3, interaction of protein VIII with the packaging motor protein IVa2 has 
been observed, which points to its probable role in genome packaging (Singh et al., 2005). 
Protein IX is a genus-specific component of mastadenoviruses and is not present in any 
other genera of the Adenoviridae family (Figure 2A). It is the smallest of all minor coat 
proteins with a size of 14.3 kDa and cements hexon-hexon interactions (Everitt and Philipson, 
1974; Vellinga et al., 2005; San Martin, 2012). Protein IX is not essential for virus assembly 
but IX-deletion mutants exhibit poor thermo-stability (Colby and Shenk, 1981).   
The central core region of the adenovirus virion contains polypeptides V, VII, µ, IVa2, p23 
and the terminal protein (TP) (Berk, 2007; Echavarría, 2004). The first three of these proteins 
are basic in nature and interact with the DNA (Anderson et al., 1989; Hosokawa and Sung, 
1976; Russell et al., 1968). Protein V acts as the linker between the core and the capsid 
proteins VI and the penton base (Everitt et al., 1975; Matthews and Russell, 1998), whereas 
pVII and µ facilitate viral DNA condensation (Chatterjee et al., 1986; Rux and Burnett, 2004). 
TP covalently attaches to the viral DNA termini via a phosphodiester linkage, circularizes it 
and acts as a primer for DNA replication (Rekosh et al., 1977). Polypeptide IVa2 is a 
multifaceted protein, which plays roles in transcription regulation and DNA packaging (Gustin 
et al., 1996; Zhang and Arcos, 2005). Protein 23 is the principal viral protease, responsible for 
the cleavage of several capsid and core proteins (Anderson, 1990). 
1.4 Taxonomic classification  
Classification of early human adenoviruses was done based on their ability to agglutinate 
human and animal red blood cells (Rosen, 1958; Hierholzer, 1973). With the advent of more 
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advanced methodologies this was replaced by other, more precise criteria such as virion 
polypeptide profiles, DNA restriction endonuclease patterns and DNA hybridization analyses 
(Wadell, 1979; Wadell et al., 1980; Wigand et al., 1980; Garon et al., 1973; Green et al., 
1979). Presently, there are 54 known serotypes of adenoviruses infecting humans, which are 
grouped under seven species (Martin et al., 2007), A-G, and have been associated with 
different tissue tropisms (Table 1).  
Phylogenetic distance, genomic distance, nucleotide composition and cross-neutralization 
has also been used for classification (Harrach, 2011) and now, the family Adenoviridae 
consists of five recognized genera; Mastadenovirus (infecting mammals), Aviadenovirus 
(infecting birds), Atadenovirus (infecting ruminants as well as reptiles and birds, Siadenovirus 
(infecting birds and frog) and Ichtadenovirus (infecting fish) (Figure 4; Harrach (2011)).  
Table 1: Human adenovirus serotypes and associated infections 
Modified from Cupelli and Stehle (2011) 
The name Atadenovirus found its origin in the fact that the first characterised 
atadenoviruses had a strong bias towards A+T in their genomes (Benko and Harrach, 1998). 
Adenoviruses from the Atadenovirus genus have been isolated from squamate reptile hosts, 
ruminants and birds and have a characteristic gene organization and capsid morphology. 
The origin of Siadenoviruses is not clear and they have been isolated from one amphibian 
host, from Sulawesi turtles and from several species of birds (Davison et al., 2000; Harrach, 
2011; Kovacs and Benko, 2011; Park et al., 2012). The genus takes its name from a specific 
open reading frame with high sequence similarity to bacterial sialidase proteins (Davison et 
al., 2000), although the functional significance of this gene is not known.  
Only one Ichtadenovirus has so far been discovered, white sturgeon adenovirus 1, with the 
longest known adenovirus genome of around 48 Kb (Harrach, 2011).  
Species Serotype Infection 
A 12, 18, 31 Intestine 
B 3, 7, 16, 21, 50 11, 14, 34, 35 
Respiratory tract, eye 
Respiratory and/or urinary 
tract, eye 
C 1, 2, 5, 6 Respiratory tract 
D 8-10, 13, 15, 17, 19, 20, 22-30, 32, 33, 36, 37, 38, 39, 42-49, 51, 53, 54 Eye, intestine 
E 4 Respiratory tract, eye 
F 40, 41 Intestine 
G 52 Intestine 
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Figure 4: Phylogenetic tree of adenoviruses based on a distance matrix analysis of hexon amino acid 
(Harrach, 2011). 
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1.5  Overview of the adenovirus life cycle 
Most of the studies on the adenovirus life cycle have been carried out on human adenovirus 
serotypes 2 (HAdV-2) and 5 (HAdV-5), due to the ease of their in vitro production (Berk, 
2007). Figure 5 shows a schematic representation of adenovirus entry into the cell and its 
subsequent processing. Most of these steps are likely to be general to adenovirus infection, 
although some differences with the animal adenoviruses studied in this thesis are also likely to 
exist. 
Figure 5:  Adenovirus cellular entry (1) Virus attachment to cellular receptor (2) Internalization via 
endocytosis. (3) Partial disassembly of the virion inside early endosome (4) Interaction of pVI with 
endosomal membrane leading to membrane disruption and capsid release. (5) Transport of capsid to 
nuclear periphery where it docks on nuclear pore complex. (6) Complete capsid disassembly and DNA 
release into the nuclear pore complex. Taken from Nemerow et al. (2009).  
The first step of adenovirus infection cycle begins with the attachment of virus particles to 
specific host cell receptors. The head domain of the fibre recognizes a specific surface-
exposed cellular receptor (Zhang and Bergelson, 2005). A secondary interaction between the 
penton base protein and cellular integrins facilitates virus internalization via clathrin 
dependent endocytosis (Wickham et al., 1993; Li et al., 2001; Soudais et al., 2000; Bangari 
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and Mittal, 2005). Inside the cell, the virus encounters the acidic environment of the early 
endosome, prompting capsid destabilization and leading to its partial disassembly (Greber et 
al., 1993; Meier and Greber, 2003). Partial disassembly frees some components of the capsid, 
including protein VI that, through its N-terminal helix, destabilizes the endosomal membrane, 
resulting in the release of viral capsid into the cytoplasm (Wiethoff et al., 2005). The capsid 
then uses the extensive network of microtubules inside the cell to reach the nuclear periphery, 
where it docks itself onto the nuclear pore complex, resulting in complete capsid disassembly 
and release of the viral genetic material inside the nucleus (Trotman et al., 2001; Leopold and 
Crystal, 2007).  
1.5.1 Cellular receptors for adenovirus attachment 
As mentioned earlier, the long, trimeric, fibre proteins of adenoviruses mediate high 
affinity attachments to host cell surface receptors through their distal knob or head domain (Di 
Guilmi et al., 1995; Henry et al., 1994; Louis et al., 1994; Mei et al., 2002). The shuffling of 
the fibre domain between adenovirus types is considered as an important event behind the 
emergence of new adenovirus strains (de Jong et al., 1983; Flomenberg et al., 1987; Kajon and 
Wadell, 1996). 
1.5.1.1 Coxsackievirus and adenovirus receptor (CAR) 
CAR is a class I trans-membrane protein with a broad tissue distribution in humans. It has 
been found on cells of the lung, the pancreas and the central and peripheral nervous systems. 
However, it is scarce on malignant cells (Tomko et al., 2000). CAR was first identified as an 
adenovirus receptor for HAdV-2 and HAdV-5 (Bergelson et al., 1997). In deglycosylated 
form, it has a molecular weight of 38 kDa, while glycosylation confers an additional 8 kDa. It 
can be divided into three domains: a C-terminal 107-residue intracellular domain, a single 
trans-membrane helix and an extracellular domain of 216 amino acids. The extracellular 
region can further be divided into two immunoglobulin-like domains, D1 and D2 (Chretien et 
al., 1998). The N-terminal D1 domain is necessary and sufficient for fibre binding (Wang and 
Bergelson, 1999). The attachment of virus to surface-exposed CAR is straightforward, but an 
interesting twist came when it was found that CAR is expressed on the basolateral surface of 
polarized epithelial cells, below the tight junction (Cohen et al., 2001). This raises the question 
on how adenovirus gains access to this location. It was suggested that the virus might gain 
access through a temporary break in the cell monolayer and subsequently spread by 
overproducing fibre protein, which disrups CAR-CAR homodimers and thus the tight 
junctions (Walters et al., 2002). 
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Except for the members of species B and a few adenoviruses of species D, almost all 
human adenoviruses can bind to CAR (Cupelli and Stehle, 2011). Besides that, animal 
adenoviruses infecting chimpanzee and dog also use CAR as their entry receptor (Cohen et al., 
2002; Soudais et al., 2000; Tan et al., 2001). The crystal structure of the HAdV-12 fibre knob 
bound to CAR D1 domain shows the regions of the fibre head domain important for binding 
(Bewley et al., 1999). They are located on the lateral side of the trimer and include the AB- 
and DE-loops of one monomer and the FG-loop of a neighbouring monomer. The AB-loop 
turned out to be the most important, with several patches of conserved amino acids important 
for CAR-binding, even among divergent fibres of different CAR-binding adenovirus types 
(Roelvink et al., 1999). The binding of three CAR D1 domains to the trimeric fibre head leads 
to tighter binding and a low effective dissociation constant (Lortat-Jacob et al., 2001). 
The length of the fibre protein as well as its flexibility plays a significant role in CAR 
attachment. The beta-spiral repeat containing central shaft domain and its juncture with the 
head domain likely confers flexibility to the overall fibre and it has been observed that 
decreasing or increasing the number of these repeats in the shaft reduces CAR association (Wu 
et al., 2003; Shayakhmetov and Lieber, 2000).  
1.5.1.2 Sialic acid 
Sialic acid is one of the most common terminal modifications of cell surface glycoproteins 
and gangliosides. It acts as a common target for virus attachment (Matrosovich et al., 2013). 
Some of human species D adenoviruses use alpha-2,3-linked sialic acid as their attachment 
receptors (Burmeister et al., 2004). These are serotypes 8, 19 and 37, which are associated 
with ocular infections. Their fibre heads carry a predicted positive surface charge when 
compared to other adenoviruses (Arnberg et al., 1997). The fibre head- sialic acid interaction 
was shown to take place in a charge-dependent manner (Arnberg et al., 2002) and the fibre 
residues involved in the interaction are located at the top of the trimeric head domain 
(Burmeister et al., 2004). The weak affinity observed for the interaction (Kd in mM range; 
Burmeister et al. (2004)) suggests the involvement of multiple sialic acid moieties under actual 
in vivo conditions, as has been suggested for other viruses (Sauter et al., 1989; Dormitzer et 
al., 2002a). 
1.5.1.3 CD46 
CD46 is a membrane-linked glycoprotein associated with the complement system of 
cellular immunity (Liszewski et al., 1996). The extracellular part of CD46 consists of four 
domains, namely SCR1, SCR2, SCR3 and SCR4 (SCR stands for short consensus repeat; 
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(Gaggar et al., 2005)). Apart from regulatory functions and binding to C3b/C4b, SCRs also act 
as receptors for several pathogens such as the measles virus, streptococcal bacteria and 
herpesvirus (Giannakis et al., 2002; Buchholz et al., 1997; Greenstone et al., 2002; Hsu et al., 
1997; Liszewski et al., 2000). A higher level of CD46 expression on malignant cells in 
humans suggests a strategic adaptation of these cells for progression and survival (Hara et al., 
1992; Murray et al., 2000; Gaggar et al., 2005). 
CD46 is widely distributed on different nucleated cell types and relatively well accessible 
on the cell surface. Several species B and one species D adenovirus that doesn’t bind CAR 
have been shown to use CD46 as their cellular receptor (Sirena et al., 2004; Gaggar et al., 
2003; Wu et al., 2004a). The crystal structure of human adenovirus 11 (HAdV-11) and 35 
(HAdV-35) fibre heads bound to the extracellular region of CD46 reveals the contacting 
points between two proteins (Persson et al., 2007; Wang et al., 2007). The interaction takes 
place in a shape complementary fashion, involving SCRs 1 and 2 of CD46 and the DG-, HI- 
and IJ-loops of the fibre heads.  
1.5.1.4 Secondary receptor: integrins 
To facilitate virus entry into the cell, adenovirus interacts with vitronectin-binding αvβ3 or 
αvβ5 integrins (Wickham et al., 1993; Li et al., 2001). Integrins are heterodimeric cell surface 
glycoproteins composed of α and β subunits, of which there exist 18 and 8 different subunits 
respectively (Stewart and Nemerow, 2007). Their combinations give rise to several distinct 
types of integrins, some of which are capable of binding to viral proteins. In the case of 
adenoviruses, the viral protein component facilitating this interaction is an RGD motif present 
in the penton base that is conserved in many, if not all, types of adenoviruses (Albinsson and 
Kidd, 1999). The penton- integrin binding triggers a cascade of intracellular signaling, leading 
to virus internalization via clathrin-dependent endocytosis (Stewart and Nemerow, 2007). 
Interestingly, an RGD motif has been found in the fibre proteins of murine adenovirus 1 
(MAdV-1) and porcine adenovirus 4 (PAdV-4) (Raman et al., 2009; Kleiboeker, 1995).  
1.6 Snake adenovirus 1 (SnAdV-1) 
Adenovirus infections have been observed in many reptilian species such as lizards, snakes, 
turtles and crocodiles; and a range of associated clinical symptoms have been described 
(Marschang, 2011). SnAdV-1 was isolated from a corn snake (Elaphe guttata), which showed 
clinical signs of pneumonia (Juhasz and Ahne, 1993). Based on the organisation and of its 
27.7 kbp genome and phylogenetic considerations, it was grouped under the Atadenovirus 
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genus of the Adenoviridae family (Harrach, 2011). SnAdV-1 has a relatively unbiased AT-
content, which is in contrast to the previously characterized members of the same genus. 
However, phylogenetic analysis clearly grouped it with other members of the genus (Farkas et 
al., 2008). The first Atadenovirus to be fully sequenced was ovine adenovirus (OvAd-D) 
isolate OAV287 (Vrati et al., 1996). The capsid of OAV287 has some interesting differences 
when compared to that of other adenovirus genera (Löser, 1999; Pantelic et al., 2008). 
SnAdV-1 has one fibre gene, encoding a predicted polypeptide of 415 amino acid residues 
(Farkas et al., 2008). However, in this doctoral work, the fibre gene product was found to be 
only 345 amino acids long (Singh et al., 2013b). Its primary sequence doesn't have much 
similarity with fibres of other adenoviruses; particularly the C-terminal part is highly divergent 
(only between 12 and 18% sequence identity to adenovirus fibre heads of known structure). 
Despite the low sequence identity, some likely features can be identified. One is the presence 
of a short stretch of hydrophobic residues (13-PVYPFG-18) in the N-terminal tail region of 
the protein, which may be involved in fibre-penton interactions. A conserved cluster of basic 
amino acids was shown to be present in human adenoviruses (Chroboczek J, 1995) and their 
role as a nuclear localization signal was demonstrated (Wu et al., 2004b). Similarly, a short 
stretch of basic residues (3-KIKR-6) is apparent very near the N-terminus of the SnAdV-1 
fibre. Potential beta-spiral repeats are present between residues 38 and 224. Secondary 
structure predictions suggested that a putative loop region between residues 226 and 236 
containing several prolines might separate the shaft from the head domain. The putative head 
domain would then be 111 residues long and shorter than all adenovirus fibre heads with 
known structures. The OvAd-D fibre head, which belongs to the same genus as of SnAdV-1, 
is also significantly smaller than other adenovirus fibre heads, as shown by electron 
microscopy (Pantelic et al., 2008). 
1.7 Turkey adenovirus 3 (TAdV-3) 
Turkey adenovirus type 3 (TAdV-3) belongs to the Siadenovirus genus of the Adenoviridae 
family. It is also called turkey hemorrhagic enteritis virus (THEV) due to the clinical 
symptoms associated with its infection (Harrach, 2011). Electron microscopy of purified 
virions revealed adenovirus-like virions (Itakura and Carlson, 1975; Carlson et al., 1974; Tolin 
and Domermuth, 1975). TAdV-3 was shown to have one fibre (van den Hurk, 1992). 
Serologically indistinguishable strains of TAdV-3 are known to have variable levels of 
pathogenicity. Virulent forms cause hemorrhagic enteritis in turkeys and marble spleen disease 
in pheasants (Domermuth et al., 1979; Palya et al., 2007), while avirulent or less virulent 
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forms don't and can be used as vaccines (Domermuth et al., 1977; Silim et al., 1978; Beach et 
al., 2009b).  
A comparison of the genome sequences of virulent and avirulent TAdV-3 strains has 
revealed mutations in the fibre sequence (Beach et al., 2009a). The 454-residue fibre protein 
of TAdV-3 contains a predicted tail domain (residues 1-45), which is likely to interact with the 
penton base, and a predicted shaft domain with putative triple beta-spiral repeats between 
residues 46 and 303. The remaining part (comprising amino acids from 304 to 454) likely 
forms the head domain. Two of the aforementioned mutations in the fibre sequence are located 
in the predicted head domain, namely residues 354 and 376, which are methionines in the 
avirulent form and isoleucine and threonine in a virulent strain, respectively. 
1.8 Lizard adenovirus type 2 (LAdV-2) 
Isolation and laboratory propagation of reptilian adenoviruses is challenging, obstructing 
their characterisation (Ogawa et al., 1992; Juhasz and Ahne, 1993). Adenoviruses have been 
described in several lizard species (Ogawa et al., 1992; Julian and Durham, 1982; Wellehan et 
al., 2004), but sequence information has been limited to the DNA polymerase gene (Wellehan 
et al., 2004). Recently, Papp et al. have reported isolation of lizard adenovirus-1 from Gila 
monsters (Heloderma suspectum) and lizard adenovirus-2 (LAdV-2) from a Mexican beaded 
lizard (H. horridum) (Papp et al., 2009).  
Recently we have obtained genomic and proteomic information for LAdV-2 through 
personal communication with the groups of Dr. Balazs Harrach (VMRI, Hungary) and Dr. 
Carmen San Martin (CNB-CSIC, Madrid). The 32 kbp genome of LAdV-2 revealed an 
interesting feature; that of the presence of two fibre genes coding for two distinct fibre 
proteins (Penzes et al., 2014). Analysis of purified virions by mass spectrometry and electron 
microscopy evidenced the presence of a short fibre on most vertices, and three long fibres on 
the remaining vertices. LAdV-2 is the first characterised Atadenovirus so far that has two 
distinct fibres. The fibre-1 gene of LAdV-2 codes for a polypeptide of 331 amino acids with a 
monomeric weight of 34.7 kDa, whereas the predicted length for fibre-2 gene product is 433 
amino acids, with a molecular weight of 45.7 kDa. The two proteins differ significantly with 
each other and have a sequence identity of just 20%. 
Sequence analysis and secondary structure predications for both fibre protein shows 
characteristics of typical adenovirus fibre proteins with the presence of triple beta-spiral 
repeats in a central shaft domain (van Raaij et al., 1999b). In the case of fibre-1 the predicted 
tail domain ranges from 1-40 while the putative shaft is from amino acid 45 to 210. The fibre-
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2 is longer than fibre-1 by 102 amino acids and its putative tail domain encompasses residues 
1-45. The shaft domain is estimated to encompass residues 46-260. The remaining C-terminal 
portions of the respective proteins will probably form the head domains. Instances of two fibre 
proteins in adenoviruses have only been described in fowl adenovirus type-1 (FAdV-1), a 
member of Aviadenovirus genus, and in members of species F human mastadenoviruses (Hess 
et al., 1995; Kidd et al., 1993). 
1.9  Murine adenovirus type 2 (MAdV-2) 
The first report of the presence of adenovirus-like viral particles in mice was documented 
by Hartley and Rowe (Hartley and Rowe, 1960). Experimentally, the virus, called MAdV-1, 
was shown to cause encephalomyelitis in newborn or immunodeficient mice, as well as in 
several strains of adult mice (Guida et al., 1995; Wigand, 1980). Following MAdV-1, murine 
adenovirus types 2 and 3 (MAdV-2, MAdV-3) were identified. All three viruses are 
mastadenoviruses (Klempa et al., 2009; Sugiyama et al., 1967; Hashimoto et al., 1966). While 
MAdV-1 and MAdV-2 were isolated from house mice (Mus musculus), MAdV-3 was isolated 
from a striped field mouse (Apodemus agrarius). 
MAdV-2 was isolated from the feces of inbred, healthy house mice and in vitro studies 
showed its ability to cause cytopathic changes in mouse cell lines, particularly that of 
gastrointestinal origin, but not in monkey or human cell lines (Hashimoto et al., 1966; 
Takeuchi and Hashimoto, 1976). The tissue specificity of MAdV-2 is different from MAdV-1, 
which targets endothelial cells of the brain and spinal cord and cells of mononuclear 
phagocytic lineage (Lenaerts et al., 2009). MAdV-2 growth in cell cultures was found to be 
highly inefficient, thus limiting its availability for experimental purposes (Hamelin et al., 
1988). In vivo infection of MAdV-2 in healthy mice does not appear to cause disease, at most 
some diarrhea (Sugiyama et al., 1967). 
The genome sequence of MAdV-2 has been determined (Hemmi et al., 2011), which 
confirmed MAdV-2 is a Mastadenovirus and also showed that the genome of MAdV-2 at 
35,203 bp is the largest of the three sequenced murine adenovirus types (Hemmi et al., 2011; 
Meissner et al., 1997; Klempa et al., 2009). All major structural genes are conserved, as are 
the mastadenovirus-specific proteins IX and V. Interestingly the RGD motif is absent from the 
penton base. MAdV-2 has one fibre gene, which codes for a 787-residue long polypeptide. 
The fibre of MAdV-2 has more amino acids than those of MAdV-1, MAdV-3, HAdV-2, 
HAdV-3 and HAdV-5. Secondary structure prediction of fibre suggests a short tail domain 
(residues 1-50), a long central shaft domain (residues 53-630) and a C-terminal head domain 
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(residues 633-787). Between residues 40 and 47, a short proline-rich region may be involved 
in helping the fibre attach to the penton base. The C-terminal domain doesn’t share significant 
sequence homology with other known fibre head structures (the sequence identity ranges 
between 10-16%). As mouse adenoviruse could be interesting model system to study 
adenovirus pathogenicity and given the crucial role of fibres in mediating adenovirus-host 
interactions, structural characterisation of MAdV-2 fibre may advance our knowledge about 
specific virus-host interaction. 
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2. Objectives 
The aim of this thesis work was to structurally and functionally characterise the outer 
capsid proteins of several animal adenoviruses; snake adenovirus 1, turkey adenovirus 3, 
lizard adenovirus 2 and murine adenovirus 2. The structures of these proteins might give 
clues about receptor-binding and better understanding of adenovirus biology. In the future, 
this information may also help the design of adenovirus-based vectors for gene and cancer 
therapies. The following specific objectives were pursued: 
1. Cloning, expression, purification and crystallization of the snake adenovirus 1 fibre 
protein. Structure solution of the receptor binding head domain. Comparison of the 
structure with known structures. Identification of potential ligands 
2. Expression, purification and crystallization of avirulent and virulent turkey adenovirus 3 
fibre proteins. Structure solution of the receptor binding head domains. Comparison of the 
structures with each other and with known structures. Identification of potential ligands, 
determination of their affinities for the fibre head domain and structure solution of fibre 
head-receptor complexes. 
3. Expression, purification and crystallization of the lizard adenovirus 2 long and short fibre 
proteins. Structure solution of the head domains of the short fibre. Comparison of the 
structure with the snake adenovirus 1 fibre head. 
4. Expression, purification and crystallization of the murine adenovirus 2 fibre protein. 
Structure solution of the C-terminal domain. Comparison of the structure with known 
adenovirus fibre head structures. Identification of potential ligands. 
5. Cloning, expression, purification and crystallization of the snake adenovirus 1 LH3 
protein.  
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3. Materials and Methods 
3.1 Biological and non-biological materials 
3.1.1 Bacterial cells 
For cloning and protein expression purpose the following bacterial strains were used 
during the course of this work: 
Table 2:  Escherichia coli strains used for plasmid amplification and protein expression 
E. coli strain Genotype Description Supplier 
TOP10 
F- mcrA Δ( mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 araD139 
Δ( araleu)7697galU galK rpsL 
(StrR) endA1 nupG 
E. coli B strain 
derivative; used 
for cloning and 
plasmid 
propagation. 
Invitrogen 
(Madrid, Spain) 
BL21(DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3) 
E. coli B strain 
derivative; used 
for protein 
expression. 
Novagen  
(Merck, 
Darmstadt, 
Germany) 
Rosetta(DE3)pLysS 
 
F-ompT hsdSB(rB- mB-) gal dcm (DE3) 
pLysSRARE (CamR) 
E. coli B strain 
derivative; used 
for protein 
expression. 
Novagen 
(Merck, 
Darmstadt, 
Germany) 
B834(DE3) F-ompT hsdSB(rB- mB-) gal dcm met (DE3) 
E. coli B strain 
derivative; 
Methionine 
auxotrophs; used 
for protein 
expression. 
Novagen 
(Merck, 
Darmstadt, 
Germany) 
C41(DE3) F – ompT hsdSB (rB- mB-) gal dcm (DE3) 
E. coli 
BL21(DE3) 
derivative;  used 
for protein 
expression. 
Lucigen 
(Middleton, WI, 
USA) 
JM109(DE3) 
endA1, recA1, gyrA96, thi, hsdR17 
(rk ,mk+), relA1, supE44, λ–, Δ(lac-
proAB), 
[F´, traD36, proAB, lacIqZΔM15], lDE3 
Used for protein 
expression. 
Promega 
(Madison, WI, 
USA) 
XL10-Gold 
endA1 glnV44 recA1 thi-1 gyrA96 relA1 
lac Hte Δ(mcrA)183 Δ(mcrCB-hsdSMR-
mrr)173 tetR F'[proAB lacIqZΔM15 
Tn10(TetR Amy CmR)] 
Used for protein 
expression. 
Stratagene 
(Agilent 
Technologies, 
Santa Clara, CA, 
USA) 
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The E. coli TOP10 strain was used for cloning and plasmid propagation as it carries the 
hsdR gene that enhances the efficiency of transformation of unmethylated PCR amplified 
products and the recA1 (a mutant of recA) gene to reduce chances of getting unwanted 
recombination in the cloned genes respectively. 
E. coli strains that contain a lysogen of λDE3 were used for protein expression in an 
inducer-controlled manner. The λDE3 prophage contains a gene for the T7 RNA polymerase 
under control of the strong lacUV5 promoter. In non-induced conditions, the lac repressor 
protein, coded by the lacI gene present in the pET-type expression vectors used in this thesis 
as well as in the host chromosome, binds to the lac operator site situated upstream of the gene 
of interest, repressing transcription by T7 RNA polymerase (Bell and Lewis, 2000). Lactose 
and its more stable analogue IPTG bind to the lac repressor protein, leaving it incapable to 
bind to the operator site. The T7 promotor sequence is now readily accessible to the T7 RNA 
polymerase, allowing production of the target mRNA and expression of the target protein. 
Sometimes expressing recombinant proteins becomes limited due to the fact that certain 
tRNAs are scarce in E. coli. Rosetta(DE3)pLysS was used to supply extra amounts of these 
tRNAs in order to obtain maximum expression in case the gene encoding the target protein 
posses codons which are rare in the bacterial host. The plasmid pLysS encodes T7 
bacteriophage lysozyme, which attenuates T7 RNA polymerase activity under non-induced 
conditions, hence lowering the basal expression of target proteins that may be toxic to E. coli. 
3.1.2 Protein expression vectors 
pET28a(+) and pET28c(+) (Novagen, Merck, Darmstadt, Germany): vectors used for 
expressing target proteins in bacterial cells. These pBR322-derived vectors were used to 
express target proteins with an N-terminal 6xHis and T7 tag (M GSSHHHHHHS SGLVP 
RGSHM ASMTG GQQMG RGS). The two vectors only differ by a frame-shift in their 
multiple cloning site region. The pET system expression vectors use the T7 RNA polymerase 
provided by the host cells to express the target protein in a very efficient manner. Leaky, 
unwanted expression prior to induction is controlled by inclusion of the lacI coding segment 
in the vector. Upon full induction using IPTG, most of the bacterial resources are directed to 
express the target protein and within a few hours the target protein can comprise more than 
50% of the bacterial total protein content. The kanamycin resistance gene present in the 
pET28a(+) and pET28c(+) vectors provides an easy way to select for positive clones on 
kanamycin containing plates and continuing selection of plasmid presence in liquid growth 
media. 
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3.1.3 Bacterial growth/culture media  
a) LB medium: 10 g/l tryptone, 5 g/l yeast extract, 10 g/l sodium chloride; used for growing 
bacterial cells. Kanamycin was supplied at a final concentration of 50 µg/ml to prevent 
growth of non-specific bacteria. 
b) LB-agar: 10 g/l tryptone, 5 g/l yeast extract, 10 g/l sodium chloride, 15 g/l bacteriological 
agar; LB media supplemented with agar was used to grow bacterial colonies on a solid 
surface in order to select single colonies. Antibiotic was added as above to select for 
plasmid-containing colonies. 
c) Transformation and storage solution (TSS): LB with 12% (w/v) PEG 8000, 5% (v/v) 
DMSO, 25 mM magnesium chloride and 1% (v/v) glycerol; this solution was used to 
prepare and store chemically competent bacterial cells for plasmid transformation. 
3.1.4 Buffers 
The following general-purpose buffers were utilized during the course of this work: 
a) SDS-PAGE electrophoresis buffer: 25 mM Tris-HCl pH 8.3, 192 mM glycine, 0.1% 
SDS. 
b) TAE buffer (1X): 40 mM Tris-HCl pH 8.3, 1.1% acetic acid and 0.001% EDTA 
c) DNA loading buffer (6X): 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol 
FF, 30% (v/v) glycerol 
d) Protein sample loading buffer (1X): 60 mM Tris-HCl pH 6.8, 2% SDS, 2.5% beta-
mercaptoethanol, 0.025% bromophenol blue, 10% glycerol  
3.2 Methods 
3.2.1 Preparation of chemically competent E. coli cells and performing transformation  
To obtain transformation-competent E. coli cells, 10 ml of LB medium were inoculated 
with bacteria taken from a glycerol stock and allowed to grow overnight at 37 ºC. The 
following day 100 ml fresh LB medium was inoculated with the overnight culture in a ratio 
of 1:1000 and allowed to grow until the O.D. reached 0.3 measured at 600 nm. The cells were 
harvested by centrifuging at 3000 g for 10 min at 4 ºC and resuspended in 10 ml TSS buffer. 
Aliquots of 100 µl each were prepared and stored at -80 ºC.  
Transformations were carried out using the heat shock method: 100 µl of competent cells 
were mixed with 50-75 ng of plasmid DNA and the mixture was put on ice for 30 minutes. 
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The mixture was heated for 60 seconds at 42 ºC, followed by quick cooling on ice for 2-3 
minutes. LB medium (500 µl) was then added and the mix was incubated for 1 hour at 37 ºC 
with shaking. Finally the mix was centrifuged, around 400 µl of the supernatant was removed 
and the cells were plated on pre-warmed kanamycin-containing LB-agar plates.    
3.2.2 Working with DNA 
3.2.2.1 DNA amplification by PCR 
Gene amplification reactions were carried out by a three-step polymerase chain reaction in 
a MJ mini personal thermo cycler (Bio-Rad, Hercules, CA, USA) using reagents supplied in 
the Taq DNA polymerase kit (New England Biolabs, Ipswich, Massachusetts, USA). These 
reagents include Taq DNA polymerase, reaction buffer, deoxynucleotides and ready-to-use 
DNA marker. Each reaction consisted of the following steps: 
3-step cycle: 
Initial denaturation:  94 ºC, 5 min 
Denturation: 94 ºC, 30 sec 
*Primer annealing: (Tm-5) ºC, 1 min 
Extension: 72 ºC, 1min for each kb 
of expected fragment  
Final extension: 72 ºC, 10 min 
* The primer annealing temperature depends on the calculated melting temperature (Tm) of the 
oligonucleotides used as given by: Ta Optimal = 0.3 x(Tm of primer) + 0.7 x(Tm of product) – 25. 
Generally an annealing temperature 5 ºC below lowest Tm of the pair of primer is used  
Amplified products were subjected to 1 % (w/v) agarose gel electrophoresis and purified 
using a GeneJET gel extraction kit (Thermo Fisher, Pittsburgh, USA). 
3.2.2.2 Plasmid purification 
Plasmids were purified from 10 ml bacterial cultures grown overnight with the alkaline 
lysis method, using a Wizard Plus SV Miniprep (Promega, Madison, WI, USA) or GeneJET 
Plasmid Miniprep (Thermo Fisher, Pittsburgh, USA) kit and following the supplied protocol. 
30 cycles 
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3.2.2.3 Restriction digestion and ligation  
Amplified gene products and circular plasmids were subjected to restriction digestion 
following the enzyme manufacturers guidelines. Digested products were gel purified using a 
GeneJET gel extraction kit (Thermo Fisher, Pittsburgh, USA).  
Ligation reactions were carried out either at room temperature for 3 hours or at 16 ºC 
overnight using T4 DNA ligase and the supplied ATP-containing ligase buffer (Promega, 
Madison, WI, USA). An insert to vector ratio of 3:1 was maintained in which 100 ng of 
linearised vector was used and the required amount of digested insert was calculated using 
the following formulae:  
 
3.2.2.4 Site-directed mutagenesis  
Site-directed mutagenesis experiments were carried out using a MJ Mini thermo cycler 
PCR (Bio-Rad, Hercules, CA, USA) in a total reaction volume of 50 µl comprising of 100 ng 
of recombinant plasmid and Pfu Turbo DNA polymerase (Agilent Technologies, Santa Clara, 
California, USA). Specific methodologies adopted for each case are given in respective 
sections.  
3.2.3 Protein methods 
3.2.3.1 SDS-PAGE electrophoresis 
The electrophoretic mobility of biological macromolecules in polyacrylamide gels 
depends on their charge and size. However, in SDS-PAGE, protein molecules attain a 
uniform negative charge due to the presence of SDS and their mobility only depends on their 
size. 
A polyacrylamide concentration of between 10 and 15% was used to prepare the resolving 
part of the gel, depending on the size of the target protein. After the run, gels were stained by 
30 minutes of gentle shaking in a solution containing 0.25% Coomassie Brilliant Blue, 33% 
methanol and 10% glacial acetic acid. Destaining was for variable times using the same 
solution but without Coomassie Brilliant Blue. A molecular weight marker mixture 
(PageRuler unstained low range or broad range protein ladder; Thermo Fisher, Pittsburgh, 
USA) was run simultaneously to estimate the molecular weight of the visualized proteins. 
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3.2.3.2 Protein expression, cell harvesting and disruption 
Expression of proteins was carried out in various E. coli strains using the following 
scheme (unless otherwise mentioned): 10 ml of starter culture was prepared from transformed 
cells and allowed to grow overnight with shaking at 37 ºC. Four 0.7 litre cultures in LB 
medium were inoculated in a ratio of 1:1000 and allowed to grow aerobically at 37 ºC to an 
O.D. of 0.6–0.8 measured at 600 nm. The temperature was reduced by cooling on ice and the 
cultures were induced with 1 mM IPTG followed by overnight growth at 16 ºC. Cells were 
harvested by centrifugation at 5000 x g for 15 min and resuspended in lysis buffer consisting 
of 50 mM Tris–HCl pH 7.5, 500 mM sodium chloride, 20 mM imidazole, 10% (v/v) glycerol. 
Lysis was performed using a French press cell disruptor (three passes). Insoluble material 
was removed by centrifugation (20000 x g, 45 min) and supernatant was collected for further 
purification. 
3.2.3.3 Protein purification 
A two-stage purification strategy was adopted in order to obtain crystallization-grade 
protein for all the proteins studied in this thesis. Histidine-tagged proteins were first purified 
by nickel-nitrilotriacetic acid (Ni-NTA) affinity column chromatography followed by ion 
exchange chromatography (IEC). The six-histidine tag is very small and at a working pH of 
7.5-8.0 is usually neutrally charged, not affecting protein folding or compartmentalization.  
a) Ni-NTA metal affinity chromatography: Nitrilotriacetic acid is a tetradentate chelating 
agent which occupies four of the six ligand binding sites in the coordination sphere of the 
nickel ion (Figure 6). Thus two sites are free to interact and bind histidines presented by 
the target protein. On one side NTA is made bound to agarose bead base while the other 
side is exposed. Once the tagged protein is bound, the column is washed to eliminate any 
non-specifically bound protein. The histidine analog imidazole can be used to 
competitively elute bound six-histidine tags, thus eluting the target protein. The 
following protocol was adopted to purify target proteins: 1.5 ml of Ni-NTA resin (Jena 
Bioscience GmbH, Jena, Germany) was added to the supernatant collected after cell 
disruption and the sample was left for incubation with gentle shaking for 1 h. The 
suspension was poured into an empty column and washed twice with 10 column volumes 
of buffer consisting of 50 mM Tris–HCl pH 7.5, 500 mM sodium chloride, 30 mM 
imidazole, 10% (v/v) glycerol. This was followed by a step gradient elution with 
imidazole (50, 100, 200, 300, 400, 500 and 1000 mM) in the same buffer (each step was 
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with 2 column volumes of the respective elution buffer). The fractions containing the 
target protein were pooled and dialysed, using 10 kDa cutoff dialysis tubing (Sigma-
Aldrich, St Louis, Missouri, USA). The choice of dialysis buffers was based on protein’s 
predicted pI and is mentioned in respective sections.  
Figure 6: Ni-NTA chromatography. Nickel ion interaction with histidine residue (in blue). (from 
Qiagen Ni-NTA manual) 
b) Ion exchange chromatography (IEC): Proteins, being amphoteric in nature, contain 
both acidic and basic functional groups. The local and overall charges of a protein 
molecule depend on the pH of their environment. Ion exchange chromatography exploits 
this behaviour and can be classified broadly into two types: anion exchange 
chromatography and cation exchange chromatography. In anion exchange, negatively 
charged protein patches are attracted towards a positively charged solid support while in 
cation exchange a negatively charged solid support attracts a positively charged molecule 
(Figure 7). Ion exchange chromatography was carried out on a ÄKTA purifier FPLC (GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden), using Resource Q and Resource S 
columns (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) for anion and cation 
exchange chromatography, respectively. Protein samples were dialyzed against suitable 
buffers (mentioned in respective sections) and linear gradient elutions with 0-1 M sodium 
chloride was performed in the same buffer. Collected peak fractions were desalted and 
concentrated using Amicon Ultra concentrators (Millipore Iberica, Madrid, Spain), 
applying three washes with the buffer of choice and stored at 4 ºC prior to crystallization 
trials. 
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Figure 7: Anion and cation exchange chromatography 
3.2.3.4 Neoglycoconjugate (NGC) microarrays 
It has been shown that adenovirus may use cell surface glycans for their entry into cell via 
fibre mediated interactions (Arnberg et al., 2000). With the aim of identifying potential 
glycan ligands for the fibre head proteins under study, neoglycoconjugate (NGC) microarray 
experiments were carried out by Dr. Michelle Kilcoyne in the group of Dr. Lokesh Joshi at 
NUI, Galway, Ireland. The microarray slides used in the experiments presented different 
simple to complex glycans attached on protein or lipid backbones through linkers or spacers. 
Proteins were titrated in TBS-T buffer (1 mM CaCl2, 1 mM MgCl2, 0.05% Tween 20 pH 7.2) 
to determine optimal concentration and later 10 µg/ml was found suitable for experiments as 
at higher concentrations significant background noise was detected. In a similar way, the 
concentration of the probing anti-6X His IgG-CF640R (Sigma–Aldrich, St Louis, Missouri, 
USA) antibody was optimized. 
All experiments were carried out in triplicate, each comprising of two steps: slides were 
incubated in TBS-T for 1 hour at 23 ºC followed by three washes in TBS-T for 2 minutes and 
an onetime wash with TBS. After the wash slides were allowed to dry and a second 
incubation with monoclonal anti-6X His IgG-CF640R was performed for 1 hour at 23 ºC. The 
antibody detects the 6xHis tag present on the proteins. Binding inhibition assays were 
performed in the presence of suitable glycans. 
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3.2.3.5 Saturation transfer difference NMR spectroscopy 
The saturation transfer difference experiment is based on the transfer of magnetization 
between the protein, which is selectively irradiated by a train of radiofrequency pulses, and 
any binding ligands (Meyer and Peters, 2003). For complex ligands, such as 
oligosaccharides, those atoms lying closer in space to the protein surface receive a higher 
amount of magnetization, providing information on the ligand binding epitope (Mayer and 
Meyer, 1999).  
STD-NMR experiments with fibre head proteins were conducted at the Centro de 
Investigacion Biologia (CIB-CSIC) Madrid, by Alvaro Berbis in the group of Dr. Jesús 
Barbero. NMR spectra were acquired at 298 K in a Bruker AVANCE 500 MHz spectrometer 
equipped with a 5 mm inverse probe head. Experiments were performed in fully deuterated 
10 mM potassium phosphate buffer, pH 7.7. Samples contained 1.5 mM of ligand and 15 µM 
of fibre head protein. Data were analyzed with Bruker TopSpin 3.0 and figures were made 
with MestReNova v.8.0.2. 
3.2.3.6 Isothermal titration calorimetry (ITC)  
Isothermal titration calorimetry experiments were carried out at IQFR-CSIC, Madrid, 
Spain by Dr. Margarita Menendez. Titrations were performed at 25 °C with a Microcal VP-
ITC microcalorimeter (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The proteins 
were exhaustively dialyzed before against 10 mM MES, pH 6.0 (in case of TAdV-3 fibre) 
and 10 mM Tris-HCl, pH 8.0 (in case of MAdV-2 fibre), and sugar solutions were prepared 
with the final dialysates. Titrations were performed by stepwise injections of the ligand-
containing solution (21-24 mM) into the reaction cell loaded with the protein solution at 
concentrations of 78–474 µM. When required, a second set of injections was coupled to the 
first one after refilling the injection pipette with the same sugar solution, and ConCat32 
program was used to couple the raw data of both series. The heat of ligand dilution was 
determined separately and subtracted from the total heat produced following each injection. 
Protein concentrations were determined spectrophotometrically at 280 nm using the 
calculated molar extinction coefficient of monomer. Titration data were analyzed with the 
Microcal-ITC ORIGIN software. 
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3.2.4 Crystallographic methods 
3.2.4.1 Protein crystallization  
Crystallization of protein molecules can’t be put under the same umbrella with that of 
small molecules as both differ significantly in their physical and chemical properties. In 
contrast to stable and rigid small molecules, protein molecules are highly labile, dynamic and 
show more complexity in the way they interact with each other. Their crystals, as well, 
demonstrate differences in internal and external properties. Small molecule crystals are 
physically stronger, more brittle and they usually diffract X-rays much better than protein 
crystals. Such properties can be explained by their highly ordered lattice system and strong 
crystal contacts. On the other hand, the total number of different bonding interactions within 
a protein crystal is far less than in a small molecule crystal (McPherson, 2008), resulting in 
an overall weak lattice force and thus explaining their softness, fragility and relatively poor 
diffraction properties. Moreover, protein crystals are also very sensitive towards changes in 
external conditions such as pH, temperature and osmolarity, owing to their high solvent 
content (Littlechild, 1991) usually between 30 and 80% (Matthews, 1985) 
A primary consideration in protein crystallization is sample quality. A sample should 
satisfy properties that are critical for successful crystallization: homogeneity, stability and 
solubility. Availability of identical units of target molecule in the sample is a must, as it will 
form the periodic lattice of the crystal. The presence of any impurity in the sample may 
hamper this process. These impurities could be externally or internally originated, internally 
if the molecules, independent of one another, change their state by some means. This will 
eventually lead the solution from a state of homogeneity to heterogeneity. Therefore the 
molecule should be maintained in a stable state. A molecule should also be highly soluble 
and in a monodisperse solution before starting crystallization trials. There should not be any 
sort of aggregates, molecular clusters or non-specific oligmers present in the solution 
(Bergfors, 1999). 
Although small molecules and protein macromolecules are very different in their 
physiochemical properties, both follows same basic rule for crystallization. Their solutions 
must be in a state of supersaturation in order to initiate crystal formation. The solution can be 
forced to attain this state by a variety of means such as altering the temperature, the pH and 
the precipitant concentration of the solution. This would eventually lead to a change in 
protein solubility, pushing the system towards supersaturation.  
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Vapour diffusion is an approach where changing the precipitant and protein concentration 
simultaneously may lead to supersaturation. I employed the sitting drop method, where the 
drop is in a sitting position (Figure 8). In both cases a concentration gradient develops 
between the drop containing the protein and the mother liquor in reservoir as the 
concentration of precipitant is higher in the reservoir when compared to the drop. This will 
lead water to evaporate from the drop thus lowering its volume and increasing protein and 
precipitant concentration. At some point, the protein concentration may attain a state of 
supersaturation and if all other parameters, which are important for crystallization, such as 
pH, temperature, additives etc., are optimal, the protein may crystallize. 
Figure 8: Sitting drop and hanging drop techniques for crystallization of biological macromolecules. 
The drop containing the macromolecule is shown in pink whereas the mother liquor containing 
reservoir is in blue. 
3.2.4.2 Crystal harvesting  
Depending on their growth conditions, crystals were either cryoprotected or harvested 
directly for data collection as mentioned in respective sections. Crystals were mounted in 
LithoLoops (Molecular Dimensions, Newmarket, Suffolk, England) or MicroMounts 
(Mitegen, Ithaca, New York, USA) and vitrified at 100 K. X-ray diffraction data were 
collected at 100 K. 
3.2.4.3 X-ray diffraction data collection 
For crystals obtained during the course of this thesis work, data sets were collected at 
different synchrotron beamlines: 
A. European Synchrotron Radiation Facility (ESRF), Grenoble, France: Beamlines 
BM14, BM30A, ID14-EH1, ID14-EH4 and ID29 were accessed for data collection. 
B. ALBA synchrotron, Barcelona, Spain: The beamline dedicated for macromolecular 
crystallography, BL13-XALOC, was used.  
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C. Soleil synchrotron, Paris, France: Beamline Proxima-1 was employed. 
In addition, the home X-ray source at the CSIC Institute for Physical Chemistry (IQFR-
CSIC, Madrid) was used in some cases for crystal diffraction testing. 
3.2.4.4 X-ray diffraction data processing 
Diffraction data sets were processed with different computational programs. In order to 
retrieve structural information out of the diffraction spots some basic pre-processing is 
required which are: 
1. Data indexing: The main purpose behind this step is to determine the cell parameters of 
the unit cell present in the crystal by the position of reflection peaks. Simultaneously the 
crystal symmetry (i.e. space group) can also be inferred. Usually a few images are 
sufficient for assigning Miller indices, although sometimes the initial space group 
assignment must be revisited in light of the complete dataset. MOSFLM (Kabsch, 2010; 
Battye et al., 2011) program was used to index data sets collected during this thesis work 
unless otherwise mentioned. 
2. Data integration: Once the space group and unit cell parameters are determined all 
recorded each measured spot is assigned an intensity value. In this thesis work, data 
integration was carried out using MOSFLM (Kabsch, 2010; Battye et al., 2011) unless 
otherwise mentioned. 
3. Merging and scaling: Two or more diffraction images may contain symmetrically 
equivalent reflection peaks as the crystal is being rotated to collect redundant dataset. 
These equivalent peaks are identified and relative images are assigned a uniform intensity 
scale. Finally these intensities are converted into structure factor amplitudes; achieving 
structure factor from integrated reflections is called data reduction and now the single 
output file is ready to be used for initial phasing process. I used POINTLESS, SCALA 
and TRUNCATE (Evans, 2011), all of which are part of CCP4 (Winn et al., 2011), for 
data reduction during this work. 
Additionally, SCALEIT (Howell and Smith, 1992; Winn et al., 2011) was used to 
compare native data with derivative data, where applicable. 
3.2.4.5 Structure determination 
The ultimate goal in macromolecular crystallography is to obtain structural information, 
which is defined in terms of electron densities and that we interpret as atomic positions in 
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three-dimensional space. What are recorded in a diffraction experiment are intensities of the 
diffraction spots originating from the crystal unit cell. Once having the intensities, I(hkl), we 
can calculate the structure factor amplitudes of the reflections, F(hkl), by the relation: 
 
 
The amplitudes can be related to the electron density ρ(xyz) in the crystal by a Fourier 
transformation: 
To resolve the above equation the missing parameters α(hkl), or the phase angles of each 
structure factor, must also be determined. However, there is no way to measure α, so in order 
to calculate it additional methods had to be developed: 
1. MIR/SIR: There are methods by which phase can be determined by substituting one or 
several atoms in the native protein crystal with heavy atoms. These derivative crystals can 
be prepared by soaking native crystals with suitable heavy atoms or by co-crystallization. 
In single or multiple isomorphous replacement techniques (SIR/MIR) interpretation of 
difference Patterson map reveals the location of introduced heavy atom in the unit cell of 
the derivative crystal. Having the structure factors for both heavy atom derivative crystal 
(Fph) and the heavy atom (Fh) alone as well as the phase for the heavy atom alone (αH), 
the phase for the protein can be calculated by employing the following relation: 
The absolute requirement for the above method to work is that both the native and 
derivative crystals should be isomorphous. This means that their space groups and unit cell 
dimensions as well as the positions of the constituting atoms, except for the introduced heavy 
atoms, should be same. 
2. Molecular Replacement: This method requires a structural model homologous to the 
target protein molecule. The possible solution space is then searched using the model 
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applying methods first described by Michael Rossmann and David Blow (Rossmann, 
1962). Statistically, a sequence based similarity greater than 25% is required to apply this 
method successfully; a good degree of structural similarity between the search model and 
the target protein is also essential for this method to work successfully. 
3. Anomalous dispersion methods: Phase can also be calculated by using anomalous 
scattering property of heavy atoms introduced in protein crystal. Electron dense heavy 
atoms like Hg, Se, Pb etc. scatter the X-ray beam differently than usual atoms present in 
protein molecules. Thus the intensity difference between Bijvoet pairs:  and 
 can be exploited to determine the unknown protein phase. In order to do so, it is 
obvious that the intensity difference between Bijvoet pairs should be as high as possible 
and therefore the wavelength is selected very carefully keeping in mind the absorption 
edge of incorporated heavy atoms. Data sets can also be collected at one or more 
wavelengths. In the case of single wavelength data collection the technique is called 
single-wavelength anomalous dispersion (SAD) phasing whereas the multi-wavelength 
anomalous phasing (MAD) term is used if more than one datasets were used for structure 
solution (Hendrickson, 1985). Synchrotron beamlines, where the X-ray can be tuned, are 
normally necessary to perform a SAD or MAD experiment. One advantage of this 
technique over SIR or MIR is that isomorphism between native and derivative crystals is 
not essential.  
4. Direct methods: These methods can only be applied where there is some prior knowledge 
of phases for some reflections are available. For protein structure solution the requirement 
is of very high-resolution data approaching to 1.2 Å or better. This implicates restriction 
of their application to very small molecules, as in general, resolutions decreases with 
increasing complexity. 
Besides these methods there are other methods such as SIRAS and MIRAS where 
isomorphous replacement is combind with anomalous dispersion.  
In this thesis work, molecular replacement and experimental phasing by SAD and MAD 
techniques were employed to solve the structures of different proteins. Molecular 
replacement was carried out with PHASER (McCoy et al., 2007) and experimental phasing 
by SAD or MAD was performed using the AUTOSHARP pipeline (Vonrhein et al., 2007), 
which incorporates SHELX (Sheldrick, 2008) for locating heavy atom sites, SOLOMON 
(Abrahams and Leslie, 1996) for solvent correction and ARP-WARP for automated density 
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interpretation (Langer et al., 2008). Manual adjustments of crystallographic models were 
performed with COOT (Emsley et al., 2010) and refinement with REFMAC5 (Murshudov et 
al., 2011). Validation of models were carried out with MOLPROBITY (Chen et al., 2010), 
interaction properties, including buried surface area, were calculated with PISA (Krissinel 
and Henrick, 2007) as implemented by the European node of the Protein Structure Database 
(http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver). Structural homologues were 
identified using DALI server (http://ekhidna.biocenter.helsinki.fi/dali_server/; Holm and 
Rosenstrom (2010)) and structure superimpositions were done with CCP4MG (McNicholas 
et al., 2011) and PyMOL (Schrödinger, LLC). Structure based sequence alignments were 
performed with with MULTISEQ (Roberts et al., 2006) and phylogenetic trees were 
generated with the MEGA 6 package (Tamura et al., 2013).  
3.3 Snake adenovirus 1 fibre protein  
3.3.1 Viral DNA isolation  
Snake adenovirus 1 propagated in iguana heart cells (IgH-2; ATCC reference CCL-108; 
Sorensen and Mesner (2005)) and purified in double caesium chloride gradients as described 
(Menendez-Conejero, 2013) was obtained from Rosa Menendez-Conejero, Gabriela 
Condezo-Castro and Carmen San Martín (Dpto. de Estructura de Macromoléculas, CNB-
CSIC). The final virus concentration was 3.2 × 1010 viral particles per millilitre of 0.15 M 
sodium chloride buffered with sodium 4-(2-hydroxyethyl)-1-piperazineethanesulfonate 
(HEPES) pH 7.8 (as quantified by absorbance measurements; Maizel et al. (1968)). 
Proteinase K (New England Biolabs, Ipswich, Massachusetts, USA) was added to a final 
concentration of 1 mg/ml to 0.15 ml virus solution. The tube was incubated overnight at 37 
ºC. The next day, 0.15 ml water was added and DNA was extracted with 0.3 ml 
phenol:chloroform:isoamyl alcohol [25:24:1 (v:v:v)] saturated with 10 mM Tris–HCl pH 8.0, 
1 mM EDTA (Sigma–Aldrich, St Louis, Missouri, USA) and then with chloroform:isoamyl 
alcohol [24:1 (v:v)]. DNA was precipitated by addition of sodium chloride to a final 
concentration of 0.4 M and absolute ethanol [5:2 (v:v) ethanol:sample ratio] and incubation 
overnight at -20 ºC. Following centrifugation (10 min at 16100 x g), the DNA pellet was 
washed with 0.3 ml 70% (v/v) ethanol. Approximately 0.6 µg of viral DNA was obtained. 
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3.3.2 Construction of expression vectors 
Expression constructs for full-length and N-terminally truncated versions of snake 
adenovirus 1 (SnAdV-1) fibre protein were designed, the putative C-terminal head domain 
likely being important for trimer assembly and correct folding. Truncations were made taking 
into account secondary structure prediction (PSIPRED server at 
http://bioinf.cs.ucl.ac.uk/psipred/; McGuffin et al. (2000)) and potential shaft domain repeats 
(van Raaij et al., 1999b). 
 DNA fragments for constructs starting at different residues (1, 82, 171, 234, 293 and 343) 
were amplified by PCR using the oligonucleotides shown in Table 3. Fragments were 
digested with restriction enzymes BamHI and HindIII and cloned in the pET28c(+) 
expression vector previously treated with the same enzymes. The expression constructs were 
named pET-28c-SnAdV1f1, pET-28c-SnAdV1f82, pET-28c-SnAdV1f171, pET-28c-
SnAdV1f234 and pET-28c-SnAdV1f293, respectively. DNA Sequencing (Secugen SL, 
Madrid, Spain) of recombinant plasmids revealed a major discrepancy between the database 
sequence and the cloned sequences. An insertion of two bases, which results in a change of 
the five amino acids beyond position 339 and a termination codon (TGA) after position 345 
was evident (Singh et al., 2013b). All constructs contained an N-terminal 6xHis tag. 
Table 3: SnAdV1 fibre protein fragments and corresponding oligonucleotide used for coding 
segment amplification. 
 
Fragments Oligonucleotide forward Oligonucleotide reverse 
1-345 f1-ForBamHI (5´-ggtcggatcctgaagaagataaaacgatcagcggc-3´) 
82-345 f82-ForBamHI (5´-ggtcggatccctcctcttcagcaaagcgg-3´) 
171-345 f171-ForBamHI (5´-ggtcggatcctggagtcctatcctcttcccc-3´) 
234-345 f234-ForBamHI (5´-ggtcggatccccagcccgccttctaagac-3´) 
293-345 f293-ForBamHI (5´-ggtcggatcctctcttctttcctcactgccc-3´) 
343-345 f343-ForBamHI (5´-ggtcggatcctgaaagtgatatccatttatttcatggac-3´) 
SnAdVf-RevHind 
(5´-gatcccaagctttcagcttaactcgggacattcttg-3´) 
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3.3.3 Site-directed mutagenesis in expression construct pET-28c-SnAdV1f234 
In order to allow phasing by MAD on incorporated selenium atoms, two leucine codons at 
positions 322 and 324 were mutated to methionine codons in plasmid pET-28c-SnAdVf234. 
A single set of primers (5´-GAC GAG GGA ATT ATG ACT ATG GAG ATT TCT CGC-3´ 
and 5´-GCG AGA AAT CTC CAT AGT CAT AAT TCC CTC GTC-3´) was designed, 
containing the desired leucine to methionine changes shown in bold. A 50 µl reaction mixture 
containing 100 ng pET-28c-SnAdV1f234 plasmid and Pfu Turbo DNA polymerase (Agilent 
Technologies, Santa Clara, California, USA) was subjected to 16 cycles of PCR with a final 
extension step of 7 min. For digestion of parental plasmid DNA, the PCR product was treated 
with DpnI (Agilent Technologies). Fourty units of DpnI were used, where a unit is defined as 
the amount required to digest 1 µg of Dam-methylated pBR322 DNA in 1 h at 37 ºC. The 
reaction was incubated for 3 h at 37 ºC. The two introduced mutations were confirmed by 
DNA sequence analysis (Secugen SL, Madrid, Spain) and the resulting vector was named 
pET-28c-SnAdV1f234mut. 
3.3.4 Expression and purification of SnAdV1f1, SnAdV1f82, SnAdV1f171 and 
SnAdV1f234 
E. coli BL21(DE3) cells were transformed with respective plasmids and four 700 ml 
cultures were grown. After lysis, target proteins were purified from the supernatant by Ni-
NTA chromatography and dialysed against buffer containing 10 mM Tris-HCl pH 8.5 for 
strong anion-exchange chromatography using a Resource Q column. The protein was eluted 
with a linear gradient of 0–1 M sodium chloride in 10 mM Tris-HCl pH 8.5.  
3.3.5 Expression and purification of f234-345mut with selenomethionine 
Selenomethionine-derivatised protein (from the construct starting at residue 234 in which 
leucines 322 and 324 were mutated to methionine) was prepared by transforming methionine 
auxotroph E. coli B834(DE3) cells with pET-28c-SnAdV1f234mut. A 50 ml culture in LB of 
transformed bacteria were harvested by centrifugation (5000 x g, 10 min) and resuspended in 
100 ml SelenoMet medium (Molecular Dimensions, Newmarket, Suffolk, England) 
supplemented with methionine. This culture was grown at 37 ºC until the O.D. reached 0.2 as 
measured at 600 nm and then used as inoculum for 1.6 l SelenoMet medium (Molecular 
Dimensions, Newmarket, Suffolk, England), supplemented with selenomethionine. After 
growth and induction at a measured O.D. of between 0.6 and 0.8 at 600 nm, the culture was 
Materials	  and	  Methods	  
42 
allowed to grow overnight at 16 ºC. The same cell disruption and protein purification 
procedures were followed as performed in the case of the native protein construct starting at 
residue 234, except for the addition of 10 mM beta-mercaptoethanol to all buffers. The 
obtained protein (234-345Semet) was desalted and concentrated, keeping 10 mM beta-
mercaptoethanol in the final buffer (10 mM Tris-HCl pH 8.5, 10 mM beta-mercaptoethanol). 
3.3.6 Crystallization of fragments (171-354), (234-354) and (234-345Smet) 
Initial crystallization trials for the native protein construct starting at residue 234 were 
carried out using sitting-drop vapour diffusion. Commercially available kits were employed 
at 277 and 294 K using either robotic or manual setups. In robotic setups, a Genesis RSP 150 
workstation (Tecan, Männedorf, Switzerland) was used, with MRC 96-well sitting-drop 
crystallization plates (Molecular Dimensions, Newmarket, Suffolk, England). Reservoir 
volumes were 50 µl and drops were prepared by mixing 0.2 µl protein solution with 0.2 µl 
reservoir solution. For manual setups, CompactClover plates (Jena Bioscience GmbH, Jena, 
Germany) were used, with reservoir volumes of 0.15 µl and drops prepared by mixing 1 µl 
protein solution with 1 µl reservoir solution. The crystals used for data collection were 
always those from manual setups. 
Soaking with several heavy atoms (Hg, Au, Pb, Zn, Br, I) were carried out in original 
mother liquor except for one instance were native 234 crystals were transferred to 3 M 
sodium malonate pH 5.0 (Holyoak et al., 2003). 
X-ray diffraction data for all the crystals were collected at the European Synchrotron 
Radiation Facility (ESRF), Grenoble, France or the Diamond Light Source (DLS), Harwell, 
England at 100 K. Data collected at the DLS were integrated using XIA2 (Winter et al., 
2013), which incorporates XDS (Kabsch, 2010) and AIMLESS (Evans and Murshudov, 
2013). Structure solution with selenomethionine derivative multi-wavelength anomalous 
dispersion (MAD) data was performed with the AUTOSHARP pipeline (Vonrhein et al., 
2007). Reflections for calculating the free R-factor were selected in thin shells and the same 
reflections were selected for the free and working R-factor for refining the selenomethionine 
and native model (both in I213 space group). A similar approach was adopted to select 
reflections in thin shells for both P212121 space group crystals but independently from each 
other. Reflections were selected randomly in case of F23 crystal. Structure solution for the 
P212121 data sets was performed by molecular replacement using PHASER (McCoy et al., 
2007), taking the previously determined solution as a search model.  
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3.4 Turkey adenovirus 3 (TAdV-3) fibre protein 
3.4.1 Construction of expression vectors 
Based on secondary structure prediction of the fibre protein of TAdV-3, two expression 
constructs were prepared by Mónika Z. Ballmann in the group of Dr. Balázs Harrach and Dr. 
Mária Benkő at Institute for Veterinary Medical Research, Centre for Agricultural Research, 
Hungarian Academy of Sciences, Budapest, Hungary. One of the constructs was for the full-
length protein (residues 1-454) while the other was meant to express putative C-terminal fibre 
head domain (residues 304-454). The respective coding segments were amplified from a 
commercially available turkey hemorrhagic enteritis vaccine containing attenuated live 
avirulent virus and cloned into the pET28a(+) expression vector, between the EcoRI and 
HindIII restriction sites. The constructs were named pET28a(+)-THEVfib1-454 and 
pET28(+)-THEVfib304-454. The foreign proteins expressed in this vector have an N-
terminal tag (M GSSHH HHHHS SGLVP RGSHM ASMTG GQQMG RGSEF) for easy 
purification by nickel-affinity chromatography.  
3.4.2 Site-directed mutagenesis to generate virulent fibre head protein of TAdV-3 
Two sets of mutagenic oligonucleotides were designed to generate the mutations in a two-
step procedure (Table 4). Met354 to Ile mutation was generated adopting methodology 
described in section 3.2.2.4. Parental DNA was digested by DpnI treatment and the product 
was gel purified using GeneJET gel extraction kit (Thermo Fisher, Pittsburgh, USA). TOP10 
cells were transformed with the PCR product and grown in 10 ml LB culture. Following 
plasmid purification the mutation was confirmed by sequencing (Secugen SL, Madrid, Spain) 
and the plasmid was named pET28a(+)-THEVfib304-454_mutM2I. In order to generate the 
double mutant (M354I and M376T), the pET28a(+)-THEVfib304-454_mutM2I plasmid was 
subjected to the same mutagenic PCR procedure but with the oligonucleotide set containing 
Met376 to Thr mutation. Mutation was confirmed by sequencing and the recombinant 
plasmid was called pET28a(+)-THEVfib304-454_DoubleMut expressing the THEVfib304-
454_virulent fibre head protein. 
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Table 4: Mutagenic primers to generate virulent version of TAdV-3 fibre head domain. 
3.4.3 Site-directed mutagenesis to generate five single amino acid mutants in the fibre 
head fragment fib(304-454) 
Site-directed mutagenesis was performed to generate five separate single amino acid 
mutants in the fibre head protein of avirulent TAdV-3. The mutations were: Arg368Ala, 
Glu392Ala, Asn407Ala, Lys421Ala and Lys439Ala. The pET28a(+)-THEVfib304-454 
recombinant plasmid was used as the template, while five sets of oligonucletides were used in 
separate reactions to introduce the desired mutations (Table 5). Reaction conditions were 
same as described in section 3.2.2.4 and above. 
Table 5: Mutagenic primers to generate single point mutants of avirulent TAdV-3 fibre head 
domain. 
3.4.4 Expression and purification of putative fibre head fragment fib(304-454) 
For expressing and purifying putative fibre head domain of avirulent TAdV-3, E. coli 
BL21(DE3) was transformed with the recombinant plasmid pET28a(+)-THEVfib304-454. 
After cell growth and lsyis, the protein was purified from the supernatant by Ni-NTA 
chromatography. Fractions containing the target protein were pooled and dialysed three times 
against 500 ml buffer containing 25 mM MES-NaOH pH 6.0 using dialysis tubing of 10 kDa 
MW cutoff. The dialysed sample was loaded onto a 6 ml Resource S column and eluted with 
a 0-1 M sodium chloride gradient in the same buffer. The protein eluted at around 0.3-0.4 M 
sodium chloride. Fractions containing pure protein were pooled and concentrated to 11 
mg/ml using Amicon Ultra concentrators, incorporating three washes with 25 mM MES pH 
6.0 to remove sodium chloride. Protein was stored temporarily at 4 ºC prior to use in 
crystallization trials. 
Mutation Oligonucleotide forward Oligonucleotide reverse 
Met to Ile f304-For-Mut_I 
(5´-gataacataggtgtaatagaaaaccctacc-3´) 
f304-Rev-Mut_I 
(5´-ggtagggttttctattacacctatgttatc-3´) 
Met to Thr f304-For-Mut_T 
(5´-gctgatttcttgagtcctacgttaaataatacatatatagtgcca-3´) 
f304-Rev-Mut_T 
(5´-tggcactatatatgtattatttaacgtaggactcaagaaatcagc-3´) 
Mutation Oligonucleotide forward Oligonucleotide reverse 
Arg368Ala 5´-agtattgaattagcatctgctgatttcttg-3´  5´- caagaaatcagcagatgctaattcaatact-3´ 
Glu392Ala 5´-ggggtaagggtagcatcacctactattcct-3´ 5´-aggaatagtaggtgatgctacccttacccc-3´ 
Asn407Ala 5´-atacttgaaaacgcttcctctttcattcaagtaggg-3´ 5´-ccctacttgaatgaaagaggaagcgttttcaagtat-3´ 
Lys421Ala 5´-aggttaacagttgcgaatggtaaccctcatatg-3´ 5´-catatgagggttaccattcgcaactgttaacct-3´ 
Lys439Ala 5´-cctgggaatattgcaatgataaagataaaatctgtaatg-3´ 5´- cattacagattttatctttatcattgcaatattcccagg-3´ 
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The same procedure and maintaining similar buffers as above was adopted for expressing 
and purifying the putative fibre head domain of virulent TAdV-3 as well as for all five single 
amino acid mutants of the avirulent fibre head protein. 
3.4.5 Expression and purification of avirulent fib(304-454) with selenomethionine  
To prepare selenomethionine-derivatised protein, a 50 ml culture of pET28a(+)-
THEVfib304-454 transformed B834(DE3) cells was grown overnight at 37 ºC in LB media 
supplemented with kanamycin. Next day, cells were harvested by centrifugation (5000 g, 10 
min) and resuspended in 100 ml SelenoMet medium (Molecular Dimensions, Newmarket, 
Suffolk, England) supplemented with methionine. This culture was allowed to grow at 37 ºC 
until O.D. reached 0.2 at 600 nm and then used as inoculum for 1.6 l SelenoMet medium 
(Molecular Dimensions, Newmarket, Suffolk, England) supplemented with 
selenomethionine. Following growth at 37 ºC, once an O.D. of 0.6-0.8 had been achieved, the 
cultures were cooled on ice and induced with IPTG, to be followed by overnight growth at 16 
ºC. The cell disruption and protein purification procedures were the same as for the native 
protein except for the addition of 7-10 mM beta-mercaptoethanol to all buffers to prevent 
oxidation of selenomethionine residues. The selenomethionine-derivatised protein was 
desalted and concentrated for crystallization in the same way as the native protein, but 
including beta-mercaptoethanol. 
3.4.6 Crystallization, data collection and data processing of avirulent fibre head, 
avirulent fibre head with selenomethionine and virulent fibre head 
To obtain suitable crystallization conditions, commercial screens from several suppliers 
were tested at 4 and 21 ºC either by manual or robotic setups. Reservoir volumes were kept 
0.15 µl and drops were made by mixing 1 µl each of protein and reservoir solution. Based on 
initial hits, a condition containing 1.0 M diammonium phosphate, 0.1 M sodium citrate pH 
5.5 was chosen for optimization in sitting-drop vapour-diffusion crystallization experiments 
in CombiClover 4 Chamber plates (Jena Bioscience, Jena, Germany).  
Soaking experiments on crystals of avirulent native fib304-545 protein were performed 
with 2,3'- and 2,6'-sialyllactose sugars (Elicityl, Crolles, France) at 21 ºC. Crystals were 
soaked between 2 h to overnight in their original growth condition with a sugar concentration 
of 30-50 mM. Crystal harvesting and mounting were done in same way as for the native 
crystals.  
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For data collection, crystals were transferred to a solution containing the same components 
as the reservoir solution plus 25% (v/v) glycerol and soaked for 30 s. Data was collected on 
beamline ID14-4 of the European Synchrotron Radiation Facility (ESRF), Grenoble, France 
using an ADSC Q315r CCD detector and on BL13-XALOC beamline at ALBA synchrotron 
light source, Barcelona, Spain using a Pilatus 6M (Dectris) detector. Structure solution with 
Se-derivative data set was performed with the AUTOSHARP pipeline (Vonrhein et al., 
2007), employing SAD. As the data indicated presence of only one monomer in the 
asymmetric unit, reflections for calculating the free R-factor were selected randomly and the 
same reflections were selected for the free and working R-factor for refining the 
selenomethionine and native models. For refinement of ligand-bound models, the same set of 
reflections was used for the free and working R-factor as were selected and used for the 
native model. 
3.4.7 Thermofluor protein unfolding assay 
This assay was performed to determine melting temperatures of proteins and was 
conducted in the presence of fluorescent dye SYPRO Orange (Life Technologies SA, 
Madrid, Spain) that can bind to hydrophobic patches on protein surface (Lavinder et al., 
2009). Upon gradual increment in temperature a protein starts to unfold and more and more 
hydrophobic patches become available for the dye to bind, giving rise to an increment in 
fluorescent signal. At one temperature protein exists in equally populated folded and 
unfolded states, which is reffered to as the melting point (Tm) for that particular protein. 
Thermal shift assays on fibre head proteins were carried out in an iCycler iQ PCR 
Thermal Cycler (Bio-Rad, Hercules, CA, USA). 30 µl reaction volumes were prepared in 200 
µl capped PCR tubes by mixing fluorescent dye SYPRO Orange (Life Technologies SA, 
Madrid, Spain) with 30 µg of protein, maintaining final dye concentration of 1x. Thermal 
denaturation curves and melting temperatures (Tm) values were obtained by heating the 
samples through 4 ºC to 94 ºC with a ramp rate of 1 ºC/min. The fluorescence in each well 
was measured at regular intervals of 0.5 ºC. 
3.4.8 Surface Plasmon resonance (SPR) 
Surface plasmon resonance experiments were carried out on a BIACORE 3000 (GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden) platform in order to determine binding 
kinetics of virulent and avirulent TAdV-3 fibre head proteins with 2,3'-sialyllactose. The 
Streptavidin sensor chip (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was prepared 
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by consecutive injection of solution containing 1 M sodium chloride and 50 mM NaOH prior 
to ligand immobilization. Biotinylated glycan 2,3'-sialyllactose-sp-biotin was procured 
(Elicityl, Crolles, France) and passed in varying amount over the chip to attain suitable ligand 
capture level, which later was set to 150 RU for all assays. Free biotin binding sites were 
blocked by injecting 100 µM of D-biotin. One of the flow cells of the chip was kept blank 
and used as reference. 
All interaction assays were conducted at 25 ºC. HBS-EP (0.01 M N-2-
hydroxyethylpiperazine-N-2-ethanesulphonic acid-NaOH pH 7.4, 0.15 M NaCl, 3 mM 
EDTA, 0.005% v/v Surfactant P20; GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was 
used as running buffer during the operation and flow cell surface regeneration was performed 
with 10 mM glycine-HCl pH 2.0 solution, whenever required. Protein samples were prepared 
in running buffer and were injected at 30 µl/min in a broad concentration range of 10 µg/ml 
to 240 µg/ml. The association phase between analyte and ligand was monitored for 8 minutes 
whereas their dissociation was recorded for 4 minutes. Obtained data were processed with 
BIACORE 3000 control software (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). 
3.5 Lizard adenovirus-2 short (fibre-1) and long (fibre-2) fibres  
3.5.1 Construction of expression vectors 
Expression constructs for lizard adenovirus-2 short (fibre1; 331 amino acids) and long 
(fibre2; 433 amino acids) fibres were supplied by Mónika Z. Ballmann, Institute for 
Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of 
Sciences, Budapest, Hungary. The inserts were cloned in pET28a(+), between the EcoRI and 
HindIII restriction sites, for expression with an N-terminal tag (M GSSHH HHHHS SGLVP 
RGSHM ASMTG GQQMG RGSEF). While designing the constructs, the C-terminal end 
carrying the putative fibre head domain was preserved and truncations were done on the N-
terminal side. All prepared constructs were checked by restriction analysis for presence of 
insert as well as by DNA sequencing using T7 forward and reverse primers. Different 
constructs are given in Table 6. 
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Table 6: Expression constructs and respective proteins of lizard adenovirus 2 short and long 
fibres. 
3.5.2 Expression and purification of fib1(220-331)  
I decided to express the protein at 16 ºC based upon its solubility behaviour. BL21(DE3). 
Supernatant obtained from four 700 ml LB cultures was subjected to Ni-NTA 
chromatography in order to separate out the target protein. The fractions containing pure 
protein, as indicated by SDS-PAGE, were pooled and dialysed three times against 10 mM 
Tris–HCl pH 8.5 for strong anion-exchange chromatography using a Resource Q column. 
Elution was performed with a 0–1 M sodium chloride gradient in the same buffer. Fractions 
containing pure protein were pooled and concentrated using Amicon Ultra concentrators, 
incorporating three washes with 10 mM Tris–HCl pH 8.5 to remove sodium chloride and 
stored temporarily at 4 ºC prior to use in crystallization trials. 
3.5.3 Crystallization, data collection and data processing of fib1(220-331)  
For initial trials, four commercially available kits were employed, in total testing 250 
conditions at 4 and 21 ºC either by manual or robotic setups, keeping the total drop volume at 
2 µl or 1 µl. Two conditions produced crystals: one containing 20% (w/v) PEG 3350 and 0.2 
M tri-potassium citrate, while the second contained 0.1 M Tris-HCl pH 8.0 and 30% (v/v) 
PEG 600. The PEG 3500 concentration in the drop was gradually increased to 35% prior to 
crystal harvesting in the PEG 3500 condition while crystals were mounted directly from the 
PEG 600 condition. X-ray diffraction experiments were conducted and data sets were 
obtained at 100 K on beamline ID29 of the European Synchrotron Radiation Facility (ESRF), 
Grenoble, France and on Proxima-1 beamline of the Soleil synchrotron, Paris, France, in both 
occasions using a Pilatus 6M (Dectris) detector. Reflections were taken in thin shells for 
calculating the free R-factor and the same reflections were selected for the free and working 
R-factor for refinement purpose.  
Fibre1 constructs Respective protein Fibre2 constructs Respective protein 
pET28a(+)-Liz-F1-1 fib1(1-331) pET28a(+)-Liz-F2-1 fib2(1-433) 
pET28a(+)-Liz-F1-46 fib1(46-331) pET28a(+)-Liz-F2-40 fib2(40-433) 
pET28a(+)-Liz-F1-160 fib1(160-331) pET28a(+)-Liz-F2-118 fib2(118-433) 
pET28a(+)-Liz-F1-220 fib1(220-331) pET28a(+)-Liz-F2-245 fib2(245-433) 
pET28a(+)-Liz-F1-241 fib1(241-331) pET28a(+)-Liz-F2-305 fib2(305-433) 
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3.5.4 Expression and purification of fib2(245-433)  
Four 700 ml cultures in LB media were inoculated with a starter culture of pET28a(+)-
Liz-F2-245 transformed C41(DE3) cells in a v/v ratio of 1:1000. Cells were lysed, 
supernatant was collected and subjected to Ni-NTA chromatography for purification of the 
target protein. Collected fractions were checked for the presence of target protein, pooled 
together and dialysed three times against anion exchange chromatography buffer (10 mM 
Tris–HCl pH 8.5) using dialysis tubing of 10 kDa cutoff. A Resource Q column was used for 
anion exchange chromatography and elution was performed with a 0-1 M sodium chloride 
gradient in the same buffer. Fractions were pooled and concentrated prior to use in 
crystallization trials. 
3.5.5 Crystallization, data collection and data processing of fib2(245-433)  
Four commercially available kits were tested and only one condition consisting of 0.2 M 
di-ammonium tartrate and 20% w/v PEG 3500 could yield crystals. Crystals were harvested 
after gradually increasing the PEG 3500 concentration to 35% in order to prevent freezing. 
X-ray diffraction data was collected on Proxima-1 beamline of the Soleil synchrotron, Paris, 
France using a Pilatus 6M (Dectris) detector.  
Automatic data processing was performed with XIA2 pipeline, which incorporates XDS 
(Kabsch, 2010) and AIMLESS (Evans and Murshudov, 2013). 
3.6 Murine adenovirus-2 (MAdV-2) fibre protein  
3.6.1 Construction of expression vector  
Three expression constructs were made in pET28a(+) vector by Márton Vidovszky of the 
group of Dr. Balázs Harrach at the Institute for Veterinary Medical Research, Centre for 
Agricultural Research, Hungarian Academy of Sciences, Budapest, Hungary. Constructs 
design was based on secondary structure prediction (PSIPRED server at 
http://bioinf.cs.ucl.ac.uk/psipred/); one full length (1-787 residues) and two N-terminal 
truncated versions (517-787 and 586-787 residues) were prepared. All inserts were cloned 
between EcoRI and HindIII cloning sites. Residues 586-787 were presumed to compose the 
fibre head domain. Details of construct and respective encoded proteins are provided in Table 
7. 
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Table 7: Expression constructs and respective proteins of MAdV-2 fibre. 
3.6.2 Expression and purification of fib(517-787) and fib(586-787) 
The MAdV-2 fib(517-787) fibre protein fragment was expressed in BL21(DE3) cells. Ni-
NTA purification was performed to separate out the target protein from the supernatant. 
Presence of target protein in different fractions was determined by SDS-PAGE analysis. 
Fractions containing protein were pooled together to be dialysed against buffer containing 10 
mM Tris-HCl pH 8.5 using dialysis tubing of 10 kDa MW cutoff prior to anion exchange 
chromatography. Post anion exchange chromatography purification, during which the protein 
was eluted using a linear gradient of 0–1 M sodium chloride, fractions containing pure 
protein were pooled together, washed and concentrated using Amicon Ultra concentrators in 
buffer consisting of 10 mM Tris-HCl pH 8.5. The MAdV-2 fibre protein fragment fib(586-
787) was also purified in a similar manner using the same buffers. Both proteins were stored 
temporarily at 4 ºC prior to further utilization. 
3.6.3 Crystallization, data collection and data processing of MAdV-2 fibre protein 
constructs 
For crystallizing the fib(586-787) protein, around 350 conditions were tested at 21 ºC, in 
manual as well as in robotic setup, to obtain initial hits. Drop volume was kept 1 µl (0.5 µl 
protein + 0.5 µl reservoir solution) or 2 µl (1 µl protein + 1 µl reservoir solution). 
Optimization of initial hits resulted in plate like crystals, which appeared in a condition 
containing 5M ammonium formate and HEPES-NaOH pH 7.5. Crystals from this condition 
were mounted and vitrified directly. Two more conditions consisting of 0.1 M magnesium 
chloride, 0.1 M HEPES-NaOH pH 7.5 and 10 % w/v PEG 4000 and 0.15 M ammonium 
sulphate, 0.1 M HEPES-NaOH pH 7.0, 20 % w/v PEG 4000 also yielded crystals. These 
crystals were first transferred to a solution containing the same components as the reservoir 
solution plus 20% (v/v) glycerol and soaked for 30 s prior to mounting and vitrification.  
For heavy atom derivatisation, methyl mercury chloride (CH3HgCl) solution was added to 
the reservoir in a final concentration of 5 mM and left overnight to equilibrate the osmotic 
Construct Encoded protein 
pET28a(+)-MAdV2_fib1 fib(1-787) 
pET28a(+)-MAdV2_fib517 fib(517-787) 
pET28a(+)-MAdV2_fib586 fib(586-787) 
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balance of the chamber. 2 µl reservoir solution was then added to the drop and crystals were 
soaked between 30 s to 1 min. 
X-ray diffraction data sets were collected at 100 K on BL13-XALOC beamline at ALBA 
synchrotron, Barcelona, Spain using a Pilatus 6M (Dectris) detector. The AUTOSHARP 
version 3.10.2 pipeline (Vonrhein et al., 2007) was used to determine the structure from a 
single mercury derivative data set employing single-wavelength anomalous dispersion. Due 
to presence of non-crystallographic symmetry, reflections for calculating the free R-factor 
were selected in thin shells and the same reflections were selected for the free and working 
R-factor for refining the derivative and native models.  
3.6.4 Expression and purification of the human coxsackievirus and adenovirus receptor 
(hCAR) 
Expression of the D1 domain of the human coxsackievirus and adenovirus receptor 
(hCAR) was mostly based on a method described previuosly previously (van Raaij et al., 
2000). A pAB3 expression vector containing the hCAR-D1 domain (residues 18-140) coding 
segment and a C-terminal 6xHis tag was used to tranform XL-10 gold cells. The cells were 
then allowed to grow aerobically at 25 ºC in two 700 ml cultures until the O.D. of 0.6-0.8 
measured at 600 nm was attained, thereafter induced with 0.2 mM IPTG and left for further 
16 hours with shaking incubation at the same temperature. Cells were harvested by 
centrifugation at 5000 x g for 15 min and resuspended in lysis buffer consisting of 20 mM 
Tris–HCl pH 8.0, 300 mM sodium chloride, 10 mM imidazole, 5% (v/v) glycerol and a 
Complete protease inhibitor cocktail tablet, EDTA free (Roche, Indianapolis, USA). Lysis 
was carried out in a French press (three passes) and the cell debris was removed by 
centrifugation at 20000 x g for 45 min resulting in a clear supernatant. The supernatant was 
incubated with 1 ml Ni–NTA resin (Jena Bioscience GmbH, Jena, Germany) at room 
temperature for 1 h and then loaded onto an empty column, followed by washing twice with 
10 column volumes of buffer containing 20 mM Tris–HCl pH 8.0, 300 mM sodium chloride, 
20 mM imidazole, 5% (v/v) glycerol. Step-gradient elution of the bound protein was 
performed using imidazole (50, 100, 200, 300, 400 and 1000 mM) in the same buffer. Elution 
fractions were checked by SDS-PAGE and pooled together. Dialysis against buffer consisting 
of 10 mM Tris-HCl pH 8.5 was performed using 10 kDa MW cutoff dialysis tubing to 
remove imidazole and sodium chloride followed by anion exchange chromatography using a 
Resource Q column in which the protein was eluted with a linear gradient of 0-1 M sodium 
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chloride. Pure protein-containing fractions were pooled together, washed and concentrated 
using Amicon Ultra concentrators in 10 mM Tris-HCl pH 8.0. 
3.6.5 Affinity assay with MAdV-2 fibre head 
A gel filtration assay was performed to analyze binding of hCAR to the MAdV-2 fibre 
head. Both proteins (in 10 mM Tris-HCl pH 8.0, 150 mM sodium chloride) were mixed in a 
trimer to monomer molar ratio of 1:3 and incubated for 30 mins at 4 ºC. A 25 ml Superdex 
200 GL gel filtration column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was 
prepared with buffer containing 10 mM Tris-HCl pH 8.0 and 150 mM NaCl and the mix was 
loaded onto it. Elution was performed with 1 column volume of the same buffer as used for 
column equilibration and peaks were analysed by SDS-PAGE to detect presence of proteins. 
3.7 Snake adenovirus-1 (SnAdV-1) LH3 protein 
3.7.1 Construction of the expression vector 
Coding sequence for 373 amino acid residues long LH3 protein was amplified with a set 
of primers (ForBamHI-LH3: 5´-gggggatccatgacttctgttgaagat-3´ and RevNotI-LH3: 5´-
attatagcggccgctcatgcggcgggctg-3´) adding a forward BamHI and reverse NotI restriction sites 
to the insert by a 3 step PCR reaction using genomic DNA of SnAdV-1 as a template (kindly 
provided by Dr. Carmen San Martin, CNB-CSIC, Madrid, Spain). The insert was cloned in 
pET28a(+) previously digested with same set of restriction enzymes. The protein was 
expressed with an N-terminal 6XHis tag. Insert sequence was confirmed by DNA sequencing 
(Secugen SL, Madrid, Spain) and recombinant vector was named pET28a(+)-LH3.  
3.7.2 Protein expression and purification  
Four 700 ml cultures in LB medium were inoculated with a starter culture of pET28a(+)-
LH3 transformed JM109(DE3) cells. Cells were grown, harvested and lysed as previously 
described. Target protein was purified from the collected supernatant by Ni-NTA 
chromarography and fractions containing the target protein were collected and dialysed 
against buffer consisting of 10 mM Tris-HCl pH 8.5 using 10 kDa dialysis tubing. This is 
followed by anion exchange chromatography using a Resource Q column. After this step, 
protein was washed and concentrated using Amicon Ultra concentrators in 10 mM Tris-HCl 
pH 8.5 and stored temporarily at 4 ºC prior to crystallization trials. 
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3.7.3 Limited proteolysis with alpha-chymotrypsin 
Limited proteolysis experiments on LH3 protein were carried out in order to identify a 
stable domain and also to facilitate crystallization of the protein. Protein samples (2 mg/ml) 
were incubated at 37 ºC, 55 ºC and 65 ºC for 20 min followed by cooling down to 37 ºC. 
Alpha-chymotrypsin solution (Sigma-Aldrich, St Louis, Missouri, USA) was prepared in 1 
mM HCl and 2 mM CaCl2 at 1 mg/ml concentration and added to the samples in a protease to 
protein ratio of 1:2 and incubated at 37 ºC for 20 min. The reaction was stopped by addition 
of protein gel loading buffer consisting of SDS and Complete protease inhibitor cocktail 
tablet (Roche, Indianapolis, USA). The results were analyzed by SDS-PAGE gel after which 
the sample was loaded onto a Resource Q column for separation of proteolysed products. 
For in-situ proteolysis the previously described method of Dong et al. was adopted (Dong 
et al., 2007). Alpha-chymotrypsin solution was added to the purified protein on ice 
immediately prior to crystallization trials in a protease to protein ratio of 1:100. 
Crystallization was performed in sitting drops at 21ºC, adding 0.5 µl of the protease/protein 
mixture to 0.5 µl of the precipitant solution. 
3.7.4 Western blot analysis 
The proteolysed protein sample was separated through anion exchange chromatography 
and 5 µg of the prominent peak fraction was transferred to a nitro-cellulose membrane using 
wet blotting system (Bio-Rad, Hercules, CA, USA). Membrane blocking was done by 
incubation with PBS solution containing 5% (w/v) non-fat milk and 0.05% TWEEN 20 for 1 
h at room temperature followed by three wash with PBS containing 0.05% TWEEN 20. The 
protein was detected using Anti-polyHistidine-Peroxidase conjugate antibody (1:2000; 
Sigma-Aldrich, St Louis, Missouri, USA) in a solution containing PBS, 5% (w/v) non-fat 
milk and 0.05% TWEEN 20 for 1 h at room temperature. Followed by washing, the 
membrane was developed using Amersham ECL prime western blotting detection reagent 
(GE Healthcare Bio-Sciences AB, Uppsala, Sweden) following the instructions of the 
supplier.  
3.7.5 Electron microscopy 
Negative staining EM was performed using a JEOL JEM 1230 microscope at 100 KV. 
The sample was prepared in several dilutions and adsorbed on glow discharged carbon coated 
grids for 5 minutes. Excess fluid was removed by touching on the edge of the grid with a 
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piece of Whatman paper, without allowing it to become completely dry. The grids were then 
incubated the staining agent, 2% uranyl acetate, for 45 sec. After staining, the grids were 
blotted and air-dried on a filter paper in a Petri dish. 
3.7.6 Surface methylation 
Surface methylation was tried as a rescue approach to crystallize LH3 protein. The 
protocol described by Walter et al., which targets surface exposed lysine residues, was 
adopted (Walter et al., 2006).  
3.7.7 Crystallization, data collection and data processing of LH3 protein  
Crystallization trials were performed by sitting drop vapor diffusion technique at 4 and 
21 ºC, manually as well as with robotic setup. Obtained crystals were also soaked in original 
reservoir solution supplemented with methyl mercury chloride (CH3HgCl) in order to obtain 
heavy atom derivatised crystals for structure solution. 
For data collection, crystals were transferred to wells containing same mother liquid plus 
20% glycerol. Data was collected on BM30A beamline at the European Synchrotron 
Radiation Facility (ESRF, Grenoble, France) using an ADSC Q315r CCD detector and on 
BL13-XALOC beamline at ALBA synchrotron light source, Barcelona, Spain using a Pilatus 
6M (Dectris) detector.  
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4. Results and Discussion 
4.1 Structure of the C-terminal fibre head domain of snake adenovirus 1 
Atadenoviruses have a characteristic gene organization and capsid morphology (Pantelic 
et al., 2008). Snake adenovirus type 1 (SnAdV-1) contains a single fibre gene that codes for a 
345 residue protein. The high-resolution crystal structure of the 107 residues long SnAdV-1 
fibre head domain was determined by the multi-wavelength anomalous dispersion (MAD) 
method. Crystals of four different types were obtained, of which the best diffracted to a 
maximum resolution of 1.4 Å. This is the first Atadenovirus for which the structure of the 
fibre head has been determined. Despite the absence of significant sequence homology, this 
snake atadenovirus fibre head has the same beta-sandwich propeller topology as other 
adenovirus fibre heads. However, it is about half the size, mainly due to much shorter loops 
connecting the beta-strands. Glycan microarray profiling showed that the fibre head might 
bind sialyllactose, which was further confirmed by STD-NMR and ITC, although the binding 
affinity was low. 
4.1.1 Purification and crystallization 
4.1.1.1 Construction of expression vectors 
Based on primary sequence and structure prediction analysis of the SnAdV-1 fibre protein, 
six constructs starting at residues 1, 82, 171, 234, 293 and 343 were designed and cloned into 
the pET28c(+) expression vector. The constructs were designed to express the target protein 
with an amino-terminal six-histidine purification tag. DNA sequencing of the generated 
constructs revealed a frame-shift mutation in the fibre gene that created a stop codon just 
after residue 345. This finding was consistent with the mass spectroscopy data performed on 
whole virus (Singh et al., 2013b) and hence the products of the last two expression constructs 
were not detectable by denaturating gel electrophoresis due to their size (Figure 9). Using a 
one-step site-directed mutagenesis protocol, a double mutant of putative fibre head fragment 
234 was generated, in which two leucine residues (323 and 325) were replaced by methionine 
to facilitate structure solution (Singh et al., 2013b). 
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Figure 9: Mass spectrometric analysis of SnAdV1 fibre protein in purified virions. Peptides 
identified by Mascot in the database sequence (coverage 28%; top) and in the newly determined 
sequence (coverage 38%; bottom) are shaded grey; the C-terminal peptide identified that is specific to 
the new sequence is also underlined. 
4.1.1.2 Protein purification and crystallization 
A two-step purification strategy was adopted to purify the expressed target proteins as 
described in Materials and Methods. Fragments starting at residues 1 and 82 tend to 
aggregate in solution, probably due to the presence of a flexible shaft region, whereas protein 
expression was undetectable in case of fragments 293 and 343. Sufficient amounts of well-
behaving protein could only be obtained for constructs containing residues 171-345 and 234-
345, from which fragment 234 was presumed to be the fibre head domain. In strong anion-
exchange chromatography, the proteins eluted between 0.2 and 0.4 M sodium chloride in two 
separate peaks (Figure 10). Usually, the first peak was more prominent and was used for 
crystallization, but in one case crystals were also obtained from the second peak (native form 
1, isomorphous crystals obtained from both peaks, pooled independently). This was observed 
for C-terminal domains for other adenovirus fibres (van Raaij et al., 1999a), but it is not clear 
to us how the protein differs between the peaks, although charge must somehow be involved. 
The electrophoretic behaviour under denaturing conditions (observed size of around 16 kDa; 
Figure 11A) is consistent with the tagged protein construct starting at amino acid 234 and 
ending at residue 345 (expected monomer size of 15 kDa), but not including 70 extra residues 
as would have been expected from the database sequence (expected monomer size of 24 
kDa). The protein construct starting at amino acid 171 has an observed monomer size of 
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around 26 kDa (Figure 11B), where 22 kDa would have been expected if it ends at residue 
345 or 31 kDa if it ends at residue 415. While for the 234-345 construct pure protein could be 
obtained, the 171-345 construct contained some impurities as evident from the SDS-PAGE 
gel (Figure 11B). For both constructs, the protein remains trimeric unless heated to at least 95 
ºC for a few minutes before SDS–PAGE. Note the trimer band of the 171-345 construct 
entered only a few millimeters into the gel, possibly because of the protein being in a slowly 
migrating ‘hydra’ form, owing to unfolding of the shaft part in SDS, as previously observed 
for the human adenovirus type 2 fibre protein (Mitraki et al., 1999).  
Figure 10: Anion exchange chromatography profiles for the SnAdV-1 construct 171 (top) and 
SnAdV-1 construct 234 (bottom). In green the sodium chloride concentration gradient is indicated. 
Yields of the 234-345 construct were typically around 5 mg of purified and concentrated 
protein per litre of bacterial culture, while for the 171-345 construct around 6 mg per litre of 
bacterial culture could be obtained, of which around half was lost upon concentration, 
indicating that the protein has a tendency to aggregate. 
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Figure 11: Denaturing gel electrophoresis of purified snake adenovirus 1 fibre protein constructs. 
Lanes are marked M (molecular weight markers, with the size indicated in kDa), U (unheated sample) 
and B (sample heated to 368-373 K for at least 5 min). (A) Purified 234-345 construct protein. (B) 
Purified 171-345 construct protein. 
Initial crystallization trials for the native 171-345 and 234-345 protein fragments were 
performed using sitting-drop vapour diffusion as described in Materials and Methods. Several 
hundred conditions were tried, of which five conditions produced crystals (Table 8). A 
solution consisting of 1.7 M ammonium sulfate, 0.085 M HEPES sodium salt pH 7.5, 1.7% 
(v/v) polyethylene glycol (PEG) 400, 15% (v/v) glycerol, was further selected for 
optimization in sitting-drop vapour-diffusion crystallization experiments. Crystals of 
fragment 171–345 of the fibre protein were obtained after about 1 year in 1.5 M ammonium 
sulfate, 0.075 M Tris–HCl pH 8.5, 25% (v/v) glycerol at 21 ºC. Selenomethionine-derivatised 
crystals of fragment 234 were also obtained in the same optimization screen around condition 
consisting of 1.7 M ammonium sulfate, 0.085 M HEPES sodium salt pH 7.5, 1.7% (v/v) 
polyethylene glycol (PEG) 400, 15% (v/v) glycerol after about 30 days. Obtained crystals are 
shown in Figure 12 while statistics of the data collected from native and derivative crystals 
are given in Table 9 and 10 respectively.  
A B 
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Table 8: Crystal producing conditions for SnAdV-1 fibre constructs 171-345 and 234-345 
Figure 12: Crystals of snake adenovirus 1 fibre protein constructs. (a) Native crystal form1 (construct 
234-345). (b) Native crystal form2 (construct 234-345). (c) Native crystal form3 (construct 234-345). 
One of the crystals has grown from or around a fibre unintentionally present in the drop. (d) Native 
crystal form 4 (construct 171-345). (e) Selenomethionine-derivatised crystal of form 3 (construct 234-
345). The bars represent 0.5 mm. 
Condition Composition 
1 0.2 M sodium citrate, 0.1 M HEPES-NaOH (pH 7.5), 30% (v/v) 2-Methyl-2, 4-pentanediol  
2 0.17 M lithium-sulphate, 0.085 M Tris-HCl (pH 8.5), 25.5% (w/v) PEG 4000, 15% (v/v) glycerol  
3 1.26 M sodium citrate, 0.09 M HEPES-NaOH (pH 7.5), 10% (v/v) glycerol  
4 1.7 M ammonium sulphate, 0.085 M HEPES-NaOH (pH 7.5), 1.7% (v/v) PEG 400, 15% glycerol  
5 
1.6 M ammonium sulphate, 0.08 M sodium acetate (pH 4.6), 20% (v/v) 
glycerol  
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Table 9: Crystallographic data measured from native crystals 
Data collection Native 1 Native 2 Native 3 Native 4 
Construct 
(residues) 
234-345 234-345 234-345 171-345 
Synchrotron, 
beamline 
ESRF, ID14-4a ESRF, ID29b ESRF, ID14-1 DLS, I02 
Detector ADSC Q315r Pilatus 6M ADSC Q210 Pilatus 6M 
Distance (mm) 386 344 141 271 
Wavelength (Å) 0.9393 0.9999 0.9334 0.9797 
Number of images 117, 282c 3600 100 400 
Oscillation range 
(º) 
1.5, 0.4 0.1 0.5 0.15 
Space group P212121 P212121 I23 or I213 F23 
Cell edges (Å, a, b, 
c) 
79.6, 122.3, 
133.7 
96.8, 96.8, 
153.3 
149.6, 149.6, 
149.6 
121.5, 121.5, 
121.5 
Resolution range 
(Å) 
30.0-2.70 
(2.85-2.70) 
70.0-1.90 
(2.00-1.90) 
20.0-1.70 
(1.79-1.70) 
43.0-1.35 
(1.38-1.35) 
Reflections 36484 (5266) 113650 
(16374) 
60984 (8834) 33985 (2424) 
Multiplicity 9.3 (9.0) 11.9 (12.1) 6.2 (6.2) 5.8 (2.4) 
Completeness (%) 99.7 (99.8) 99.9 (99.9) 99.9 (100.0) 99.5 (95.3) 
Mean <I/s(I)> 10.1 (2.8) 19.6 (6.5) 17.3 (4.2) 18.5 (2.2) 
Rsym (%)d 16.7 (87.9) 7.2 (39.0) 6.5 (40.0) 4.8 (37.3) 
CC Imean  0.993 (0.794) 0.999 (0.953) 0.999 (0.896) 0.998 (0.732) 
CC anom -0.206 (0.021) -0.254 (-
0.046) 
-0.067 (0.010) 0.053 (0.046) 
Wilson B (Å2) 55.1 25.1 16.5 15.6 
Values in parentheses are for the highest resolution bin. 
aMcCarthy et al., 2009. 
bde Sanctis et al., 2012. 
cData was collected in two different runs 
dRsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection and <Ih> is 
the mean observed intensity for that reflection. 
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4.1.2 Structure determination of the SnAdV-1 fibre head domain 
The structure of the SnAdV-1 fibre head domain was determined up to 1.6 Å resolution by 
multi-wavelength anomalous dispersion, using data collected from a selenomethionine 
derivative crystal. Four monomers were present in the asymmetric unit, three (chains A, B 
and C) forming the biological trimer and the other (chain D) forming a trimer with two 
crystallographically equivalent monomers in the crystal (space group I213 has three-fold 
crystallographic symmetry axes). A total of eight selenium sites (2 per monomer) were 
expected and all of them were successfully found by SHELX (Sheldrick, 2008). After 
phase-refinement with SHARP, the overall phasing statistics were excellent, with the most 
significant contributor to phase information being the dataset collected at the high-energy 
remote wavelength (overall phasing power of 2.665). Phasing statistics were very good 
(Table 11). Amino acids from the N-terminal T7 and 6xHis tags could not be modelled in the 
structure due to lack of density, as was also the case for residues 234-236 of each of the 
chains and residue Lys345 of chains A, B and C. Using NCS-restraints, the structures of both 
the seleno-methionine variant and native protein could be refined to low R-values at 1.6 and 
1.7 Å resolution, respectively, with good geometry and Ramachandran statistics (Table 11). 
The head domain, with its eight-stranded beta-sandwich, starts at residue 238. 
The structures of P212121 crystal forms were solved by molecular replacement using a 
trimer of the determined structure as a template and refined using NCS-restraints at 2.7 and 
1.9 Å resolution, respectively. The two different crystal forms belonging to the orthorhombic 
space group P212121 both had four complete trimers in the asymmetric unit. The purified 171-
345 construct protein crystallized in space group F23 after a period of about one year. After 
structure solution by molecular replacement and refinement of coordinates and individual 
atom anisotropic temperature factors at 1.33 Å resolution, it was noted that density for 
residues 171-231 was absent, indicating a possible proteolysis event during crystallization. 
The asymmetric unit of the crystals contains one monomer of the SnAdV1 fibre head, with 
all the residues of the fibre head (Pro232 to Lys345) being well-resolved. Refinement 
statistics for all models are given in table 11. 
When the structures of the fibre head monomer of the different crystal forms are 
superimposed, no significant differences in main chain conformations were observed. The 
r.m.s.d. between the structures is less than 0.38 Å and even the loop regions superimpose 
very well, suggesting little flexibility. When trimers are superimposed, the r.m.s.d. is less 
than 0.5 Å, suggesting the orientation of the monomers in the trimer is also fixed. Given the 
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structural similarity between the crystal forms, the description below is based on the highest-
resolution structure obtained, but is general to all. 
Table 10: Crystallographic data measured from a selenomethionine derivative crystal  
Data collection  
Construct (residues) 234-345 
Synchrotron, beamline ESRF, ID14-4a 
Detector ADSC Q315r 
Space group I23 or I213 
 Inflection point Peak Remote 
Wavelength (Å) 0.9793 0.9791 0.9768 
Distance (mm) 279 279 211 
Number of images 200 200 200 
Oscillation range (º) 0.5 0.5 0.5 
Cell edge (Å, a=b=c)b 149.50 149.45 149.54 
Resolution range (Å) 30.0-1.90 (2.00-1.90) 30.0-1.90 (2.00-1.90) 30.0-1.60 (1.69-1.60) 
Reflections 43740 (6346) 43706 (6352) 72960 (10590) 
Multiplicity 12.2 (11.7) 12.2 (11.7) 12.2 (12.2) 
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0) 
Mean <I/s(I)> 17.5 (8.9) 16.2 (8.5) 18.2 (6.2) 
Rsym (%)d 10.4 (25.4) 11.3 (25.9) 8.8 (40.2) 
CC Imean 0.998 (0.981) 0.998 (0.981) 0.999 (0.957) 
CC anom 0.500 (0.227) 0.646 (0.403) 0.498 (0.127) 
Wilson B (Å2) 14.9 14.7 13.9 
Values in parentheses are for the highest resolution bin. 
aMcCarthy et al., 2009. 
bAlthough the three datasets were collected from the same crystal, cell parameters were refined 
independently for all three datasets. 
dRsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection 
and <Ih> is the mean observed intensity for that reflection. 
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Table 11: Crystallographic structure solution and refinement (1 Å = 0.1 nm) 
Phasing      
 Remote Peak Inflection point Overall  
Wavelength 0.9768 0.9791 0.9793   
Resolution range used 
(Å) 
29.3-1.6 29.3-1.9 29.3-1.9   
Reflections 
(acentric/centric) 
69500 / 2391 41317 / 2402 41283 / 2374   
Heavy atom sites    8 Se  
Correlation coefficient 
(all/weak) 
   60.91 / 52.64  
Patterson figure of merit    16.56  
Correlation coefficient 
(E) 
   0.560  
R-cullis isomorphous 
(acentric/centric) 
0.646 / 0.616 0.686 / 0.665 - / -   
R-cullis anomalous 
(acentric) 
0.641 0.455 0.518   
Phasing power 
isomorphous 
(acentric/centric) 
1.378 / 0.886 0.864 / 0.466 - / -   
Phasing power 
anomalous (acentric) 
1.899 2.665 2.356   
FOM* (acentric/centric)    0.554 / 0.357  
      
Solvent flattening#       
R-factor (before/after)    0.3720 / 0.1560  
Correlation on |E|2 
(before/after) 
   0.5492 / 0.9063  
Correlation on |E|2 / 
contrast (original / 
inverted) 
   0.1248 / 1.2247  
      
Refinement      
 Selenomethionine Native 1 Native 2 Native 3 Native 4 
Space group I213 P212121 P212121 I213 F23 
Cell parameters (a, b, c, 
Å) 
149.5, 149.5, 
149.5 
79.6, 122.3, 
133.7 
96.8, 96.8, 
153.3 
149.6, 149.6, 
149.6 
121.5, 121.5, 
121.5 
Monomers / asymmetric 
unit 
4 12  12  4 1 
Resolution (Å) 29.3-1.6  
(1.70-1.60)† 
29.9-2.7  
(2.86-2.70) 
29.7-1.9 
(2.03-1.90) 
29.3-1.7  
(1.80-1.70) 
43.0-1.33  
(1.37-1.33) 
Reflections used 70937 (11269) 32882 (5194) 111478 (19922) 59326 (9523) 32152 (2285) 
Reflections used for Rfree 1975 (362) 2057 (329) 2003 (278) 1604 (233) 1832 (138) 
R-factor& 0.158 (0.190) 0.212 (0.316) 0.173 (0.212) 0.167 (0.226) 0.117 (0.210) 
R-free 0.189 (0.192) 0.247 (0.340) 0.239 (0.250) 0.201 (0.239) 0.138 (0.225) 
Number of atoms 3927 9799 10974 4006 1019 
Average B / Wilson B 
(Å2) 
18.4 / 13.9 49.5 / 55.1 32.1 / 25.1 19.1 / 16.5 22.1 / 15.6 
Ramachandran statistics 
(%) 
98.9/100.0 96.7/99.9 98.5/100.0 98.8/100.0 100.0/100.0 
r.m.s.d. bonds (Å)/angles 
(°) 
0.012/1.5 0.016/1.3 0.014/1.4 0.013/1.5 0.013 / 1.6 
PDB code 4D0U 4D1F 4D1G 4D0V 4UMI 
*Figure of merit = cos(phase error) 
#41.5% solvent content 
† Values in parentheses are for the highest resolution bin (where applicable). 
& Rsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection and <Ih> is 
the mean observed intensity for that reflection. 
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4.1.3  Structure of the SnAdV-1 fibre head 
The structure of 107-residue SnAdV-1 fibre head revealed a compact head domain (Figure 
13C). Despite the low sequence identity with other fibre heads, the topology of the beta-
sandwich is identical to that of known adenovirus fibre head structures and contains ABCJ 
and GHID beta-sheets (Figure 13B; the E- and F-strands in the long DG-loop of human 
adenoviruses 5 and 2 are absent (Xia et al., 1994; van Raaij et al., 1999a). However, it is 
significantly smaller. In the trimeric assembly, the ABCH-sheet is partially buried, facing the 
inner side, while the GHID-sheet is solvent exposed. Given their locations, the former 
contributes the majority of inter-monomeric contacts whereas latter facilitates intra-
monomeric interactions. The strands of the buried sheet are longer in comparison to that of 
the exposed sheet, as reflected by their average length of 10 residues per strand, vs 6 for the 
strands of the exposed sheet.  
Figure 13: Structure of the snake adenovirus fibre head. (A) Monomer structure. The beta-strands are 
labeled. (B) Topology. The ABCJ and GHID beta-sheets are coloured yellow, the alpha-helix in the 
DG-loop is shown in red. The termini are labelled. (C) Trimer structure, side view, with the three 
monomers colored differently. (D) Trimer structure, top view. 
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The beta-strands in the structure are connected by loops or by beta-turns. Seven such 
connections exist; three loops of variable size (CD, DG and IJ) and four beta-turns of 2 
residues each (AB, BC, GH and HI). Due to prominence of these tight beta-turns, the overall 
trimeric assembly is very compact, with a diameter of 4.6 nm and a height of 3.8 nm 
(compared to a diameter of 6.2 nm and a height of 4.0 nm for the HAdV-5 fibre head; Xia et 
al. (1994)). The CD- and IJ-loops contain 7 residues each, while the DG-loop is composed of 
16 amino acid residues. Two small beta-strands, E and F, can be observed on DG-loop in the 
case of HAdV5 (Xia et al., 1994). Here, the-DG loop does not contain these strands, but a 
prominent alpha-helix (Figure 13A). 
4.1.4 Structural homologues of SnAdV-1 fibre head 
As mentioned, the fibre head of SnAdV-1 has little sequence homology with other 
adenovirus fibre heads (between 12 and 18% sequence identity). However, analogous 
proteins from other adenoviruses as well as from bacteriophages were identified to share the 
same beta-sandwich topology. A structural homology search showed receptor binding protein 
of bacteriophages TP901-1 (PDB code: 2F0C; Z-score=7.5; Figure 14A) and P2 (PDB code: 
2BSE; Z-score=7.3) as the closest match with Z-values of more than 7. According to Holm et 
al. (Holm and Rosenstrom, 2010), significant similarities have a Z-score above 2 and they 
usually correspond to similar folds. Strong matches have a Z-score above n/10 − 4, where n is 
the number of residues in the query structure, giving a Z-value of around 6 in this particular 
case. Further hits included the avian reovirus attachment protein sigma C (PDB code: 2BT7; 
Z-score=5.8; Figure 14B), human adenovirus 19p fibre head domain (HAdV-19p; PDB code: 
1UXB; Z-score=5.3) and human adenovirus 37 fibre head domain (HAdV-37; PDB code: 
1UXA; Z-score=5.2; Figure 14C) in descending order of similarity. 
The 99- and 98-residue C-terminal receptor binding domains of TP901-1 and P2 
bacteriophages are beta-barrels made up of six anti-parallel beta-strands in case of the former 
and seven in case of the latter. Their compact structures are pretty comparable in dimensions 
and show little structural deviations when superposed onto SnAdV-1 fibre head (Figure 14A). 
A putative binding site in TP901-1 receptor binding protein has been described (Spinelli et 
al., 2006b). Two of the constituting residues of this site are located on the 5th strand of the 
beta-barrel, which is structurally equivalent to the H strand of SnAdV-1 fibre head. Aligning 
these strands gives an r.m.s.d. value of 0.8 Å for 6 Cα atoms. All these viruses contain DNA 
as their genetic material and similarities observed in their host-receptor engaging proteins 
points towards a possible divergent evolution, although nothing can be said with certainity. 
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Figure 14: Structural comparison of SnAdV-1 fibre head with other viral receptor-binding proteins. 
Superposition of the SnAdV-1 fibre head monomer structure (green) onto the bacteriophage TP901-1 
receptor-binding protein monomer (A; PDB entry 2F0C; red), onto the avian reovirus fibre head 
domain monomer (B; PDB entry 2BT7; blue) and the HAdV-37 fibre head monomer (C; PDB entry 
2WBW; yellow). The SnAdV-1 fibre head monomer is in the same orientation as in Figure 13A. The 
top of the trimer is indicated with * and the side with #. 
Among adenoviruses, the fibre head domains of HAdV-19p and HAdV-37 have shown 
most resemblance to SnAdV-1 fibre head (Figure 14C). All of these structures have a similar 
beta-sandwich arrangement of two beta-sheets but, unlike SnAdV-1 fibre head, structures of 
the formers consists of longer loops connecting beta strands. In case of human adenoviruses, 
loops have been implicated in fibre-receptor interactions (Bewley et al., 1999; Persson et al., 
2010) and it can be speculated that a change in their length and orientation could lead to a 
differential binding pattern. Besides loop lengths, the average number of residues per strand 
is also higher in case of HAdV-19p and HAdV-37 fibre heads, which makes them taller (10 
against 8 in case of SnAdV-1). 
A structure based maximum likelihood phylogenetic tree constructed with previously 
identified homologues is shown in Figure 15. It clearly demonstrates the grouping of SnAdV-
1 fibre head together with sigma C as well its closeness with bacteriophage proteins than to 
the adenovirus fibre heads. 
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Figure 15: A structure based maximum likelihood phylogenetic tree constructed with structural 
homologues of SnAdV-1 fibre head. Bootstrapping employing 1000 replicates accessed correctness of 
the tree. Frequencies are indicated over the branch nodes. 
4.1.5 Trimer interface and stability 
The trimeric packing of the SnAdV-1 fibre head is highly stable and, as stated above, on a 
SDS gel monomeric units are only visible after heating the protein at 95 ºC. Each monomer 
has a total solvent accessible surface area of 5.9 x 103 Å2, out of which 1.4 x 103 Å2 (24%) 
gets buried upon trimer formation. Inter-monomeric contacts between assembled monomers 
are extensive, involving a total of 23 interfacing residues from each monomer. Eleven 
hydrogen bonds and ten salt bridges are contributed by each monomer in the assembly. The 
majority of these residues are located on strands B, C and J with some on interfacing loops. 
Due to this strong bonding at the trimeric core, the monomers are held tightly to each other. 
4.1.6  Receptor binding 
Surface exposed loops and charge distribution over the surface play crucial roles in 
adenovirus fibre-receptor interaction (Bewley et al., 1999; Persson et al., 2010). Where 
binding to receptors such as CAR and CD46 depends on the shape and orientation of loops, 
interaction with charged ligands takes place in a charge-dependent manner with less 
conformational dependency (Bewley et al., 1999; Arnberg et al., 2002; Persson et al., 2007). 
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As mentioned above, the loops of the SnAdV-1 fibre head are relatively short and less likely 
to exhibit high conformational flexibility.   
Positively charged patches are naturally inclined to bind negatively charged molecules 
such as sialic acid, which is a common terminally attached glycan found on cell surface 
proteins. The surface of the SnAdV-1 fibre head is mixed in its charge distribution; the top 
and bottom of the head domain harbour positive patches, while the sides have a mixed charge 
distribution (Figure 16). Its close structural resemblance to HAdV-19p and HAdV-37 fibre 
heads, where sialic acid binds to the top of the trimer in a charge dependent manner 
(Burmeister et al., 2004), tempted me to speculate a similar saccharidic affinity behaviour for 
SnAdV-1 fibre head protein. In order to identify such possible ligands neoglycoconjugate 
microarray (NGC) experiments were carried out by Dr. Michelle Kilcoyne from the group of 
Prof. Lokesh Joshi at the National University of Ireland, Galway.  
The result showed several glycans displaying interactions (Figure 17). Alpha-linked 
sialated sugars 2,3'- and 2,6'-sialyllactose, lacto-N-tetraose and xylose were found to be the 
most prominent ones (Figure 17). The sialated glycans and xylose were selected for further 
experiments. As both alpha-linked sialated sugars contain lactose moieties, it was probable 
that the signals were arising due to protein interacting with lactose and not with the sialic acid 
unit of the glycan. Experiments were repeated in presence of lactose and no binding 
inhibition was observed, verifying that the interactions were specific to the sialic acid unit. 
Figure 16: Qualitative electrostatic surface diagram of the SnAdV-1 fibre head. (A) Side view in the 
same orientation as Figure 13C. (B) Top view in the same orientation as Figure 13D. 
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These findings were followed up and solution experiments were performed to varify the 
results. STD-NMR (by Alvaro Berbís, CIB-CSIC, Madrid) and ITC (by Dr. Margarita 
Menéndez, IQFR-CSIC, Madrid) experiments performed with 2,3'- and 2,6'-sialyllactose 
confirmed the interaction, however, the affinity between the protein and the ligands was 
found to be very low. Co-crystallization and ligand soaking experiments did not yield ligand-
bound structures, perhaps due to low binding affinity and low predicted pI of the protein.  
The observed disagreement between glycan screening and solution based experiments can 
been seen in the light of inherent experimental differences between them. The way glycans 
are attached and presented on a microarray slide could significantly affects their interaction 
with proteins (Kilcoyne et al., 2012). Thus, its likely that one would get positive binding with 
relatively good strength in a glcyan array experiment, however, the same might not be 
obtainable to the same extent under more relaxed solution environment. I speculate that the 
same reason is behind these fluctuating results. Nevertheless, these observations could not 
completely rule out the possibilities of a glycan being the natural receptor for SnAdV-1 fibre 
head as the tested sugars were simpler in nature and that the virus might need a more 
complex partner for actual binding. Future research in this direction may give us some more 
clues. 
Figure 17: Glycan array of his-tagged SnAdV-1 fibre head construct 234-345. Histograms represent 
the average of three replicate experiments and error bars are one standard deviation. Each experiment 
is the median of 6 data points (6 features, 18 data points total). (See table AI in annex for details of 
neoglycoconjugtes and glycoproteins). 
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4.1.7 Conclusion 
The crystallographic structure of the fibre head domain of snake adenovirus 1 is described 
here. This is the first Atadenovirus for which the fibre head structure has been solved. The 
compact trimeric structure is pretty stable as evident by denaturing gel electrophoresis and 
has extensive non-covalent interactions among its monomeric units. From a dimension and 
length point of view, together with the LAdV-2 fibre 1 head, the structure is the smallest 
known adenovirus fibre head structure; however, it retains the same ABCJ-GHID beta-
sandwich topology. It’s interesting to observe that the structure is more similar to receptor 
binding proteins of bacteriophages than to other adenovirus fibre heads. Glycan array 
screening identified sialyl-lactose as a potential ligand. This suggests that the virus may 
utilize a cell surface glycan as its attachment receptor, however, perhaps more complex then 
the glycans screened here. 
An important application of adenoviruses is their use as vectors for human gene and 
cancer therapy and for vaccination purposes. Animal adenoviruses may be of special interest 
due to the lack of neutralizing antibodies in human sera against them. The detailed structure 
of the SnAdV-1 fibre head and other animal adenovirus fibre heads, together with the 
identification of their natural receptors, may lead to the development of new strategies to 
target adenovirus vectors to cells of interest. 
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4.2 Structure and sialyllactose binding of the carboxy-terminal head 
domain of the fibre from a Siadenovirus, turkey adenovirus 3. 
Turkey adenovirus 3 (TAdV-3), also known as turkey hemorrhagic enteritis virus 
(THEV), belongs to the Siadenovirus genus. The carboxy-terminal region of its fibre does not 
have significant sequence similarity to any other adenovirus fibre heads of known structure. 
The crystal structure of the trimeric fibre head domain was determined at 2.2 Å resolution. 
Each monomer contains a beta-sandwich, which, surprisingly, is more similar to the one in 
the reovirus fibre head than to other adenovirus fibres, although the ABCJ-GHID topology is 
conserved in all. A beta-hairpin insertion of the C-strand of each trimer subunit embraces its 
neighbouring monomer. The calculated electropositive surface charge of the trimer suggested 
that it may bind an acidic receptor, and glycan array experiments showed interaction with 
2,3'- and 2,6'-sialyllactose. Surface plasmon resonance assays, nuclear magnetic resonance 
(NMR) spectroscopy and isothermal titration calorimetry confirmed these interactions. Kd 
values calculated by ITC showed that virulent fibre head has a slightly lower affinity than 
avirulent for 2,3'-sialyllactose. I obtained co-crystal structures with 2,3'- and 2,6'-sialyllactose 
and the site of interaction on 2,3'- and 2,6'-sialyllactose was mapped by saturation transfer 
difference NMR spectroscopy. Isothermal titration calorimetry was performed with different 
site-directed mutants to confirm the interaction site on the fibre head. Two sequence 
differences between virulent and avirulent TAdV-3 map on the fibre head; where virulent 
TAdV-3 contains Ile354 and Thr376, avirulent TAdV-3 contains Met354 and Met376. 
Although receptor-binding properties of the avirulent fibre head domain are similar to those 
of the virulent fibre head, we obtained evidence for differences in biophysical properties, 
suggesting increased flexibility of the beta-hairpin for the virulent form.  
4.2.1 Purification and crystallization 
4.2.1.1 Construction of expression vectors  
Protein sequence analysis of the TAdV-3 fibre suggests that, like other adenovirus fibres, 
it contains a short, highly charged, penton base attachment sequence and a shaft domain 
containing putative triple beta-spiral repeats (Figure 18; van Raaij et al. (1999b)). The 
remaining carboxy-terminal sequence (amino acids 304–454) may form a head domain, 
although it shows only between 10 and 20% sequence identity when aligned with known 
adenovirus head domain structures. The highest sequence identity, 31 identical residues out 
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of 152, is with canine adenovirus 2 fibre head (Seiradake et al., 2006).  
Figure 18: Predicted domain organization of turkey adenovirus 3 (TAdV-3). (A) The amino-acid 
sequence in one-letter code. The predicted virus-binding tail (residues 1-45) is shown in italics, the 
shaft domain (46-303) in normal type and the expressed predicted head domain (304-454) in bold. 
Putative triple beta-spiral repeats in the shaft domain are indicated by underlining the mainly 
hydrophobic residues that may form the central hydrophobic core and peripheral hydrophobic patches 
(van Raaij et al., 1999b) and putting the turn amino acid (generally Gly or Pro) of each potential triple 
beta-spiral repeat in small type. (B) Schematic drawing of the fibre indicating the tail, shaft and head 
domains. 
At the protein level, the major differences found between the virulent and avirulent 
variants of the virus are two amino acid mutations in the fibre protein: Ile354 and Thr376 in 
the virulent form are replaced by methionines in the avirulent form (Beach et al., 2009a). 
Hence, in order to generate the virulent fibre head, a two-step site directed mutagenesis 
approach was adopted where aforementioned mutations were generated. 
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4.2.1.2 Protein purification and crystallization 
Expression vectors for native and mutant TAdV-3 fibre proteins were used to produce 
milligram amounts of soluble protein. Proteins were eluted from the nickel column at 
relatively high imidazole concentrations, consistent with them being stable trimers as 
expected; and thus containing three six-histidine tags per protein unit. In cation-exchange 
chromatography, the proteins (predicted pI 9.9) eluted in several peaks around 0.3–0.5 M 
sodium chloride when a linear gradient was used, each of which contained pure or nearly 
pure fibre head protein (Singh et al., 2013a).  
Figure 19: Purification of TAdV-3 avirulent fibre head. (A) Chromatogram of the final strong anion 
exchange purification step. Pure protein elutes in several peaks; protein from each peak was kept 
separate. Protein from the highest two peaks (E1 and E2) was used for crystallization trial. In green 
the sodium chloride concentration gradient is indicated. (B) Native PAGE-gel run for protein eluted in 
peaks E1 and E2 showing differential mobility. Gel is stained with silver stain. 
Figure 19A shows the cation-exchange chromatography profile for avirulent fibre head. 
Protein from the different peaks was kept separate and, after concentration, used for 
crystallization. In all cases, isomorphous crystals for protein from each of two major peaks 
were obtained in conditions containing diammonium phosphate as a precipitant, sodium 
chloride as an additive and sodium citrate at pH 5.5-5.8 as a buffer. It appears that the protein 
exists in several states differing in charge, but it is not clear to us what causes these 
differences. A native PAGE gel shows the differential mobility of proteins from two peaks 
(Figure 19B). It’s noteworthy that the same was observed for HAdV-2 fibre head expressed 
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in baculovirus-infected insect cells (van Raaij et al., 1999a). Both the fibre variants as well as 
the mutants showed almost identical elution profiles during purifications. 
A total of about 500 conditions were tried and crystals were obtained within a time period 
of four days in at least three of those conditions, all containing diammonium phosphate:  
1. 1.0 M diammonium phosphate, 0.1 M imidazole pH 8.0), 
2. 1.0 M diammonium phosphate, 0.1 M Tris pH 8.5) 
3. 1.0 M diammonium phosphate, 0.2 M sodium chloride, 0.1 M sodium citrate pH 5.5). 
Crystals for his-tagged avirulent and virulent fibre heads were obtained (Figure 20A). The 
crystals were cubic in shape and belonged to space group I23 (unit-cell parameter 99 Å). 
Complete and highly redundant X-ray diffraction data sets were collected from each of the 
native crystal and a avirulent fibre head crystal derivatised with selenomethionine, the latter 
using a wavelength at which the anomalous signal of the Se atoms was maximized (Table 13; 
Figure 20B). The data used extended to 2.0 Å and 2.3 Å in case of avirulent and virulent fibre 
native data sets respectively and 2.14 Å resolution for the derivative crystal. Merging R 
factors for shells higher than 2.4 Å resolution were quite high; however, the correlation 
between independent measurements of the same reflection and mean I/"(I) in the highest 
resolution bins are still significant (Table 12) 
Figure 20: Crystallization and diffraction analysis of TAdV-3 fibre head. (A) Crystals belonging to 
space group I23. The scale bar measures approximately 0.5 mm. (B) Diffraction pattern of TAdV-3 
fibre head crystals. The beam centre is indicated by a crosshair and resolution rings (in Å) are shown.  
Results	  and	  Discussion	  
77 
Table 12: Data quality as a function of resolution (For TAdV-3 fibre data sets) 
Native (avirulent)      
Resolution (Å) Reflections Rsym Mean <I/s(I)> CC-Imean CC-anom 
6.96 287 0.029 36.0 0.999 0.076 
4.92 490 0.044 36.4 0.999 0.341 
4.02 642 0.079 35.0 0.996 -0.236 
3.48 725 0.075 31.1 0.997 -0.021 
3.11 833 0.074 26.6 0.998 -0.015 
2.84 906 0.104 19.0 0.997 -0.006 
2.63 987 0.182 12.7 0.990 -0.080 
2.46 1067 0.313   8.1 0.974 -0.028 
2.32 1136 0.479   5.4 0.928 -0.029 
2.20 1183 0.694   3.8 0.856  0.019 
      
Native (virulent)      
Resolution (Å) Reflections Rsym Mean <I/s(I)> CC-Imean CC-anom 
7.27 256 0.029 35.0 0.999  0.160 
5.14 440 0.046 33.0 0.999 -0.241 
4.20 559 0.061 35.0 0.997 -0.081 
3.64 658 0.060 30.9 0.997 -0.267 
3.25 722 0.069 25.9 0.997 -0.082 
2.97 821 0.087 19.8 0.996 -0.205 
2.75 869 0.126 12.7 0.993 -0.136 
2.57 948 0.202 8.1 0.982 -0.059 
2.42 998 0.365 5.0 0.937 -0.015 
2.30 1053 0.534 3.6 0.903  0.081 
      
Selenomethionine      
Resolution Reflections Rsym Mean <I/s(I)> CC-Imean CC-anom 
6.96 287 0.049 59.3 1.000 0.916 
4.92 498 0.083 54.5 0.999 0.689 
4.02 634 0.093 59.3 0.999 0.430 
3.48 732 0.074 51.1 0.999 0.644 
3.11 844 0.083 44.0 0.999 0.748 
2.84 916 0.128 31.8 0.999 0.616 
2.63 999 0.206 21.8 0.997 0.537 
2.46 1066 0.350 14.1 0.993 0.314 
2.32 1121 0.538 9.6 0.985 0.131 
2.20 1201 0.814 6.5 0.960 0.080 
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4.2.2 Structure determination of the TAdV-3 fibre head domain 
Out of six selenium sites expected from the sequence, four were located by the automated 
phasing procedure, and refinement of these sites resulted in high-quality phases (see phasing 
statistics in Table 13). Solvent flattening resulted in an easily interpretable map in which 137 
amino acids were automatically traced. The asymmetric unit contains one protein monomer 
and the biologically relevant trimer is generated by the crystallographic three-fold symmetry 
axis. Manual completion resulted in a model consisting of 138 amino acid residues (317-
454), one phosphate and 47 water molecules. The model was also independently refined 
against native data collected from crystals of the avirulent form and virulent forms, and here 
manual adjustment resulted in a model containing the same 138 residues plus ordered solvent 
(Table 13). The phosphate ion mediates a crystal contact between Lys421 and Asn422 of one 
monomer and Arg368 and Lys439 of a monomer belonging to another trimer. No density was 
visible for residues N-terminal to 317 or for the purification tag. 
The final refined structures have good geometry and acceptable Ramachandran statistics 
(Table 13). The structures each contain one genuine cis-peptide bond, between Ser374 and 
Pro375. The head domain appears to start at around residue 317, rather than around 304 as 
we predicted. It is possible that the shaft domain ends around residue 303, and the head 
domain, starting at residue 317, is connected to the shaft domain by a short linker sequence, 
which also occurs in other virus fibres (for example HAdV-2; van Raaij et al. (1999a)). 
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Table 13: Crystallographic data measurement and refinement statistics for native and 
selenomethionine derivative TAdV-3 fibre head crystals 
 Avirulent native Selenomethionine Virulent native 
Data collection    
Synchrotron and beamline ESRF ID29 ESRF ID29 ALBA BL13-XALOC 
Wavelength (Å) 0.9768 0.9791 0.9795 
Crystal-detector distance (mm) 263.0 329.6 381 
Oscillation range (°) 1.0 1.0 0.5 
Number of images 100 360 180 
Space group I23 I23 I23 
Cell edge (Å, a=b=c) 98.57 98.75 98.96 
Mosaicity (°) 0.5-0.6 0.2 0.3-0.5 
Resolution range (Å) 30-2.2 (2.32-2.20)* 30-2.2 (2.32-2.20)* 31.3-2.3 (2.42-2.30)* 
Reflections 8256 (1183) 8297 (1201) 7327 (1053) 
Multiplicity 11.6 (12.0) 43.2 (43.1) 8.9 (9.2) 
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0) 
Mean <I/s(I)> 17.5 (3.8) 29.0 (6.5) 6.3 (1.4) 
Rsym (%)† 8.8 (69.4) 10.4 (81.4) 6.2 (53.4) 
VM (Å3Da-1)‡ 1.94 1.94 2.02 
Wilson B (Å2) 43.1 45.1 56.8 
Phasing    
Heavy atom sites  4 Se  
Correlation coefficient (all/weak)   55.47 / 33.95  
Patterson figure of merit  22.19  
Correlation coefficient (E)   0.500  
R-cullis** (anomalous, acentric)  0.574  
Phasing power** (anomalous differences)  2.066  
FOM = cos(phase error)** (acentric/centric)  0.4152 / 0.0728  
Solvent flattening (44.6% solvent content)    
R-factor (before/after)  0.4800 / 0.2760  
Overall corr. on |E|2 (before/after)  0.3057 / 0.7166  
Correlation on |E|2 / contrast (original/inverted)  0.4630 / 0.2240  
Refinement    
Resolution range (Å) 28.51-2.20 (2.3-2.2) 28.51-2.20 (2.3-2.2) 30.0-2.30 (2.4-2.3) 
Reflections used 7866 (1128) 7909 (1145) 6962 (984) 
Reflections used for Rfree 384 (55) 385 (56) 334 (40) 
R-factor 0.199 (0.251) 0.207 (0.254) 0.197 (0.245) 
R-free 0.242 (0.332) 0.252 (0.295) 0.239 (0.321) 
Protein/phosphate/water atoms  1092/5/57 1092/5/47 1091/10/40 
<B> overall/protein/ion/water (Å2) 42.0/41.7/83.8/43.7 42.1/41.9/74.9/43.3 64.7/65.4/59.3/52.8 
Ramachandran statistics(%) 97.1/99.3 96.3/99.3 94.1/99.3 
r.m.s.d. bonds (Å)/angles (°) 0.014/1.5 0.014/1.5 0.013/1.5 
PDB code 3ZPE 3ZPF 4CW8 
* Values in parentheses are for the highest resolution bin (where applicable). 
† Rsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection and <Ih> 
is the mean observed intensity for that reflection. 
‡ According to Matthews (1968) 
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4.2.3 Structure of the TAdV-3 fibre head 
The TAdV-3 fibre head is around 5 nm high and about 4.5 nm in diameter (Figure 21A). 
SnAdV-1 fibre head is 3.8 nm high and 4.6 nm in diameter while HAdV-5 fibre head is 
around 4 nm high and 6.2 nm in diameter. Thus, a higher height-to-diameter ratio of TAdV-3 
fibre head makes it appear more slender and cylindrical (Figure 21A). 
The topology of TAdV-3 fibre head is similar to that reported for other adenovirus fibre 
head structures (Xia et al., 1994), despite the low sequence homology (only 10-20% sequence 
identity when aligned with known adenovirus head domain structures).  
Figure 21: Structure of the TAdV-3 fibre head. Side view (A) and top view (B) of the fibre head 
trimer. Between panels A and B the structure has been turned approximately 90º towards the reader. 
Each monomer is colored differently. (C)  Side view of a monomer with the N-terminus, C-terminus 
and beta-strands labeled. (D) Topology diagram of the monomer labelled as in C, but with the start 
and end residue of each strand also indicated. In panels A and B Met354 and Met376 are shown in 
space-filled representation and labeled. 
Each monomer contains an eight-stranded beta-barrel (ABCJGHID), in which the C- and 
J-strands are kinked (Figure 21D). The C-strand is interrupted by a 27-residue stretch that 
forms a beta-hairpin "arm" contacting a neighbouring monomer (see below). The bottom 
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section of the C-strand was named C, the beta-strands of the arm C' and C'', and the top 
section of the C-strand C''' (Figure 21C). Similarly, the J-strand is divided into an upper part 
(J) and a lower part (J'). The upper part interacts both with the C'''-strand and the G-strand, 
while the lower part interacts with the C-strand. Beta-strands E and F present in the HAdV-5 
fibre head (Xia et al., 1994) are absent in the presented structure. The beta-strands in the fibre 
head are connected with predominantly short loops, in some cases simple beta-turns. The 
C'''D-loop contains a few residues (369-371) in 310-helical conformation. The long DG-loop 
runs along the bottom of the beta-sandwich and contains amino acid side chains that 
contribute significantly towards the hydrophobic core of the monomer. The insertion of a 
beta-hairpin in the C-strand contacting a neighbouring monomer is a unique feature of this 
structure.  
4.2.4 Structural differences between the avirulent and virulent fibre head structures 
TAdV-3 (also known as THEV) is found in virulent as well as in avirulent form. The 
virulent form is highly pathogenic, while the avirulent form can cause some clinical 
symptoms but seldom results in death of the infected birds. It is therefore used in vaccination 
of turkeys against turkey hemorrhagic enteritis. At the protein level, differences found 
between the two variants of the virus are two amino acid mutations in the fibre protein: 
Ile354 and Thr376 in the virulent form are replaced by methionines in the avirulent form 
(Beach et al., 2009a). The mechanism that causes the difference in virulence is unknown, but 
it is perhaps not a coincidence that these residues are near potential glycosylation sites. 
Sequence analysis suggests four potential N-linked glycosylation site motifs (N-X-T/S): 
356-NPT-358, 362-NKS-364, 378-NNT-380 and 406-NNS-408. Any mutation in the region 
surrounding glycosylation sites may change the hemagglutination profile of the virus 
(Arnberg et al., 1997). Although Met354 and Met376 have a 36 Å intra-monomer distance, 
they approach each other to 13 Å inter-monomer distance in the trimer. 
When the structures of avirulent and virulent forms are compared, the structures are 
virtually identical with an r.m.s.d. of 0.53 Å when the C-alpha atoms of residues 317-454 are 
superposed. The largest difference is in the C'C"-loop, which moves upwards a few Å (Figure 
22). This loop is near both residues that differ between the avirulent and virulent forms, i.e. 
near residue 354 located in the C'-strand of the same monomer (Met in the avirulent form and 
Ile in the virulent form), but also near in space to residue 376 in the C"D-loop of a 
neighboring monomer, which is Met in the avirulent form and Thr in the virulent form. The 
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reason for the different position of the C'C"-loop is not clear, as the two mutated residues 
occupy very similar positions in their respective structures. 
Figure 22: Comparison between the structures of the avirulent and virulent versions of the TAdV-3 
fibre head trimer. One monomer of the avirulent form is shown in yellow secondary structure cartoon 
representation, the other two in white, while the virulent fibre head trimer is shown in red and gray, 
respectively. Residues 354 and 376, which differ between the two forms, are shown in stick 
representation and labeled. 
4.2.5 Trimer stability and behaviour in solution  
Each TAdV-3 fibre head monomer has a surface area of 9.4 x 103 Å2, of which 2.6 x 103 
Å2 (27 %) is buried in the trimer. The calculated energy gain upon trimer formation is around 
60 kcal/mol and a salt bridge is formed between Glu401 and Arg390 of a neighbouring 
monomer. These properties are comparable to other adenovirus and reovirus fibre heads, 
suggesting that the stability of the trimer is comparable. As mentioned above, a beta-hairpin 
"arm" (residues 349-364) contacts a neighbouring monomer. Out of the sixteen residues, 
eleven participate in inter-monomer contacts, so the arm may well provide extra trimer 
stability. The stable nature of trimers is evident from thermal denaturation profiles where 
both variants showed high thermal resistance. Both proteins have melting temperatures (Tm) 
close to 80 ºC (Figure 23).  
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Figure 23: Thermofluor unfolding assay of avirulent and virulent TAdV-3 fibre head proteins. Curve 
represents average of three independent reactions for each protein carried out at same time. The mid-
points of melting curves indicating Tm are shown by blue (avirulent) and brown (virulent) dotted 
lines. 
Differences in behaviour of avirulent and virulent fibre head variants in solution were 
observed. Although both proteins are pretty soluble, the virulent fibre head had a tendency to 
aggregate. A higher inter-particle interaction could be assumed as a possible reason behind 
aggregation. Further evidence came from diffusion ordered spectroscopy (DOSY) NMR, 
which can tell about rate of molecule diffusion at a given concentration. In DOSY 
experiments carried out at room temperature, the self-diffusion value for virulent fibre was 
smaller compared to avirulent, indicating a bigger molecular size for the former (Figure 24), 
which possibly be due to inter-molecular interactions of virulent fibre trimers. I speculate that 
perhaps the beta-hairpin "arm" is less stable (conversely more flexible) in the virulent version 
and exists in a more open conformation, thus making the protein more prone to establish 
contact with other protein molecules in solution. However, structurally I have not seen 
evidence for this flexible behaviour and both protein variants appeared almost identical 
except for a slightly upward shift in the beta-hairpin arm of virulent fibre head as described 
above. 
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Figure 24: Behaviour of TAdV-3 fibre head proteins in solution. Diffusion ordered spectroscopy 
(DOSY)-NMR profiles of avirulent and virulent fibre heads at different concentrations. Y-axis 
denotes rate of diffusion; larger the size of the molecule, the smaller will be its diffusion rate.  
Despite of the observed difference in beta-hairpin "arm" positioning between virulent and 
avirulent fibre heads, their near-identical unfolding temperatures indicate that the overall 
trimeric assembly is not getting affected by this variation. Although there is certainly a 
possibility that this variation may bring local changes in the structures, which in turn may 
have functional implications (discussed below). 
4.2.6 Comparison with other fibre heads 
A structure similarity search showed that the TAdV-3 fibre head structure is more similar 
to reovirus fibre heads sigma1 and sigmaC (Chappell et al., 2002; Guardado Calvo et al., 
2005) than to other adenovirus fibre heads. When the TAdV-3 fibre head was superposed on 
the mammalian reovirus sigma1 fibre head domain (PDB entry 2OJ5; Figure 25A) the 
r.m.s.d. was 2.9 Å for 106 superimposed C-alpha atoms (Z-score 8.3). After these two 
proteins, the next most similar protein identified was the lactococcal bacteriophage TP901-1 
receptor-binding protein (PDB entry 2F0C; Figure 25B) with an r.m.s.d. of 2.9 Å for 90 
superimposed C-alpha atoms (Z-score 5.7). Finally, when the structure was superposed onto 
the HAdV-5 fibre head domain (PDB entry 1KNB; Figure 25C), the r.m.s.d. was 3.8 Å for 96 
superimposed C-alpha atoms (Z-score 4.8). 
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Figure 25: Structural homologues of the TAdV-3 fibre head. Superposition of the TAdV-3 fibre head 
monomer (green) onto mammalian reovirus sigma1 head domain (orange, panel A: PDB entry 2OJ5, 
r.m.s.d 2.8 Å for 104 superimposed C-alpha atoms), onto lactococcal bacteriophage TP901-1 
receptor-binding protein (cyan, panel B: PDB entry 2F0C, r.m.s.d. 3.1 Å for 88 superimposed C-alpha 
atoms) and onto HAdV-5 head domain (magenta, panel C: PDB entry 1KNB, r.m.s.d. 2.8 Å for 83 
superimposed C-alpha atoms). They are all in approximately the same orientation as in Figure 21C. 
Asterisks show the location of the DG-loops. 
The structure shares the secondary structure topology with the reovirus fibre heads, and 
also the kinked nature of strands C and J (the latter is called H in the reovirus fibre heads). 
Other adenovirus fibre heads do not have kinks in the C-strand and only have the equivalent 
of the J'-strand and not the J-strand. An evolutionary link has been proposed between 
adenovirus fibres and reovirus attachment proteins, based on their striking similarity in 
beta-sheet composition and topology of the head domain and the presence of beta-spiral 
repeats in their shaft domains (Chappell et al., 2002). However the eight anti-parallel beta-
strands, which are present in both of these proteins, have a somewhat different arrangement, 
even if the topology is the same. In the case of adenovirus fibres these anti-parallel sheets are 
arranged in beta-sandwich architecture of two four-stranded sheets, while in reovirus sigma1 
and sigmaC the eight beta-strands form a beta-barrel, i.e. the two sheets contact each other at 
the ends (Chappell et al., 2002; Guardado Calvo et al., 2005). In the case of the TAdV-3 fibre 
head, the two beta-sheets contact each other only at one end, the one that is located towards 
the inside of the trimer (Figure 21A).  
Besides reovirus proteins, the search also revealed the lactococcal phage TP901-1 
receptor-binding protein (Veesler et al., 2012) as a structural homologue. Like the TAdV-3 
fibre head, the C-terminal head domain of this protein (residues 63 to 163) contains an eight-
stranded curved beta-sheet. However, the lactococcal phage protein head domain is much 
smaller, with most beta-strands being much shorter (i.e. the TAdV-3 fibre head is "higher"). 
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When comparing adenovirus fibre heads only, the closest neighbour is that of the porcine 
adenovirus 4 (Guardado-Calvo et al., 2010), whereas the closest human adenovirus analogues 
appeared to be the fibre head of HAdV-19p and HAdV-37. However, as all other adenovirus 
fibre heads known, they contain a beta-sandwich of four beta-strands in each sheet, in which 
the two sheets do not contact each other at any of the sides to form a larger curved sheet or 
beta-barrel. 
None of the trimeric receptor-binding domains mentioned before show the beta-hairpin 
insert in the C-strand. However, both reovirus and adenovirus fibre heads have a much more 
elaborate DG-loop than the TAdV-3 fibre head, which in both cases is involved in receptor-
binding (Bewley et al., 1999; Kirchner et al., 2008). SnAdV-1 fibre head also lacks any such 
beta-hairpin insertion in its structure but it does have a long DG loop, albeit occupied by a 
prominent alpha-helix (see section 4.1.3). 
4.2.7 Surface potential of the trimer and sialyllactose binding 
Different types of adenovirus fibre heads have different surface charge distributions and 
predicted iso-electric point values. Human adenovirus 3 has a predicted iso-electric point of 
5.0, while HAdV-37 has a value of 9.1. The TAdV-3 fibre head has an even higher predicted 
iso-electric point of 9.9 and large electropositive patches are present on the surface of the 
trimer (Figure 26). HAdV-37 fibre head binds sialic acid (as well as CAR; (Burmeister et al., 
2004; Seiradake et al., 2009)), and the interaction with sialic acid is charge dependent 
(Arnberg et al., 2002). The fact that a siadenovirus-specific open reading frame exists of 
which the putative gene product has a high sequence similarity with bacterial sialidase 
proteins was also suggestive of sialic acid playing a role in Siadenovirus biology. 
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Figure 26: Surface properties and ligand binding of the TAdV-3 fibre head. Side view (A) and top 
view (B) with calculated negatively charged regions in red and positive regions in blue. The location 
of some of the polar, electropositive and electronegative amino acid side-chains that contribute to 
these charged regions are indicated. 
Glycan microarray profiling of both variants of His-tagged TAdV-3 fibre head protein was 
performed with a library of 74 glycoconjugates. The proteins showed substantial interaction 
with two sialylated glycans, 2,3'- and 2,6'-sialyllactose, both consisting of a sialic acid moiety 
attached to lactose in different linkage positions (Figure 27). The observed fluorescence 
intensities were 5,000 and 6,100 RFU for 3'- and 6'-sialyllactose, respectively, which was 
significantly higher than the experimental threshold (Figure 27). No binding inhibition was 
observed in the presence of lactose and galactose, indicating that the sialic acid portion of the 
carbohydrates were involved in contact with the proteins. Xyloses linked to BSA through a 4-
aminophenyl linker were also identified as a potential ligand for the viral proteins.  
Results	  and	  Discussion	  
88 
Figure 27: Histogram representing the fluorescence intensity of avirulent TAdV-3 fibre head bound 
to presented glycans on the microarray surface detected by fluorescently-labelled anti-his antibody. 
Histograms represent the average of three replicate experiments and error bars depict one standard 
deviation of the mean calculated over three microarray slides. Bars for 2,3'- and 2,6'-sialyllactose are 
indicated. (See table AI in annex for details of neoglycoconjugtes and glycoproteins). 
To validate these results, TAdV-3 fibre head protein binding to 2,3'- and 2,6'-sialyllactose 
was examined by STD-NMR. The STD experiment is based on the transfer of magnetization 
between the protein, which is selectively irradiated by a train of radiofrequency pulses, and 
any binding ligands (Meyer and Peters, 2003). For complex ligands, such as 
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oligosaccharides, those atoms lying closer in space to the protein surface receive a higher 
amount of magnetisation, providing information on the ligand contact atoms (Mayer and 
Meyer, 1999). The carbohydrates 2,3'- and 2,6'-sialyllactose in the presence of either the 
virulent or the avirulent versions of TAdV-3 fibre head proteins resulted in STD-positive 
peaks, which indicated that both ligands were bound by the proteins in solution (Figure 28). 
In all instances, the highest degree of saturation was observed at the sialic acid, and to a much 
lesser degree, at the galactose region (Figure 29). These experiments not only confirmed the 
protein-carbohydrate interaction but also mapped the protons of the carbohydrate residues 
with which the proteins interact, indicating that binding of sialyllactose to TAdV-3 fibre head 
occurs mainly at the level of the sialic acid residue. 
 
Figure 28: STD experiment performed on TAdV-3 fibre heads. In each section, upper spectrum 
indicates off-resonance (reference) spectrum, with labels indicating the assignments for a number of 
representative ligand signals. STD spectrum (up-scaled 100X) is shown on the lower half. Peaks 
marked with “P” correspond to signals belonging to the protein. 
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Figure 29: Epitope mapping of 2,3'- and 2,6'-sialyllactose. STD positive peak contribution by 2,3'- 
and 2,6'-sialyllactose in presence of  (A) virulent TAdV-3 fibre head protein and (B) avirulent TAdV-
3 fibre head protein with labels indicating the STD intensity for each signal, relative to the STD 
intensity for the 5''-N-acetyl peak. Red circles: I > 50%, orange circles: 50% I > 30%, yellow circles: 
30% > I > 10%. Note the highest degree of saturation observed at the sialic acid part of the sugars in 
both cases.  
STD-NMR was also performed with xylose, but no interaction with the proteins was 
observed. The chemical properties of slide surfaces in glycan microarrays as well as different 
linkers attaching glycans to their carrier molecules can affect the way a glycan is being 
presented and can impact target protein-ligand interaction (Kilcoyne et al., 2012). I speculate 
that this disagreement between glycan microarray profiling and STD-NMR results may be 
due the presentation of the carbohydrates and the linker between xylose and BSA.  
To better understand the strength of these interactions, surface plasmon resonance (SPR) 
was used to determine the affinity of the TAdV-3 fibre head-sialyllactose interaction. Only 
one carbohydrate, 2,3'-sialyllactose, was selected for this study as it shares the same contact 
atoms with 2,6'-sialyllactose. The sugar was immobilized on a streptavidin sensor chip using 
its biotin tail, avirulent and virulent fibre head protein solutions were passed over the chip in 
different concentrations and protein-ligand association was monitored. Due to weak binding 
strength, the equilibrium state was not achieved for either protein. A subsequent increase in 
association time gave the same outcome, so it was not possible to calculate reliable kinetic 
parameters of the proteins. However, sensograms clearly showed specific interaction of both 
proteins with the carbohydrate (Figure 30). Thus, isothermal titration calorimetry (ITC) was 
employed to determine binding parameters of 2,3'-sialyllactose binding to avirulent and 
virulent variants of the TAdV-3 fibre head protein. 
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Figure 30: SPR analysis of 2,3'-sialyllactose binding to (A) avirulent and (B) virulent TAdV-3 fibre 
head proteins. Sensogram indicates protein concentration in µg/ml used during experiments: 7.5 
(brown), 15 (red), 30 (deep blue), 60 (light blue), 120 (deep green), 240 (light green) and 480 
(purple). 
ITC results showed that both proteins bound to 2,3'-sialyllactose with mM affinity (kd 
value between 3.5-5.5 mM; Table 14; Figure 31). The variation of the heat released per mole 
of ligand injected with the sugar/protein ratio can be described with a model of one binding 
site per protein monomer subunit. The thermodynamic parameters derived from curve fitting 
suggested slightly different ways of interaction for the avirulent and virulent forms of the 
TAdV-3 fibre head protein, since both the enthalpic and the entropic contributions of the 
sugar binding differ (Table 14). The lower enthalpic stabilization of the complex in the 
virulent form is partially compensated by a more favorable entropic contribution. 
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Table 14: ITC-derived thermodynamic parameters for 2,3’siallylactose binding to TAdV-3 
virulent and avirulent fibre head proteins. Measurements (MES bufffer, pH 6.0, 25ºC) were 
fitted assuming three independent sites per protein trimer. 
Protein Kb (M-1) 
KD 
(mM) 
- ΔH 
(kcal/mol of sites) 
- ΔS 
(cal/mol of sites/deg) 
TAdV-3 (virulent) 182 5.4 1.83 - 4.2 
TAdV-3 
(avirulent) 
275 3.6 4.43 3.70 
Lys421Alaa 
 
n.o.b - - - 
Lys439Alaa 311 3.2 3.9 1.5 
Arg368Alaa 310 3.2 3.86 1.55 
Glu392Alaa ∼ 50 ∼20 n.d. n.d. 
Asn407Alaa 360 2.7 4.66 3.93 
aTAdV-FH avirulent mutants. bNot observed. cNot determined. 
Figure 31: ITC profiles of the TAdV-3 fibre head when analysed with 2,3'-sialyllactose. Isotherm 
obtained from avirulent and virulent fibre heads (A) and that from single point mutants; (B) 
Arg368Ala, (C) Lys439Ala, (D) Asn407Ala and (E) Glu392Ala. (F) Titration curve for K421A 
mutant showing heat changes obtained when ligand alone and with protein was injected.  
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4.2.8 Co-crystal structures with 2,3'- and 2,6'- sialyllactose 
Soaking of avirulent and virulent TAdV-3 fibre head crystals were performed with 2,3'- 
and 2,6'-sialyllactose as described in Material and Methods. The ligand bound structures were 
solved by molecular replacement using the native model. Data collection and refinement 
statistics are given in Table 15. 
Table 15: Crystallographic data measurement and refinement statistics for ligand bound 
crystals 
 2,3'-Sialyllactose 2,6'-Sialyllactose 
 Avirulent Virulent Avirulent Virulent 
Data collection     
Synchrotron and beamline ESRF BM30 ESRF BM30 ESRF BM30 ESRF BM30 
Detector ADSC Q315r ADSC Q315r ADSC Q315r ADSC Q315r 
Wavelength (Å) 0.9797 0.9797 0.9795 0.9795 
Crystal-detector distance 
(mm) 
291.0 291.0 291.9  291.8  
Oscillation range (°) 1.0 1.0 1.0 1.0 
Number of images 67 150 80 51 
Space group I23 I23 I23 I23 
Cell edge (Å, a=b=c) 98.36 98.82 98.45 98.86 
Mosaicity (°) 0.6-0.7 1.1-1.2 0.5-0.7 0.5-0.7 
Resolution range (Å) 49.1-2.5  
(2.64-2.5)* 
49.4-2.5  
(2.64-2.50)* 
49.2-2.2  
(2.32-2.20)* 
40.3-2.3  
(2.42-2.30)* 
Reflections 5623 (811) 5711 (815) 8227 (1177) 7109 (1037) 
Multiplicity 7.7 (7.9) 16.6 (17.2) 9.3 (9.6) 5.9 (6.0) 
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0) 98.3 (99.9) 
Mean <I/s(I)> 14.2 (2.4) 23.9 (4.2) 18.9 (4.1) 15.5 (2.7) 
Rsym (%)† 10 (91.9) 7.9 (74.0) 6.9 (55.8) 6.4 (65.8) 
VM (Å3Da-1)‡ 1.98 2.0 1.99 2.0 
Wilson B (Å2) 45.0 50.5 41.1 53.8 
Refinement     
Resolution range (Å) 40.19-2.50 (2.6-2.5) 40.34-2.50 (2.6-2.5) 49.27-2.20 (2.3-2.2) 34.95-2.30 (2.4-2.3) 
Reflections used 5355 (768) 5434 (384) 7841 (1118) 6781 (493) 
Reflections used for Rfree 261 (43) 263 (16) 383 (56) 328 (21) 
R-factor 0.193 (0.267) 0.194 (0.223) 0.177 (0.225) 0.206 (0.318) 
R-free 0.254 (0.346) 0.273 (0.368) 0.215 (0.32) 0.261 (0.400) 
Protein/phosphate/ligand/wate
r atoms  
1092/5/21/30 1091/5/21/24 1092/5/21/52 1091/5/21/23 
<B>overall/protein/ion/liganda
/water (Å2) 
51.2/51.12/87.7/76.9/
41.3 
57.1/57.6/44.6/60.0/4
9.25 
47.1/46.7/41.0/80.6/
45.6 
64.8/63.9/129.4/139.0
/55.3 
Ramachandran statistics (%) 90.4/98.5 97.1/100 97.1/100 95.6/97.8 
r.m.s.d. bonds (Å)/angles (°) 0.010/1.5 0.014/1.5 0.007/1.2 0.009/1.4 
 * Values in parentheses are for the highest resolution bin (where applicable). 
† Rsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection and <Ih> 
is the mean observed intensity for that reflection. 
‡ According to Matthews (1968) 
a Refined with occupancy of 1.0 
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The structures revealed two possible binding sites for the ligands on the protein. The 
ligand was found making contacts with two protein monomers, each of them belonging to 
independent asymmetric units. The pattern of interaction arosed two possibilities: the 
interaction mediated by one of the monomeric site is an artifact of crystal contact or both 
monomeric sites actually contribute in ligand binding (Figure 32A). Further experiments 
were conducted to establish the actual binding site. I identified key interacting residues of the 
protein and prepared single point mutants for each to test their effect on 2,3'-sialyllactose 
recognition by ITC. The substitution of residues Lys439, Arg368 and Asn407 by alanine (all 
part of site 1 as indicated in figure 32B) had very little impact on the binding 
thermodynamics, although a small increase in affinity was found for the three mutants 
accompanied by certain enthalpic/entropic compensation in the energetic of complex 
formation (Figure 31; Table 14). In contrast, the substitution of Glu392 with alanine 
drastically reduced the affinity of the mutant for 2,3'-sialyllactose and a similar replacement 
at position 421 (Lys421Ala mutant) rendered carbohydrate binding undetectable (Table 14; 
Figure 31). These two residues constitute binding site 2 (Figure 32B). These mutagenic 
effects on ligand binding were validated by STD-NMR and similar results were obtained 
(Figure 33). 
Figure 32: Interaction between 2,3'- or 2,6'- sialyllactose and TAdV-3 fibre head within crystals. (A) 
Schematic representation of the interactions. Ligand located between two monomers, each belonging 
to independent asymmetric units, is shown in orange while binding site over each monomer is 
indicated in brown and orange ovals. Biologically relevant trimers are generated by the 
crystallographic three-fold symmetry axis. (B) The binding sites mapped over the trimeric fibre head. 
Results	  and	  Discussion	  
95 
 
Figure 33: STD experiments performed on 2,3'-sialyllactose in the presence of different TadV-3 fibre 
head mutants. A: Off-resonance (reference) spectrum. B: STD spectrum with wt virulent protein. C: 
STD spectrum with R386A mutant protein. D: STD spectrum with E392A mutant protein. E: STD 
spectrum with N407A mutant protein. F:  STD spectrum with K421A mutant protein. G: STD 
spectrum with K439A mutant protein. 
Site 2 is located towards the lower half and close to the interface between two monomers 
of the trimeric assembly (Figure 32B). Each monomer of the trimer contributes a site for 
ligand binding and there was no evidence for cooperativity. In all cases, unbiased densities 
were observed only for the sialic acid units and hence lactose parts were not modelled 
(Figure 34). This was expected based on the findings of glycan array and STD-NMR, where 
the sialic acid part was shown to be more important for binding. The two protein variants 
have shown differential preference for the ligands where the densities for 2,3'-sialyllactose 
were slightly stronger comparing to that for 2,6'-sialyllactose and, for both ligands, avirulent 
fibre head has shown a higher binding affinity. Average temperature factors of the ligands 
were comparable to those of proteins in all but one case (Table 15). There were no significant 
differences between ligand-free and ligand-bound models and overall r.m.s.d. values of 0.3-
0.4 Å was obtained upon superposing them.  
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Figure 34: Experimental electron density obtained for 2,3'-sialyllactose sugar bound to avirulent 
TAdV-3 fibre head. (A) A section of unrefined experimental map showing density for sialic acid unit. 
2Fo-Fc density (blue) is contoured at 1 σ while positive Fo-Fc density (green) is contoured at 3 σ. (B) 
Unbiased density observed for sialic acid. The 2Fo-Fc map covering the ligand is calculated from 
structure factors obtained prior to ligand fitting and contoured at 1 σ.  
The structures revealed the sialic acid binding site of TAdV-3 fibre head (Figure 35A,C). 
Participating protein residues are same in both fibre head variants with Thr419, Val420, 
Lys421, Asn422 and Gly423, which are located on the H strand and HI loop of the monomer, 
constituting the binding site. The surface exhibits a strong electropositive charge distribution 
that drives the binding of negatively charged sialic acid molecule (Figure 35B). Ligands in 
their energy minimum chair conformation readily present axial carboxylic group and make 
several hydrogen and hydrophobic interactions with above mentioned residues. ε-amino 
group of Lys421 makes a close distance hydrogen bond with carboxylic group O8 of sialic 
acid while its α, δ and ε carbons are engaged to sialic acid via several hydrophobic 
interactions (Figure 35D). Thr419 and Val420 mainly contribute hydrophobic interactions 
while Asn422 and Gly423 makes hydrogen as well as hydrophobic bonds with the sugar 
molecule. Apart from these contacts, Glu392 located over the adjacent DG loop of the same 
monomer plays a crucial role in overall stabilization of the ligand by making two 
hydrophobic contacts with C10 and C11 of sialic acid. Jointly with Thr419 and Val420, 
Glu392 stabilizes the N-acetyl group of sialic acid (Figure 35D). Both Lys421 and Glu392 
engage terminal regions of sialic acid and thus provide the molecule an end-to-end attractive 
force. As previously stated, mutation of either of Lys421 or Glu392 heavily disrupts binding 
of the ligand exemplifying their role in establishment of the interaction. 
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Figure 35: Structure of the avirulent TAdV-3 fibre head bound to 2,3'-sialyllactose. (A) Side view 
and of trimeric fibre head bound to the ligand. Trimer was generated by crystallographic 3-fold 
symmetry axis. (B) Surface representation of the ligand bound structure. Binding site surface is 
depicted in mesh. Notice the orientation of carboxylic and N-acteyl groups of sialic acid (C) Close 
view of the ligand binding site. The bound sialic acid unit is displayed with its 2Fo-Fc electron 
density contoured at 1 σ and calculated as in figure 34B. Interacting regions of HI and DG loops are 
shown in green color. (D) Fibre head-2,6'-sialyllactose-interaction plot. The central sialic acid unit is 
labeled. Residues forming hydrogen bonds are indicated in green while those making hydrophobic 
contacts are in black. Dashed green and red lines denote hydrogen and hydrophobic bonds, 
respectively.   
4.2.9 TAdV-3 fibre head has a sialyllactose-binding site different from other 
adenoviruses 
Both variants of the TAdV-3 fibre head can bind sialylated glycans as shown by solution 
experiments and ligand bound structures. However, it’s intriguing to observe that one protein 
(aviruelnt) engages the ligand with a slightly higher affinity than the other (virulent) 
especially when both variants are almost identical in structure. The only observable 
difference in their structures lies in the beta-hairpin arm region, which shows movement and 
is slightly bended upwards in case of virulent. This movement might not be very influential 
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upon the overall trimeric structure but can certainly bring local conformational changes. The 
ligand-binding site of the protein is situated very close to the beta-hairpin region and I 
speculate that this might be the reason why there is variation in ligand attachment. Other 
possibility could be the requirement of a more complex glycan for attachment of virulent 
fibre. It was observed in case of HAdV-37 that the binding of its fibre head with cellular 
glycosylated receptor (with two terminal sialic acid moieties) was many folds stronger in 
comparison to simple sialyllactose (Nilsson et al., 2011). So, if indeed the virulent fibre head 
binds a glycan cellular receptor under physiological conditions, then perhaps it requires a 
more complex and branched molecule in order to make binding feasible and effective. 
Many viruses can bind sialic acid via their receptor-recognising proteins. These includes 
VP1 and VP4 proteins of polyomavirus and rotavirus respectively, influenza virus 
haemagglutinin, and fibre proteins of adenovirus and reovirus besides many others (Reiter et 
al., 2011; Seiradake et al., 2009; Burmeister et al., 2004; Dormitzer et al., 2002b; Stehle and 
Harrison, 1997; Weis et al., 1988). Although the nature of interaction remains charge-
dependent, the sialic acid binding site over these proteins varies significantly in term of 
location. Among adenoviruses itself, different fibre heads have varying silaic acid binding 
locations. Figure 36 shows a comparison between sialic acid binding locations of TAdV-3, 
CAdV-2 and HAdV-37 fibre head domains. CAdV-2 and HAdV-37 have these sites located 
over top of their trimeric assemblies while sialic acid attaches close to the monomeric 
interface and towards the bottom of the TAdV-3 fibre head trimer (Figure 36). Mammalian 
reovirus fibre shares a close resemblance to TAdV-3 fibre head with conserved topological 
features. Its receptor binding protein sigma1 can also bind sialic acid, however, in this case 
the viral protein uses its shaft domain to engage the molecule (Reiter et al., 2011).  
Apart from differences in their binding locale, some differences can also be observed in 
nature of bonds involved in these viral protein-sialic acid interactions, which mainly occurs 
due to type of participating amino acid residues. For instance, HAdV-37 and VP1 make salt 
bridge connections with the incoming ligands whereas salt bridges are not present in TAdV-3 
fibre head, influenza virus haemagglutinin and VP4 interactions with sialic acid. Main forces 
involved in latter cases are hydrogen bonds and hydrophobic interactions. However, 
conservation of sialic acid epitopes can easily be noted. Carboxyl group of sialic acid is 
readily presented for binding in case of VP1, VP4 and HAdV-37, a feature also observed in 
case of TAdV-3 fibre head-sialic acid interaction.  
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Figure 36: A comparative view of sialyllactose binding adenovirus fibre heads and their binding sites. 
(A) TAdV-3 fibre head bound to sialyllactose acid molecule. The site is located towards the lower 
half and close to the monomeric interface of the trimer. (B) HAdV-37 fibre binds sialic acid over top 
of its assembly, very close to the 3-fold axis. (C) Similar to HAdV-37 fibre head, sialic acid binding 
site of CAdV-2 is also located on the top of the trimeric assembly, however it’s away from the 3-fold 
symmetry axis. In all depictions density is shown only for the sialic acid unit of sialyllactose. 
4.2.10 Conclusion 
The atomic structures of the fibre head of the avirulent and virulent variants of TAdV-3 
are described. This is the first Siadenovirus for which the structure of the fibre head has been 
determined. The structure revealed a strongly positively charged surface, which may be 
important for host cell interaction. Interactions of fibre head variants with 2,3'-sialyllactose 
and 2,6'-sialyllactose have been shown by several biophysical methods and co-crystal 
structures were determined. The co-crystal structures revealed the sialic acid binding site of 
the TAdV-3 fibre head, which is located close to monomer-monomer interface and bears a 
postive surface charge distribution. A beta-hairpin insertion in the C-strand contacting a 
neighbouring monomer is unique to the TAdV-3 fibre head structure. The lack of sequence 
similarity to other Siadenovirus fibre heads precludes me from suggesting that other 
siadenovirus fibres also contain this beta-hairpin, although this is certainly possible. The fibre 
head shares its ABCJGHID beta-barrel topology with reovirus fibre heads, while certain 
bacteriophage baseplate receptor-binding proteins and other adenovirus have a beta-sandwich 
with separate ABCJ- and GHID-sheets. As reoviruses are double-stranded RNA viruses and 
there seems to be no possible direct evolutionary relationships between adenoviruses and 
reoviruses, it is unclear if (and how) the fibre genes may have passed between them or 
whether the evolutionary process involved has been convergent rather than divergent. 
Knowledge of the structure may also allow the design of chimeric adenoviruses incorporating 
the TAdV-3 fibre head and investigating their tropism, which in turn may lead to vaccination 
or gene therapy vectors that may target specific cell types. 
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4.3 Crystal structure of lizard adenovirus 2 short fibre head domain 
Lizard adenovirus type 2 (LAdV-2) is the first characterized Atadenovirus that has two 
distinct fibres on its virion (Penzes et al., 2014). The fibre-1 gene of LAdV-2 codes for a 
polypeptide of 331 amino acids with a monomeric weight of 34.7 kDa whereas the predicted 
length for the fibre-2 gene product is 433 amino acids with a molecular weight of 45.7 kDa. 
The two proteins differ significantly with each other and have a sequence identity of just 
20%. I determined the high-resolution crystal structure of the 101 residues long LAdV-2 
short fibre head domain by molecular replacement technique using SnAdV-1 fibre head as 
search model, with which it shares 54% sequence identity. Crystals belonged to  the P1 space 
group and diffracted synchrotron radiation to maximum resolution of 2.0 Å. The structure is 
very similar to the SnAdV-1 fibre head, albeit 6 residues shorter. 
4.3.1 Purification and crystallization 
4.3.1.1 Construction of expression vectors 
The amino acid sequence analysis of the LAdV-2 short and long fibres showed 
characteristics of a typical adenovirus fibre protein with presence of beta-spiral repeats in 
central shaft domain (van Raaij et al., 1999b). The tail and shaft regions of short fibre (fibre-
1) run till residue 210 and after a short linker the putative head domain could be presumed to 
start. The long fibre or fibre-2 is 102 residues longer than the short fibre and in this case the 
beta-spiral region is predicted to encompass residues 46-260. The remaining C-terminal 
portion of the protein will probably form the head domain. Based on these features, cloning 
was performed and expression vectors were generated for several N-terminal truncated 
versions of the fibres, including C-terminal fibre heads. 
4.3.1.2 Protein purification and crystallization 
Expression vectors for short and long fibre protein constructs were used to produce 
milligram amounts of soluble protein, which was purified by nickel-affinity chromatography 
followed by strong anion-exchange chromatography. In case of the short fibre, the putative 
head construct starting at residue 220 was highly soluble and the protein yield was 
approximately 25 mg from 1 litre of bacterial culture. On the other hand, the protein yields 
for the two long fibre constructs starting at residues 245 and 305 were relatively lower at 
around 15 mg/litre of bacterial culture.  
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Proteins were eluted from the nickel column between imidazole concentrations of 0.1-
0.5 M. In anion-exchange chromatography, the construct 220 of short fibre eluted in two 
peaks around 0.2-0.5 M sodium chloride when a linear gradient was used, each of which 
contained pure or nearly pure fibre head protein (Figure 37). Interestingly, this behaviour is 
very similar to that of SnAdV-1 fibre head protein, which also elutes in two prominent peaks 
(see section 4.1.1.2). The peak fractions were pooled and kept separate for crystallization 
purpose. The putative head domain construct 245 of long fibre showed a single peak of pure 
protein during anion-exchange chromatography (Figure 38).  
Figure 37: Purification of LAdV-2 short fibre head domain. (A) Protein elutes in two prominent 
peaks in anion-exchange (Resource Q) chromatography. In green the sodium chloride concentration 
gradient is indicated. (B) Separately pooled peaks are run over a SDS-gel. Lanes are marked M 
(molecular weight markers, with the size indicated in Kd), U (unheated sample) and B (sample heated 
to 95 ºC for at least 5 min). Trimeric protein in unheated fraction is shown by an asterisk symbol 
while hash indicates monomeric protein in the respective heated fraction. 
Figure 38: Purification of the LAdV-2 long fibre construct 245. (A) Chromatogram showing elution 
pattern during anion-exchange chromatography. In green the sodium chloride concentration gradient 
is indicated. (B) SDS-PAGE run of peak fraction pooled after anion-exchange chromatography. Lanes 
are marked M (molecular weight markers, with the size indicated in Kd), U (unheated sample) and B 
(sample heated to 95 ºC K for at least 5 min). 
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Crystals of short fibre head were obtained in four of the conditions, two of which resulted 
in good quality data sets. Condition 1 contains 20% (w/v) PEG 3350 and 0.2 M tri-potassium 
citrate, while condition 2 contains 0.1 M Tris-HCl pH 8.0 and 30% (v/v) PEG 600. Plate like 
crystals appeared in condition 1 and belonged to space group P1. They diffracted to a 
maximum resolution of 2 Å (Figure 39A; Table 16). They are expected to contain four 
trimers in the asymmetric unit, leading to a solvent content of 26%. Thick needle-shaped 
crystals appeared in a condition containing 0.2 M tri-Potassium Citrate, 20% w/v PEG 3350, 
which belonged to space group P3221 and diffracted to 2.8 Å (Figure 39B). In this case, there 
was 1 trimer in the asymmetric unit with solvent content of 31.8 %. 
Crystals of long fibre construct 245 took around 15 days to appear and could only be 
obtained in a single condition consisting of 0.2 M di-ammonium tartrate, 20% w/v PEG 3500. 
Diffraction quality of these crystals was very poor and obtained data was not useful. 
 
Figure 39: Crystals of lizard fibre heads. (A) Lizard short fibre head crystals belonging to P1 space 
group. (B) Thick needle shaped crystals of short fibre head domain in P3221 space group. 
Results	  and	  Discussion	  
104 
Table 16: Crystallographic data measurement and refinement statistics for LAdV-2 short fibre 
head crystals 
 Crystal form 1 
Data collection  
Constructs (residues) 220-331 
Synchrotron and beamline SOLEIL, Proxima 2A 
Detector ADSC Q315r 
Wavelength (Å) 0.9801  
Crystal-detector distance (mm) 361 
Oscillation range (°) 0.5 
Number of images 400 
Space group P1 
Cell edge (Å, a, b, c) 54, 79.5, 83.3 
Cell angles (α, β, γ) 116.76, 90.10, 92.23 
Mosaicity (°) 0.7-0.8 
Resolution range (Å) 50.00-2.00 (2.11-2.00)* 
Reflections 78829 (11467) 
Multiplicity 2.1 (2.1) 
Completeness (%) 95.3 (94.9) 
Mean <I/s(I)> 5.5 (2.3) 
Rsym (%)† 10.5 (35.0) 
VM (Å3Da-1)‡ 1.66 
CC Imean 0.984 (0.835) 
CC anom -0.431 (N.D) 
Wilson B (Å2) 13.8 
Refinement  
Resolution range (Å) 19.86-2.00 (2.1-2.0) 
Reflections used 77329 (5837) 
Reflections used for Rfree 3145 (453) 
R-factor 0.221 (0.282) 
R-free 0.279 (0.257) 
Protein/water atoms  10535/943 
Overall B (Å2) 21.35 
Ramachandran statistics (%) 97.1/100 
r.m.s.d. bonds (Å)/angles (°) 0.009/1.4 
* Values in parentheses are for the highest resolution bin (where applicable). 
†Rsymm = ΣhΣi|Ihi-<Ih>|/ΣhΣi|Ihi|, where Ihi is the intensity of the ith measurement of the same reflection and <Ih> 
is the mean observed intensity for that reflection. 
‡ According to Matthews (1968) 
N.D. = Not determined 
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4.3.2 Structure determination of the LAdV-2 short fibre head domain 
The LAdV-2 short fibre head domain has a close sequence relationship with the SnAdV-1 
fibre head: 54% identity. The data set obtained from P1 space group crystal was used to 
determine the structure of LAdV-2 short fibre head. Molecular replacement was performed 
with a trimeric model of the SnAdV-1 fibre head. Four copies of the search ensemble were 
placed in the asymmetric unit. Automatic tracing and manual completion resulted in a model 
consisting of 103 amino acids in each chain (228-331) and 943 water molecules. Amino acids 
from the N-terminal purification tag could not be modelled in the structure due to lack of 
density, as was also the case for residues 220-227 of each of the chains. The final model was 
refined using NCS-restraints to 2 Å with good geometry and Ramachandran statistics (Table 
16). The head domain appears to start at residue 230, while residues 220-229 are part of the 
linker between shaft and the head domain. 
4.3.3 General features of the LAdV-2 short fibre head 
The LAdV-2 short fibre head is the smallest adenovirus fibre head known so far, with only 
101 residues per monomer. The trimeric assembly is 3.3 nm tall with a cross-sectional 
diameter of around 4.5 nm and each monomer has a surface area of 6.04 x 103 Å2 out of 
which 23% gets buried upon trimer formation. Given the 54% amino acid sequence identity 
between the head domains of SnAdV-1 fibre and LAdV-2 short fibre, we were expecting to 
see a good degree of structural similarity. As expected, the obtained structure is virtually 
identical and resembles the SnAdV-1 fibre head in every aspect (Figure 40B). Both fibre 
heads are much smaller than other known adenovirus fibre head structures. The surface 
charge distribution of LAdV-2 short fibre head is of mixed nature with presence of both 
postive and negative patches of intermediate strength, a feature also observed in SnAdV-1 
(Figure 40A). 
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Figure 40: Structure of the LAdV-2 short fibre head. (A) Qualitative electrostatic surface diagram of 
the LAdV-2 short fibre head. (A) Side (upper section) and top (lower section) views of the trimeric 
assembly. (B) Structural superposition onto SnAdV-1 fibre head domain (orange). 
4.3.4 Conclusion 
The crystallographic structure of LAdV-2 short fibre head is determined and refined to a 
maximum resolution of 2Å. This is the second Atadenovirus protein for which atomic 
structure has been determined, the first being SnAdV-1 fibre head domain described in part 4. 
The structure is very similar to that of the SnAdV-1 fibre head, which was expected due to 
the 54% identity in sequence. Attempts were also made to crystallize the long fibre head, 
which only has 11.6% sequence identity to the short fibre head, but well-diffracting crystals 
could not be obtained. Future studies will be aimed at obtaining information on the receptor-
binding properties of these proteins. 
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4.4  Crystal structure of the carboxy-terminal fibre head domain of murine 
adenovirus 2 
Murine adenovirus 2 (MAdV-2) is a member of the Mastadenovirus genus of 
adenoviruses, along many other mammalian adenoviruses, including all human adenoviruses. 
It is the second murine adenovirus for which genomic information is available. A putative 
fibre head construct and a longer construct with potential shaft domain repeats were 
expressed and purified. Well-diffracting crystals for the putative head domain were obtained 
and its structure was determined using single anomalous dispersion (SAD) and refined to 1.8 
Å. The structure revealed two shaft domain repeats besides a complete head domain. The 
structure has conserved topological features comparable to other adenovirus fibre heads and 
its closest homolog is canine adenovirus 2 fibre head. Binding assays showed that MAdV-2 
fibre head binds N-acetyl glucosamine (GlcNAc) and that contacts involve the acetyl group 
of the glycan. This suggests MAdV-2 may use GlcNAc-decorated molecules for its cellular 
attachment. No binding with the human CAR D1 domain could be observed. 
4.4.1 Purification and crystallization 
4.4.1.1 Construction of expression vectors 
Secondary structure prediction of the 787 amino acid long MAdV-2 fibre showed presence 
of a N-terminal penton base binding sequence, a central beta-spiral repeats containing shaft 
domain and a virus distal C-terminal fibre head domain, although the sequence identity of the 
C-terminal part with other known adenovirus fibre heads was restricted to between 10-20% 
only. At sequence level the closest homologue for which structure is known was found to be 
human adenovirus 41 short fibre head with 16% identity. The genomic DNA of MAdV-2 
fibre was subjected to two separate PCR reactions with the aim of amplifying C-terminal 
fibre regions between residues 517-787 and 586-787, in which the former construct was 
expected to contain part of the shaft and the complete head domain, while the latter construct 
would contain the head domain only. The amplified PCR products were cloned into the 
pET28a(+) vector, which provides the protein with N-terminal 6xHis and T7 tags. The 
constructs were sequenced and confirmed to be as expected.  
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4.4.1.2 Protein purification and crystallization 
Following expression of the protein constructs fib(517-787) and fib(586-787) in E. coli, 
the proteins were subjected to a two-step purification protocol, where they were first purified 
by Ni-NTA metal affinity chromatography and later by strong anion exchange 
chromatography. Both C-terminal MAdV-2 fibre constructs showed strong binding tendency 
towards nickel, as evident by their chromatography profiles where they eluted at relatively 
high imidazole concentrations (Figure 41). 
Figure 41: Metal affinity purification profiles for MAdV-2 fibre construct containing resdiues 517-
787 (A) and residues 586-787 (B). Lane M indicates molecular weight marker; lanes 1 & 2: 
flowthrough unheated and heated respectively. Imidazole step gradient elution; lanes 3 & 4: 50 mM 
imidazole unheated and heated respectively, 5 & 6: 100 mM unheated and heated respectively, 7 & 8: 
200 mM unheated and heated respectively, 9 &10: 300 mM unheated and heated respectively, 11 & 
12: 400 mM unheated and heated respectively and 13 & 14: 400 mM unheated and heated 
respectively. Smaples were heated at 95 ºC for 5 min. Arrows indicate monomeric units of the 
trimeric proteins.  
Although heating of fibre protein at high temperature is generally required in order to 
visualize its constituting monomers (Mitraki et al., 2006), partial dissociation of trimeric 
proteins takes place on SDS-PAGE in this case, as monomeric species were present in the 
unheated fractions (Figure 41). In anion exchange chromatography, proteins eluted as single 
peaks at around 0.1-0.4 M sodium chloride when a linear gradient of sodium chloride was 
used (Figure 42). From 1 litre of bacterial culture, the total protein yield was around 12 mg in 
both cases. 
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Figure 42: Anion-exchange chromatography profiles of MAdV-2 fibre protein constructs (A) 
fib(517-787) and (B) fib(586-787). Both fragments elutes in sharp, single peak at 0.1-0.4 M sodium 
chloride concentration. Green line indicates sodium chloride concentration gradient. 
The longer fragment (containing residues 517-787) failed to produce crystals despite of 
extensive trials. This was perhaps due to presence of a part of a more flexible N-terminal 
domain, hindering crystallization. On the contrary, the crystals of the putative head domain 
(amino acids 586-787) were obtained in several conditions after 10-30 days. Plate-shaped 
crystals were obtained in when drops were setup in condition containing 4.0 M ammonium 
formate and 0.1 M HEPES sodium salt pH 7.5 (Figure 43A). They were found to belong to 
the orthorhombic space group P212121. Heavy atom derivatization of these crystals was 
performed by soaking them with methyl mercury chloride. The soaked crystals tested for 
diffraction were in space group C2221. A second crystal form appeared in monoclinic space 
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group P21 with a similar plate like morphology. In this case the reservoir solution contained 
0.1 M magnesium chloride, 0.1 M HEPES-NaOH pH 7.5 and 10 % w/v PEG 4000 and 0.15 
M ammonium sulphate, 0.1 M HEPES-NaOH pH 7.0, 20 % w/v PEG 4000 (Figure 43B). See 
Table 17 for crystal characteristics.  
Figure 43: Crystals of MAdV-2 putative fibre head construct 586-787. (A) Plate like native crystals 
appeared in P212121 or C2221 space group. (B) The protein construct also crystallized in P21 space 
group with similar but more robust appearance. Bar measures approximately 0.5 mm. 
4.4.2 Structure determination of the MAdV-2 fibre construct containing residues 586-
787 
The crystallized MAdV-2 fibre fragment has 16% sequence identity to its most 
homologous known structure as mentioned before. At such low sequence identity molecular 
replacement is unlikely to work (McCoy, 2007), therefore heavy atom derivatisation with 
methyl mercury chloride was performed. A single, complete and redundant data set was 
collected at a wavelength to maximize the anomalous signal from the incorporated mercury 
atoms. The crystal diffracted to a maximum resolution of 2.76 Å and the overall phasing 
power was above one up to 4.1 Å resolution. The asymmetric unit was expected to contain 
one protein trimer and therefore twelve mercury sites were expected in the asymmetric unit 
(each protein monomer contains four cysteine residues). All of these sites were identified 
successfully and refinement of these sites resulted in high-quality phases (Table 17).  
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Table 17: Crystallographic data measurement and refinement statistics for MAdV-2 fibre 
crystals 
 Hg-derivative Native 1 Native 2 
Data collection    
Synchrotron and beamline ALBA BL13-XALOC ALBA BL13-XALOC ESRF ID29 
Wavelength (Å) 1.0024 1.0022 0.9762 
Crystal-detector distance (mm) 521.5 327.0 551.7 
Oscillation range (°) 0.2 0.2 0.1 
Number of images 1440 648 1160 
Space group C2221 P21 P212121 
Cell edge (Å, a, b, c) 92.11, 164.28, 96.43 93.89, 100.61, 95.46 55.87, 91.11, 128.92 
Mosaicity (°) 0.1-0.2 0.4-0.6 0.2-0.3 
Resolution range (Å) 96.4-2.7 (3.02-2.76) 29.6-1.8 (1.9-1.8) 34.0-1.7 (1.74-1.70) 
Reflections 19199 (4473) 144440 (7093) 68912 (3722) 
Multiplicity 11.7 (8.0) 2.8 (2.9) 3.5 (1.9) 
Completeness (%) 99.7 (98.8) 98.2 (97.8) 94.3 (69.6) 
Mean <I/s(I)> 19.6 (3.2) 6.8 (2.3) 6.3 (2.1) 
Rsym (%)† 9.7 (55.2) 7.9 (33.4) 11.6 (23.3) 
VM (Å3Da-1) 2.35 2.60 2.11 
Wilson B (Å2) 51.5 16.8 14.5 
Phasing    
Heavy atom sites 12 Hg   
Correlation coefficient (all/weak)  52.40 / 22.50   
Patterson figure of merit 14.24   
Correlation coefficient (E)  0.462   
R-cullis (anomalous, acentric) 0.887   
Phasing power (anomalous differences) 0.753   
FOM = cos (phase error) (acentric/centric) 0.2405 / 0.0758   
Solvent flattening (44.6% solvent content)    
R-factor (before/after) 0.47 / 0.45   
Overall corr. on |E|2 (before/after) 0.5262 / 0.8837   
Correlation on |E|2 / contrast (original/inverted) 0.2470 / 0.1310   
Refinement    
Resolution range (Å) 82.14-2.76 (2.8-2.7) 29.66-1.80 (1.9-1.8) 34.0-1.7 (1.8-1.7) 
Reflections used 18197 (1269) 140517 (20295) 65280 (9409) 
Reflections used for Rfree 985 (69) 3644 (499) 3559 (540) 
R-factor 0.207 (0.339) 0.205 (0.259) 0.191(0.266) 
R-free 0.284 (0.400) 0.216 (0.269) 0.222 (0.273) 
Protein/water atoms/glycerol 4491 / 32  9024 / 758 / 24 4577 / 579  
<B> overall/protein/water/glycerol (Å2) 57.45 / 58.98 / 40.93 25.41/25.23/31.48/31.76 19.87 / 19.80 / 27.87 
Ramachandran statistics (%) 90.2 / 95.1  97.7 / 100 95.8 / 99.3 
r.m.s.d. bonds (Å)/angles (°) 0.008 / 1.3 0.008 / 1.3 0.009 / 1.3 
 Values in parentheses are for the highest resolution bin (where applicable). 
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Solvent flattening improved the phases further and a clearly interpretable electron density 
map was obtained. Some discontinuity was observed when the chains were automatically 
traced as well as some instances of wrong amino acid assignments were noticed, which were 
corrected manually. The partially refined model consisted of 193 amino acid residues (594-
787) from each chain. The remaining eight N-terminal residues of the protein as well the 
vector-supplied tags could not be modelled. This model was then used in molecular 
replacement search with the high-resolution native data set obtained for the P212121 crystal 
form. Automatic plus manual model building resulted in a structure with 193 residues for 
each of the three chains and a total of 594 water molecules. Manual inspection of the model 
did not show any trace for additional N-terminal residues. The other native data set from P21 
space group crystal was processed in a similar way, this time using the latest model for MR 
search. Two trimers were present in the asymmetric unit. Here, the final model contained 193 
residues for each of the six monomers, 758 molecules of water and 1 molecule of glycerol. 
All refined models showed good agreement with diffraction data, with good geometry and 
most of the residues in favoured regions of Ramachandran plot (Table 17). In both models a 
genuine cis-peptide bond was found in the shaft repeat region, involving residues Ala599 and 
Pro600. 
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4.4.3 Description of the atomic model 
The structure obtained from the MAdV-2 fibre construct 586-787 revealed the presence of 
a fibre head domain along with two beta-spiral repeats of the fibre shaft domain (Figure 44), 
although we expected these residues to form the fibre head domain only. 
Figure 44: Structure of the MAdV-2 fibre head domain with two shaft repeats. (A) A monomer 
showing the arrangement of sandwich-like head domain and beta-spiral repeats of the shaft. N and C 
terminus are indicated while strands are labeled A-J according to the nomenclature proposed by Xia et 
al. (Xia et al., 1994). Notice the presence of two small strands E and F in the DG loop. beta-spiral 
repeats are labeled S1 and S2. Side view (B) and top view (C) of the fibre head trimer along with 
shaft repeats. Between panels A and B the structure has been turned approximately 90º towards the 
reader. Each monomer is coloured differently. 
4.4.3.1 The fibre head domain 
Each monomer of the MAdV-2 fibre head contains a beta-sandwich, like other fibre heads 
for which the structure has been determined. Together they form a trimeric beta-propeller. 
Each fibre head monomer contains 153 amino acids (634-787), a number less than some 
other adenovirus fibre heads such as that of HAdV-5 (185 amino acids; Xia et al. (1994)) and 
CAdV-2 (197 amino acids; Seiradake et al. (2006)).  
The fibre head measures 6.1 nm in diameter and has a height of 4.5 nm (Figure 44B). An 
outwardly flapped HI-loop, among others, especially helps the structure attain a higher 
diameter than height. Similar flapping-out of the HI-loop can be observed in the HAdV-5 
fibre head, which has a diameter of 6.2 nm and a height of 4.0 nm (Figure 45B; Xia et al. 
(1994)). Both are significantly larger than the previously described SnAdV-1 fibre head, 
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which is just 3.8 nm tall and has a diameter of 4.6 nm. The anti-parallel beta-sheet of each 
head monomer can be divided into two halves, FEAA’BCJ and GHID, of which the strand A 
is kinked. I named this kink A' (Figure 44A). The FEAA'BCJ-sheet faces the inner side of the 
trimeric assembly and makes several inter-monomeric contacts. On the other hand, the 
GHID-sheet is mainly solvent exposed. Most of the loops connecting strands are short, with 
the exception of the DG-loop (residues 690-728). As in many other Mastadenovirus fibre 
heads, two small beta-strands E and F are present in this loop, between residues 704 and 710. 
The long DG-loop runs along the bottom of the beta-sandwich and contains amino acid side 
chains that contribute significantly towards the hydrophobic core of the monomer, as well as 
making hydrogen bonds and a few hydrophobic contacts with neighbouring monomers 
(residues 695-700; Figure 44B). 
Superposition of monomers of the trimer with each other showed no major conformational 
deviation, with average r.m.s.d. between 0.6 and 0.7 Å. Differences of more than 1 Å were 
only observed in parts of the DG-loop that are away from the trimer interface. Similarily, 
superposition of trimers from the two native models didn’t show any difference and they 
aligned with r.m.s.d. values of less than 0.5 Å. 
4.4.3.2 The shaft domain repeats 
Beta-spiral repeats are present in adenovirus fibre shaft domains as well as in receptor 
binding proteins of some other viral fibres such as the mammalian and avian reovirus 
attachment proteins sigma1 and sigmaC and the bacteriophage PRD1 fibre (Chappell et al., 
2002; Guardado Calvo et al., 2005; Merckel et al., 2005). They are characterized by two 
small beta-strands, connected through a 4 residue loop that has either glycine or proline at the 
third position (van Raaij et al., 1999b). The presence of glycine or proline facilitates the 
formation of a type II beta-turn. In the structure, two such glycine-type beta-spiral repeats are 
present (residues 601-628), and one partial repeat can also be observed (residues 594-598). 
The only cis-peptide bond of the structure (between residues 599 and 600) is in the 7-residue 
loop connecting the partial repeat and the following repeat. Amino acid residue in each beta-
strand of the repeats varies in number (between 2-5) while the loop connecting two repeats 
contains 7 residues. Similar glycine-type repeats were observed in HAdV-2 shaft; reovirus 
attachment proteins also have proline-type repeats (Chappell et al., 2002; Guardado Calvo et 
al., 2005; van Raaij et al., 1999b). The last shaft repeat is followed by a five amino acid 
linker mostly consisting of hydrophobic amino acids, which joins the shaft to the C-terminal 
head domain (629-TSPVF-633). Due to the nature of these amino acids present at shaft-fibre 
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juncture, little flexibility can be anticipated in MAdV-2 fibre shaft-head junction. The linker 
present in HAdV-2 consists of six residues that are hydrophilic (393-NKNDDK-398; van 
Raaij et al. (1999b)). 
4.4.3.3 Stability of MAdV-2 fibre 
MAdV-2 fibre has a surface area comparable to other mammalian fibre heads. The range 
of inter-subunit contacts extends from the base of the tail to almost the top of the assembly. 
These contacts are extensive and include several hydrophobic residues at the shaft as well at 
the hydrophobic core of the head. The fibre head and shaft jointly have a monomeric surface 
area of 11 x 103 Å2, of which 17% gets buried upon trimer formation. Considering only the 
fibre head, these values reduce to 7.9 x 103 Å2 and 17% respectively. The shaft domain, being 
extensively inter-twinned, buries 43% (1.4 x 103 Å2) of its monomeric surface area, which is 
3.4 x 103 Å2. There are 19 inter-monomer hydrogen bonds if both head and shaft are taken 
together, whereas this value drops to only eight upon removing shaft repeats from the 
structure. This suggests that the shaft domain contributes significantly in maintaining the 
integrity of the trimer. Besides that, 3 salt bridges are formed at each monomeric interface, 
out of which 2 are contributed by shaft repeat residue 615. The calculated energy gain upon 
trimer formation is around 80 kcal/mol, of which 38 kcal/mol comes from the shaft region. 
None of the four cysteine residues present in MAdV-2 fibre C-terminal construct is involved 
in disulphide bond formation.  
4.4.4 Structural homologues of the MAdV-2 fibre head 
The closest structural homologue of the MAdV-2 fibre head domain turned out to be 
CAdV-2 fibre head domain (PDB code 2J1K; Seiradake et al. (2006)). When both structures 
are superposed, they align with an r.m.s.d. of 2.6 Å for 411 C-alpha atoms (Z score 15.8; 
Figure 45A). The next most similar protein identified is the HAdV-35 fibre head domain 
(PDB entry 3BQ4) with a r.m.s.d. of 2.7 Å for 412 superimposed C-alpha atoms (Z-score 
14.5). Finally, when the structure is superposed onto the mammalian reovirus sigma1 
attachment protein (PDB entry 1KKE), the r.m.s.d. is 4.4 Å for 372 superimposed C-alpha 
atoms (Z-score 8.5).  
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Figure 45: Superposition of MAdV-2 C-terminal construct (cyan) onto CAdV-2 fibre head domain 
bound to CAR D1 and sialic acid (A; PDB code 2J1K; magenta) and HAdV-5 fibre head domain (B; 
PDB code 1KNB; blue). One CAR D1 (red) and three sialic acid molecules (green stick) are shown. 
CAdV-2 fibre head can bind CAR D1 and sialic acid simultaneously on its peripheral region. Both 
binding sites are close but independent of each other. Black arrow indicates location of the AB loop. 
4.4.5 Receptor binding 
Surface-exposed loops of the MAdV-2 fibre head have a certain degree of resemblance to 
loops of other Mastadenovirus fibre heads such as CAdV-2 and HAdV-5 (Figure 45). As 
mentioned above, CAdV-2 can bind three CAR D1 and three sialic acid molecules 
simultaneously with its trimeric head (Seiradake et al., 2009). The two binding sites are close 
to each other but independent. Interaction with CAR D1 is mainly with the AB-loop and 
partly by the B strand and the DE-loop of each monomer. In contrast to what is observed for 
HAdV-12 and HAdV-37, the neighbouring monomer does not participate in CAR D1 binding 
for the CAdV-2 fibre head. None of the residues involved in the interface between the 
CAdV-2 fibre head and CAR D1 are conserved in the MAdV-2 fibre head, except one 
(Thr441 in the DE-loop). The AB-loop is also shorter and protrudes somewhat less. 
However, residue conservation is not considered as a critical criterion for fibre head-CAR D1 
interaction (Seiradake et al., 2006). Moreover, human CAR D1 and mouse CAR D1 are 91% 
identical at sequence level with 17 out of 19 residues that are involved in the interaction 
between HAdV-12 and CAR D1 being conserved (van Raaij et al., 2000). Based on these 
facts, I decided to probe binding of MAdV-2 fibre head with D1 domain of CAR by gel-
filtration. MAdV-2 fibre and CAR D1 were mixed in a trimer to monomer molar ratio of 1:3, 
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incubated and analyzed by gel filtration. Both proteins elutes in distinct peaks, showing no 
evidence for binding to each other (Figure 46). 
Figure 46: Gel filtration assay of the MAdV-2 fibre head and CAR D1 domain. (A) Elution profile of 
MAdV-2 fibre head and CAR D1 when mixed in a trimer to monomer molar ratio of 1:3 and passed 
through superdex 200 column. (B) SDS-gel of pooled fractions and controls. Lanes M: molecular 
weight marker, A: MAdV-2 fibre head alone (monomeric MW 25 kD), B: CAR D1 alone (MW 15 
kD), C: mixture of fibre head and CAR D1 before loading onto column, D and E: collected fractions 
for MAdV-2 fibre head and F and G: collected fractions for CAR D1. All samples were heated in 
sample loading buffer at 95 ºC for 5 mins before loading onto SDS-gel. 
The surface of MAdV-2 fibre head has a mixed distribution of predicted positively and 
negatively charge patches (Figure 47). Basic patches can easily be seen on the exposed loop 
regions, especially on the peripheral areas and on top of the trimer, raising a possibility that 
they could bind a negatively charged molecule such as sialic acid. The CAdV-2 fibre head 
engages sialic acid using one of its peripherally located basic patches and its close similarity 
with the MAdV-2 fibre head structure prompted me to have glycan array experiments 
performed. 
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Figure 47: Surace charge distribution of MAdV-2 C-terminal construct 586-787. (A) Side view in the 
same orientation as figure 44B. (B) Top view in the same orientation as figure 44C. 
4.4.6 The MAdV-2 C-terminal construct binds N-acetylglucosamine 
N-acetylglucosamine or GlcNAc is a monosaccharide derivative of glucose and is present 
in a number of glycosaminoglycans such as heparan sulfate and hyaluronan (Esko et al., 
2009). Given the wide distribution of glycosaminoglycans in form of proteoglycans in 
diverse tissue types and extracellular matrix, many pathogenic microorganisms, including 
viruses, have adopted themselves to successfully use these molecules for attachment and 
cellular entry (Rostand and Esko, 1997). Glycan array screening of the MAdV-2 C-terminal 
construct against 74 neoglycoconjugates showed strong binding to glucose derivative 
GlcNAc (Figure 48). When the glycan array experiment was repeated in presence of 50 mM 
GlcNAc, partial inhibition in ligand binding was observed indicating that GlcNAc is able to 
bind MAdV-2 in solution as well. Binding was also observed with BSA conjugated mannose, 
albeit with lower intensity.  
ITC confirmed the interaction of MAdV-2 fibre with GlcNAc where a KD value of 2 mM 
was obtained when a model of one binding site per protein monomer subunit was used 
(Figure 49). 
Results	  and	  Discussion	  
119 
Figure 48: Histogram representing recognition of neoglycoconjugates and glycoproteins by His-
tagged MAdV-2 fibre construct 586-787 (20 mg/mL). The most intense signal is detected from 
glucose derivative carbohydrate GlcNAc, which gets partially inhibited in presence of 50 mM 
GlcNAc (see legend). (See table AI in annex for details of neoglycoconjugtes and glycoproteins). 
Figure 49: ITC profile of MAdV-2-GlcNAc interaction. Thermodynamic parameters (ΔH and ΔS) 
and association constant (K) values are indicated. 
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Involvement of heparan sulphate in HAdV-2 and HAdV-5 infections has been suggested 
in the past (Dechecchi et al., 2000). It was observed that removal of heparan sulfate-
glycosaminoglycans from cells inhibit viral binding and infection. Interestingly, similar 
abolishment was not observed upon removing chondroitin sulfate glycosaminoglycans, which  
contain N-acetylgalactosamine as the repeating sugar unit instead of GlcNAc. Based on 
analyses carried out on a large set of heparin-binding proteins, two major 
glycosaminoglycan-engaging sequence motifs have been proposed: BBXB and BBBXXB, 
where B is a basic amino acid (Templeton, 1992). The shaft of HAdV-5 contains a repeat 
motif KKTX (residue 91-94) and possible involvement of this motif in glycosaminoglycan 
binding has been postulated (Dechecchi et al., 2000; Dechecchi et al., 2001) and supported by 
later studies (Bayo-Puxan et al., 2006; Smith et al., 2003; Bayo-Puxan et al., 2009). However, 
a sequential arrangement of these basic residues may not be required and an epitope formed 
by conformational closeness of otherwise distantly located basic residues might also be able 
to bind glycosaminoglycans (Chen et al., 1997). Although it is not clear whether the binding 
site of heparan sulfate involves GlcNAc or some of its other epitopes, the saccharidic nature 
of GlcNAc make it one of the most probable candidates to be involved in these interactions.  
4.4.7 Conclusion 
The structure of a C-terminal fragment of MAdV-2 fibre was determined. The structure 
revealed the presence of two beta-spiral repeats of the shaft domain along with a somewhat 
smaller than expected fibre head domain. This is only the second adenovirus fibre for which 
triple beta-spiral repeats were visualized. The MAdV-2 fibre shaft repeats are of the glycine 
type. The head domain of the MAdV-2 fibre is structurally very similar to the CAdV-2 fibre 
head and exhibits charged surface patches. As CAdV-2 can bind CAR D1 and sialic acid, I 
investigated CAR D1 binding and carbohydrate binding. Glycan array and ITC experiments 
revealed GlcNAc as a potential ligand. Interaction with human CAR D1 could not be 
demonstrated.
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4.5 Preliminary X-ray crystallographic and biophysical studies of snake 
adenovirus-1 capsid protein LH3 
The Atadenovirus capsid contains a surface exposed, trimeric protein called LH3, which is 
not present in any other genus of Adenoviridae. The function of LH3 is not known, but it may 
help to stabilize the capsid, be involved in host cell receptor engagement, or both. The 
SnAdV-1 LH3 has been expressed in bacteria, purified and crystallized. A high-resolution 
native data set at 2.0 Å was obtained, but phasing attempts were not successful. 
4.5.1 Purification and crystallization 
4.5.1.1 Construction of the expression vector 
A gene fragment coding for full length LH3 protein (373 amino acids; monomeric MW 42 
kD) was amplified from SnAdV-1 genomic DNA by PCR and cloned into pET28a(+) 
bacterial expression vector under the T7 promotor. The protein was expressed with an N-
terminal 6xHis purification sequence (M GSSHH HHHHS SGLVP RGSHM ASMTG 
GQQMG RGSEF). 
4.5.1.2 Protein purification and crystallization  
The LH3 protein was expressed at low temperature in bacteria. For purification, the 
protein was subjected to nickel affinity chromatography, followed by strong anion exchange 
chromatography. In nickel affinity chromatography, the protein eluted in a broad imidazole 
concentration range (0.1-0.4 M), fractions of which were checked for purity and pooled 
together to be loaded onto a strong anion exchange chromatography column (the predicted pI 
of the protein is 5.8). When eluted with a linear gradient of sodium chloride, the protein 
comes out in a concentration range of 0.3-0.4 M sodium chloride and in a single peak (Figure 
50A). The oligomeric nature and purity of the protein was checked by running unheated and 
heated samples on a SDS-gel, where monomeric protein can only be observed in heated 
fractions (Figure 50B), while unheated samples show SDS-stable trimers. 
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Figure 50: Anion exchange chromatography of LH3 protein. (A) Chromatogram showing elution 
profile of LH3 when subjected to a linear gradient of sodium chloride. (B) Purity and trimeric nature 
of LH3 was assessed by denaturing SDS-PAGE, analysing sample both unheated (U) or heated to 
95 ºC (B) in denaturing sample buffer before analysis. Fractions collected after anion exchange 
chromatography. Asterisk indicates the trimeric protein, monomeric protein (#) can be observed in the 
heated samples. 
Extensive crystallization trials were performed, in total testing more than a thousand 
different conditions. Diffraction-quality crystals were obtained in two conditions, condition 1, 
which contained 20% (w/v) PEG 3350 and 0.2 M ammonium acetate; and condition 2, which 
contained 20% (w/v) PEG 3350 and 0.2 M di-ammonium hydrogen phosphate. Crystals 
grown in condition 1 diffracted X-rays to around 1.7 Å resolution and a complete dataset 
could be collected to 2.0 Å. Fine, plate like crystals belonged to space group P21 and 
apparently contain two protein trimers per asymmetric unit. This would leave 42.9% solvent 
in the asymmetric unit (Figure 51; see Table 18 for data statistics). A self-rotation function 
suggested the presence of independent non-crystallograhic three-fold symmetry axes, which 
supports the presence of two trimers the asymmetric unit of the crystal (Figure 53). 
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Figure 51: Crystallization and data collection from LH3 crystals. (A) Thin, plate like crystals grew 
from solutions containing 20% w/v PEG 3350 and 0.2 M ammonium acetate. (B) Image showing 
diffraction pattern of one of the crystal. Useful data integrated up to 2.0 Å. The beamstop is indicated 
by a cross-hair mark. 
Figure 52: Crystals obtained from methylated LH3 protein. 
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Figure 53: Self-rotation function of the LH3 native crystal data set. Two strong peaks in the chi=1200 
section suggest the presence of two trimeric molecules in the crystal asymmetric unit. Each section is 
marked on the top with its respective chi value.  
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Table 18: Crystallographic data measured from LH3 native crystal 
Data collection  
Construct (residues) 1-373 
Synchrotron, beamline ESRF, BM30 
Detector ADSC Q315r 
Distance (mm) 256.20 
Wavelength (Å) 0.9796 
Number of images 180 
Oscillation range (º) 1.0 
Space group P21 
Cell edges (Å, a, b, c) 70.57, 126.64, 120.61 
Resolution range (Å) 67.6-2.0 
(2.11-2.0) 
Reflections 130096 (17723) 
Multiplicity 3.3 (3.3) 
Completeness (%) 95.8 (89.6) 
Mean <I/s(I)> 3.7 (1.4) 
Rsym (%)a 21.3 (70.3) 
VM (Å3Da-1)‡ 2.16 
CC Imean  0.962 (0.628) 
CC anom -0.346 (0.073) 
Wilson B (Å2) 10.1 
Values in parentheses are for the highest resolution bin. 
4.5.2 Characterization of expressed and purified LH3 protein by electron microscopy 
Purified LH3 was analyzed by negative stain EM to assess its physical appearance and 
characteristics (experiments performed by Dr. Carmen San Martin, CNB-CSIC, Madrid). As 
expected, protein trimers were observed (black arrows in figure 54). However, a significant 
fraction of the molecules were found in higher order oligomeric states and aggregates 
(coloured arrows in figure 54). The number of constituting trimers in these oligomers was 
between 5 and 6. 
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Figure 54: Negative stain EM of purified LH3. Different oligomeric states of the protein can be seen; 
trimeric protein molecules (black arrows), hexameric particles (red arrows), pentamer (blue arrow) 
and aggregates (green arrow) are present 
4.5.3 Rescue strategies for crystallization 
4.5.3.1 Treatment with alpha-chymotrypsin 
As mentioned before, LH3 was difficult to crystallize and despite extensive trials, crystals 
could only be obtained in two conditions. Moreover, these crystals could not be reproduced. 
Thus, I decided to adopt some rescue strategies. Limited proteolysis experiments were carried 
out in order to attempt to purify a stable domain of LH3. Prior to proteolysis, samples were 
incubated at different temperatures to assess their effect on the outcome of proteolysis as 
described in Material and Methods. I didn’t observe any difference on the SDS-gel pattern 
when samples incubated on three different temperatures (37 ºC, 55 ºC and 65 ºC) and 
thereafter treated in an identical manner. Thus, I chose 37 ºC as the incubation temperature 
and performed further experiments with varying ratios of LH3 protein to alpha-chymotrypsin 
(Figure 55). 
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Figure 55: LH3 samples treated with alpha-chymotrypsin at 37 ºC for 20 min and run on a SDS-gel. 
Lane M: molecular weight marker; Lanes 1-2: alpha-chymotrypsin and untreated LH3 samples 
respectively as controls; Lanes 3-5: LH3 treated with alpha-chymotrypsin in a sample:enzyme ratio of 
1:8, 1:4 and 1:2 respectively. All samples in lanes 1-5 are unheated. Lane 6: untreated LH3 as a 
control; Lanes 7-9: same as of lanes 3-5. All samples in lanes 6-9 are heated at 95 ºC for 5 min prior 
gel loading. Stable fragment of LH3 retains after treatment is indicated by an asterisk. The hash shows 
the fragment in monomeric form after heating.  
A stable fragment of LH3 was identified. The fragment shows the same pattern of 
oligomerization as native LH3 and remains intact even after a treatment with relatively high 
amounts of alpha-chymotrypsin (Figure 55). The fragment along with other digestion 
products was pooled and purified by anion exchange chromatography (Figure 56A). 
Although it has been known that α-chymotrypsin has selective preference to cleave aromatic 
amino acids located at the carboxyl terminal region of proteins (Appel, 1986), western blot 
analysis was performed to determine the region of proteolytic cleavage. A western blot assay 
using an anti-his antibody proved the presence of intact N-terminal region in the stable LH3 
protein fragment (Figure 56B) hence, I presumed that the proteolytic enzyme has cleaved-off 
the C-terminal region of the protein. Crystallization trials performed with the purified 
fragment failed to yield any hit. Crystallization trials with in situ proteolysis using the same 
enzyme were also performed, however, no crystals were obtained either. 
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Figure 56: Purification of the LH3 fragment after alpha-chymotrypsin digestion. (A) Anion exchange 
chromatography profile of fragment obtained after treatment with alpha-chymotrypsin. Asterisk 
indicates the fraction, which was pooled for western blot analysis and crystallization. (B) Western blot 
of the pooled fraction. Detection of his tag confirmed the presence of intact N-terminal region in the 
protein. 
4.5.3.2 Methylation of surface exposed lysines 
Sometimes side chains of bulky amino acids that are exposed on protein surface hinder the 
process of crystallization by disturbing crystals lattice contacts. Changing the surface 
property by modifying such residues could help improving crystal quality as well as increases 
the chance of getting crystal hits. Reductive methylation of surface exposed lysins is one such 
method, which has been shown to rescue crystallization when obtaining crystals were 
difficult otherwise (Walter et al., 2006; Kobayashi et al., 1999). I adopted the protocol as 
decribed by Walter et al. to assess the feasibility of this method in this case. After a period of 
3 months conditions close to the one which produced native LH3 crystals, resulted in 
morphologically distinct, fine, needle-shaped crystals when drops where setup with 
methylated version of LH3 (Figure 52). Diffraction of these crystals has not been tested yet.  
4.5.4 Binding with carbohydrates 
Glycan array experiments were performed with 74 different neoglycoconjugates and 
glycoproteins. No binding to any of the carbohydrates was evident; the obtained fluroscence 
signals were all below the experimentally determined threshold value of 220 RFU. 
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4.5.5 Conclusion 
Crystals of the SnAdV-1 LH3 protein were of high quality, and diffracted synchrotron 
radiation up to a maximum resolution of 2 Å. Analysis of the crystallographic data suggested 
that the protein is trimeric in nature, as was expected. Due to high reluctancy of the protein to 
form crystals, structure determination has not been possible so far. I have confirmed that the 
protein is highly stable towards denaturing agents and that its monomer can only be 
visualized upon boiling the sample prior gel run. Further biochemical and biophysical 
analysis indicated that the protein might form higher order oligomers and aggregates. Glycan 
screening data showed that LH3 has no affinity for carbohydrates, however, considering its 
localization over the viral capsid, a possible involvement in host-cell recognition can not be 
completely ruled out.  
Among adenoviruses, atadenoviruses are unique in their capsid composition with the 
presence of two distinct proteins, LH3 and p32k. These ‘non-standard’ proteins may confer 
on them some distinct functions that have not been previously observed in other adenoviruses 
or they may be involved in some standard functions such as receptor recognition that are 
thought to be associated with other, well established proteins. In any case, a deeper and 
thorough characterization of these proteins, including LH3, will help reveal new facets of 
these viruses. 
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5. Conclusions 
1.  The snake adenovirus 1 fibre protein consists of 345 amino acids instead of 415 as 
reported in the database. 
2.  The 1.35 Å structure of snake adenovirus 1 fibre head, the first for an Atadenovirus 
protein, retains the overall topology of other adenovirus fibre heads, but in a much more 
compact form. 
3. The lizard adenovirus 2 short fibre head structure is virtually identical to that of the snake 
adenovirus 1 fibre head. 
4. The 2.2 Å structure of the turkey adenovirus 3 fibre head, the first for a Siadenovirus 
protein, revealed a strongly positively charged surface, which may be important for host 
cell interaction. A beta-hairpin insertion in the C-strand contacting a neighboring 
monomer is unique to the TAdV-3 structure. Its closest structural homologues were 
identified as reovirus attachment proteins. 
5. Turkey adenovirus 3 fibre head binds 2,3'- and 2,6'-sialyllactose. They bind to the side of 
the fibre head, involving residues Glu392, Thr419, Val420, Lys421, Asn422, and Gly423. 
6. The 1.8 Å structure of the carboxy terminal domain of the mouse adenovirus 2 fibre 
revealed a beta-sandwich head domain architecture similar to other Mastadenovirus fibre 
heads. The shaft domain of MAdV-2 is made up of glycine type beta-spiral repeats, a 
feature also observed in HAdV-2 fibre. 
7. In vitro, the carboxy-terminal domain of the mouse adenovirus 2 fibre binds N-acetyl-
glucosamine. 
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6. Sumario en Castellano 
Caracterización estructural y funcional de proteínas de la 
cápsida de adenovirus no humanos 
6.1 Resumen 
Aunque los adenovirus son agentes causantes de enfermedades, también se utilizan como 
modelo para investigar los mecanismos básicos de la biología molecular. El uso de vectores 
basados total o parcialmente en adenovirus no humanos como vectores para ensayos de 
terapia génica y anticancerígena presenta un interés considerable, ya que permitiría evitar la 
inmunidad preexistente en humanos, y presentaría la posibilidad de dirigirse a diferentes 
dianas celulares. 
La cápside icosaédrica de adenovirus, además de proteger el ADN de doble cadena, 
contiene elementos involucrados en la entrada del virus. Uno de estos elementos es el 
homotrímero de la fibra, la proteína responsable de la interacción inicial virus-hospedador, y 
por tanto un factor crucial en la biología de los adenovirus y en la exploración de sus 
aplicaciones médicas. En esta tesis doctoral, se han determinado las estructuras del dominio 
distal (cabeza)  de las fibras de cuatro adenovirus no humanos. Tres de las estructuras 
pertenecen a géneros recientemente establecidos de la familia Adenoviridae: Siadenovirus y 
Atadenovirus. Aunque pertenecen a distintos géneros y se dirigen a distintos organismos, las 
estructuras presentan una topología conservada de sándwich beta en su parte central. Sin 
embargo, muchas características como el tamaño, la forma y la longitud de los bucles 
conectores muestran una gran diversidad, lo que podría producir un profundo impacto en el 
tropismo viral.  
En el caso de los Atadenovirus, las dos estructuras determinadas (fibra del adenovirus de 
serpiente tipo 1 y fibra 1 del adenovirus de lagarto tipo 2) muestran que la cabeza de las 
fibras en este géneroson las más pequeñas de todas las estructuras de fibras de adenovirus 
resueltas hasta el momento. Esto se debe a que presentan bucles relativamente cortos 
conectando sus cadenas beta, lo que los hace estructuras más compactas. La presencia en su 
estructura de una prominente hélice alfa es también una característica destacable encontrada 
solamente en este género.  
El adenovirus de pavo tipo 3, un siadenovirus que existe tanto en forma avirulenta como 
virulenta, tiene una cabeza de la fibra más similar a las proteínas de unión al receptor de 
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reovirus y bacteriófagos que a las cabezas de las fibras de otros adenovirus. La presencia de 
una única horquilla beta hace esta estructura claramente distinguible entre otras proteínas 
análogas de adenovirus. Además, la notable similitud entre la cabeza de la fibra del 
adenovirus de pavo 3 y las proteínas de unión al receptor de reovirus ha reforzado la teoría de 
un vínculo evolutivo entre adenovirus y reovirus. La caracterización estructural de esta 
cabeza de fibra se ha desarrollado en más profundidad para buscar alguna perspectiva 
funcional por medio de herramientas biofísicas. Se han identificado como ligandos 
carbohidratos que contenían ácido siálico, y se han determinado con éxito estructuras de co-
cristales proteína-ligando.  La estructura de la cabeza de la fibra del adenovirus de pavo 3 
unida al ligando ha revelado un sitio completamente nuevo de unión a ácido siálico para las 
fibras de adenovirus, que se localiza muy cerca de la superficie intermonomérica del trímero.  
 El adenovirus murino de tipo 2 pertenece al mismo género que los adenovirus humanos 
(Mastadenovirus). Este virus podría utilizarse como sistema modelo para estudiar la 
patogenicidad de los adenovirus, por lo cual sería de gran ayuda el disponer de la 
caracterización tanto estructural como funcional de su fibra. En esta tesis se ha resuelto la 
estructura cristalina del dominio cabeza de la fibra, junto con dos repeticiones precedentes 
del dominio asta, a alta resolución. Aunque la estructura muestra una alta similitud con otras 
cabezas de fibras del género Mastadenovirus, existen ligeras variaciones que podrían tener 
implicaciones funcionales. Además, se ha determinado que la N-acetilglucosamina, un 
componente común de glicosaminoglicanos como el heparán sulfato y que tiene una amplia 
distribución en diversos tejidos, es un ligando para la cabeza de la fibra del adenovirus 
murino 2. 
En resumen, se presentan nuevos datos estructurales y funcionales acerca de distintas 
cabezas de fibras de adenovirus, que serán útiles en la elucidación de su tropismo y biología. 
Las nuevas estructuras también podrían tener utilidad para el diseño y el desarrollo de 
aplicaciones basadas en adenovirus no humanos. 
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6.2 Introducción 
Los adenovirus se aislaron por primera vez en 1953 de amígdalas faríngeas humanas 
(Rowe et al., 1953), y posteriormente de otros tejidos adenoideos (Hilleman, 1954; Huebner, 
1954). Basándose en estas observaciones de un origen común y el cercano parentesco de los 
agentes aislados, se les dio el nombre colectivo de adenovirus en 1956 (Enders, 1956). 
Durante las dos últimas décadas, los adenovirus han sido investigados con dos objetivos 
principales: desarrollar antivirales efectivos contra ellos, y utilizar el propio virus como 
vector para terapia génica y anticancerígena. Además, algunos adenovirus humanos se han 
usado como vacunas orales contra enfermedades respiratorias. 
 Aunque los adenovirus se asocian con ciertas condiciones patogénicas, estas condiciones 
suelen ser autolimitantes y la infección habitualmente induce una fuerte inmunidad adaptativa 
y protectora. Sin embargo, en el caso de pacientes inmunosuprimidos, la infección puede 
acarrear complicaciones clínicas severas (Kinchington et al., 2005). A pesar de todos los 
esfuerzos, actualmente no existe ningún antiviral contra adenovirus por vía sistémica o tópica 
(Kinchington et al., 2005).  
En lo que concierne al desarrollo de vectores, durante la década de los 90 se realizaron 
esfuerzos significativos en el diseño de vectores basados en adenovirus, debido a sus 
características favorables: alta capacidad para albergar transgenes, producción de 
recombinantes con título alto, y transducción eficiente (McConnell and Imperiale, 2004; 
Bachtarzi et al., 2008). Un inconveniente al usar sistemas de vectores basados en adenovirus 
humanos, como HAdV-5, es que los pacientes pueden tener inmunidad preestablecida contra 
ellos. El uso de adenovirus no humanos puede ser ventajoso, ya que podrían ser menos 
inmunogénicos y tener propiedades innovadoras de unión a receptores (Loser et al., 2002). 
Por esta razón es necesario caracterizar estos virus, poniendo énfasis en los componentes 
asociados con el tropismo. 
La familia Adenoviridae consta de cinco géneros: Mastadenovirus (que infectan 
mamíferos), Aviadenovirus (que infectan aves), Atadenovirus (que infectan rumiantes, 
reptiles y aves) , Siadenovirus (que infectan aves y ranas) e Ichtadenovirus (que infectan 
peces) (Harrach, 2011). Genéticamente, todos los adenovirus se componen de ADN 
bicatenario lineal y no segmentado, con distintivas repeticiones terminales invertidas (RTI) y 
una proteína terminal unida covalentemente al extremo 5' de cada cadena. El tamaño del 
genoma varía entre 26 y 48 kpb de longitud entre diferentes especies, junto con otras 
características como la longitud de las RTI y el grado de conservación de la secuencia. Sin 
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embargo, estas variaciones son mayoritariamente observadas en las regiones terminales, 
mientras que la región central del genoma suele estar conservada (Figura 2; Mautner et al. 
(1995); (Harrach, 2011)). 
El virión del adenovirus carace de componentes lipídicos (membranas); tiene 90 nm de 
diámetro y una simetría icosaédrica con un número de triangulación T=25. La partícula 
madura se compone de  una cápside externa y un núcleo interno, que contiene ADN y suman 
una masa total de 150 x 106 Da aproximadamente (Shenk, 1996; Vellinga et al., 2005). Las 
proteínas aportan el 87% de la masa total, mientras que una única molécula de ADN aporta el 
13% restante. Las caras de la cápside del adenovirus están formadas por hexones, y los 
vértices por pentones donde se inserta una fibra trimérica. Además de estas, hay algunas 
proteínas estructurales minoritarias que son necesarias para el ensamblaje y que funcionan 
como estabilizadoras de la cápside (San Martin, 2012). En los Atadenovirus, la cápside 
contiene dos proteínas específicas de género, p32 y LH3, que se ha propuesto que dotan de 
características distintivas a las especies de este género (Löser, 1999). 
El adenovirus de serpiente tipo 1 (SnAdV-1) fue aislado por primera vez de una serpiente 
del maíz (Elaphe guttata), que mostraba síntomas clínicos de neumonía (Juhasz and Ahne, 
1993). Basándose en la organización y las propiedades filogenéticas de su genoma de 27,7 
kpb, fue asignado al  género Atadenovirus (Harrach, 2011). El gen de la fibra del SnAdV-1 
que encontramos en la base de datos (GenBank DQ1064141.1) codificaría un polipéptido de 
415 residuos aminoacídicos (Farkas et al., 2008). Sin embargo, en esta tesis doctoral, se ha 
encontrado que solo tiene 345 aminoácidos de longitud (Singh et al., 2013).  
El adenovirus de pavo de tipo 3 (TAdV-3) pertenece al género Siadenovirus y presenta 
dos formas distintas: la forma virulenta, que causa enfermedades a menudo letales tal como la 
enteritis hemorrágica en pavos y la enfermedad del bazo marmóreo en faisanes (Domermuth 
et al., 1979; Palya et al., 2007); y la forma avirulenta o menos virulenta que se utiliza como 
vacuna contra la enteritis hemorrágica del pavo (Domermuth et al., 1977; Silim et al., 1978; 
Beach et al., 2009b). La comparación de las secuencias genómicas de las cepas virulentas y 
avirulentas de TAdV-3 mostrómutaciones en la secuencia de la fibra (Beach et al., 2009a).  
 La proteína de la fibra del TAdV-3 contiene 454 residuos, y se ha predicho que está 
formada por un dominio cola (residuos 1-45), un dominio asta con repeticiones putativas en 
triple espiral beta entre los residuos 46 y 303, y un dominio cabeza que abarcaría la parte 
restante (aminoácidos 304 al 454). Las mutaciones antes mencionadas se localizan en el 
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dominio cabeza (residuos 354 y 376), y consisten en una sustitución de metioninas en la 
forma avirulenta por isoleucina y treonina, respectivamente, en la cepa virulenta. 
 El adenovirus de lagarto de tipo 2 (LAdV-2) es el primer Atadenovirus identificado hasta 
el momento que posee dos tipos de fibra distintos en su virión (Penzes et al 2014). El gen de 
la fibra 1 de LAdV-2 codifica una proteína de 331 aminoácidos con un peso molecular de 
34,7 KDa, mientras el producto del gen de la fibra 2 tiene 433 aminoácidos con un peso 
molecular de 45,7 kDa. El modelo predicho para la fibra 1 muestra un dominio cola del 
residuo 1 al 40, mientras que el dominio asta empieza alrededor del residuo 45 y continúa 
hasta el residuo 210. Posteriormente, tras una corta región conectora, se encontraría el 
dominio cabeza. La fibra 2 es 102 aminoácidos más larga que la fibra 1, y su dominio cola 
predicho va del aminoácido 1 al 45. La primera repetición en espiral beta del asta se observa 
alrededor del residuo 46, mientras el extremo carboxilo terminal a partir del residuo 261 de la 
proteína forma el dominio cabeza. 
Muy recientemente, se ha realizado la caracterización del genoma completo del 
adenovirus murino de tipo 2 (MAdV-2) (Hemmi et al., 2011), el más largo de los tres tipos de 
adenovirus murinos secuenciados. Se encontró un único gen de fibra, que codifica una 
proteína con una longitud de 787 aminoácidos. La fibra del MAdV-2 es la más larga 
comparada con las fibras del MAdV-1 y el MAdV-3  y también con las fibras del HAdV-2, 3 
y 5. La predicción de estructura secundaria de la fibra confirma su organización general que 
coincide con las otras fibras de adenovirus. La conformación predicha seria un dominio cola 
corto (residuos 1-50), un dominio asta central con repeticiones en espiral beta (residuos 53-
630) y un dominio cabeza distal en el extremo carboxilo terminal (residuos 633-787). Justo 
antes del final del dominio cola, entre los residuos 40-47, puede apreciarse una región corta 
rica en prolina que probablemente ayuda a la fibra a unirse a la base de pentón sobre la 
cápside.  
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6.3 Objetivos 
El principal objetivo de esta tesis es la caracterización estructural y funcional de las 
proteínas externas de la cápside de varios adenovirus no humanos: SnAdV-1, TAdV-3, 
LAdV-2 y MAdV-2. Las estructuras de estas proteínas podrían dar pistas sobre la unión a sus 
receptores y conducir a aplicaciones relacionadas con terapia génica y anticancerígena basada 
en adenovirus. Los objectivos concretos que se han planteado han sido los siguientes: 
 1. Clonación, expresión, purificación y cristalización de la proteína de la fibra del SnAdV-1. 
Resolución de la estructura del dominio cabeza y su comparación con otras estructuras de 
fibras de adenovirus conocidas. Identificación de posibles ligandos.  
2. Clonación, expresión, purificación y cristalización de la proteína de las fibras virulenta y 
no virulenta del TAdV-3. Resolución de la estructura del dominio cabeza. Comparación de 
las estructuras entre sí y con otras estructuras de fibras de adenovirus conocidas. 
Identificación de posibles ligandos, determinación de la afinidad del ligando con la fibra y 
resolución de la estructura del dominio cabeza con su ligando.  
3. Clonación, expresión, purificación y cristalización de las proteínas de las fibras tanto larga 
como corta del adenovirus de lagarto 2. Resolución de la estructura del dominio cabeza de 
unión al receptor. Comparación de la estructura con la del dominio cabeza de la fibra del 
adenovirus de serpiente 1. 
4. Clonación, expresión, purificación y cristalización de la proteína de la fibra del MAdV-2. 
Resolución de la estructura del dominio carboxi-terminal. Comparación de la estructura 
con otras estructuras de fibras de adenovirus conocidas. Identificación de posibles 
ligandos. 
5. Clonación, expresión, purificación y cristalización la proteína minoritaria específica de 
atadenovirus LH3 del SnAdV-1. 
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6.4 Resultados y discusión 
6.4.1 Estructura del dominio cabeza de la fibra de adenovirus de serpiente tipo 1 
El adenovirus de serpiente tipo 1 es el primer Atadenovirus  del que se ha resuelto la 
estructura de la cabeza de la fibra. La estructura trimérica compacta es muy estable y 
conlleva interacciones no covalentes extensivas entre sus unidades monoméricas. Desde el 
punto de vista de las dimensiones y de longitud, es la cabeza de fibra de adenovirus más 
pequeña conocida hasta el momento, junto con la cabeza de la fibra 1 del atadenovirus de 
lagarto tipo 2. Sin embargo, mantiene la misma topología en sándwich beta ABCJ-GHID que 
las otras fibras. Es interesante ver que la estructura es más similar a las fibras de los 
bacteriófagos que a otras cabezas de fibras de adenovirus. Por medio de una criba con matriz 
de glicanos (glycan array) se identificó a la sialil-lactosa como un ligando potencial. Esto 
sugiere que el virus puede utilizar un glicano de la superficie celular como receptor, sin 
embargo puede que dicho glicano sea más complejo que los analizados. 
6.4.2 Estructura y unión de sialil-lactosa al dominio cabeza de la fibra de un 
Siadenovirus, el adenovirus de pavo 3 
 Se han resuelto las estructuras atómicas de la cabeza de la fibra de ambas cepas del 
TAdV-3: la avirulenta y la virulenta. Este es el primer Siadenovirus del que se ha descrito la 
estructura de la cabeza de la fibra. La estructura reveló una superficie con fuerte carga 
positiva, que podría ser importante para la interacción con su célula hospedadora. Se han 
demostrado las interacciones de la cabeza de la fibra con glicanos sialidados en ambos tipos 
de virus, y se han determinado estructuras cristalográficas de la fibra con el ligando. Las 
estructuras cristalográficas de estos complejos revelaron el sitio de unión al ácido siálico de 
la cabeza de la fibra del TAdV-3, que se localiza en la superficie intermonomérica y está 
constituido por lazos expuestos en la superficie. Una inserción de horquilla beta que 
interacciona con un monómero vecino es única entre las fibras de adenovirus. La falta de 
similitud de secuencia con otras cabezas de fibras de Siadenovirus no permite predecir si 
otras fibras de Siadenovirus también contendrían esta horquilla beta, aunque es posible. La 
cabeza de la fibra de TAdV-3 comparte su topología en barril beta ABCJGHID con cabezas 
de fibras de reovirus, mientras que las fibras de bacteriófagos y otras fibras de adenovirus 
tienen un sandwich beta con láminas ABCJ y GHID separadas. Los reovirus son virus con 
ARN de doble cadena, y por tanto no se prevén relaciones evolutivas directas entre 
adenovirus y reovirus. Por esta razón no esta claro cómo los genes de la fibra pueden haberse 
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transferido entre ellos, o si el proceso evolutivo implicado ha sido convergente en lugar de 
divergente. El conocimiento de la estructura puede permitir también el diseño de adenovirus 
quiméricos que incorporen la cabeza de la fibra del TAdV-3 e investigar su tropismo, que a 
su vez puede conducir a vacunas o vectores de terapia génica que puedan dirigirse a tipos 
celulares específicos. 
6.4.3 Estructura cristalina de la cabeza de la fibra corta del adenovirus de lagarto tipo 2 
Se ha determinado la estructura cristalográfica de la cabeza de la fibra corta del LAdV-2 
refinada hasta una resolución máxima de 2 Å.  Es la segunda proteína de Atadenovirus de la 
cual se ha determinado la estructura, siendo la primera la cabeza de la fibra de SnAdV-1 
descrita en un apartado anterior. La estructura es muy similar a la de la cabeza de la fibra de 
SnAdV-1, lo cual era de esperar debido a una similitud del 54% en la secuencia. También se 
intentó cristalizar la cabeza de la fibra larga, que sólo tiene un 12% de similitud de secuencia 
con la cabeza de la fibra corta, pero no se obtuvieron criatales que difractaran 
adecuadamente. Estudios futuros estarán dirigidos a obtener informacion de las propiedades 
de unión al receptor de estas proteínas. 
6.4.4 Estructura cristalina de la cabeza de la fibra del adenovirus murino 2 con las 
repeticiones del asta adyacentes 
La estructura del fragmento C-terminal de la fibra del MAdV-2 reveló la presencia de dos 
repeticiones en espiral beta en el dominio asta, junto con un dominio cabeza más pequeño de 
lo esperado. Esta es la segunda fibra de adenovirus en la que se han resuelto repeticiones en 
espiral triple beta. Como en el caso de la fibra del  HAdV-2, las repeticiones del asta de la 
fibra del MAdV-2 están formadas por glicinas con estructura en forma de cadena beta de 
longitud variable. El dominio cabeza de la fibra del MAdV-2 es muy similar a la cabeza de la 
fibra de CAdV-2 y muestra partes cargadas en su superficie. Como CAdV-2 puede unir CAR 
D1 y ácido siálico, se investigó la unión a CAR D1 y a carbohidratos. Mediante ensayos de 
unión a una matriz de glicanos se observó que el GlcNAc podría ser un ligando potencial; sin 
embargo, no fue posible demostrar la interacción con el dominio D1 de la proteína CAR 
humana. 
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6.4.5 Estudios preliminares por cristalografía de rayos X y estudios biofísicos  de la 
proteína LH3 de la cápsida de adenovirus de serpiente 1. 
Se han realizado estudios preliminares por cristalografía de rayos X y estudios biofísicos 
en la proteína LH3, específica del género Atadenovirus. Se obtuvieron cristales nativos de 
gran calidad que difractaron a 2 Å, y su análisis sugirió que la proteína era trimérica. Debido 
a la dificultad de obtener cristales de la proteína, no ha sido posible hasta el momento 
determinar su estructura. Se ha confirmado que la proteína es altamente estable frente a 
agentes desnaturalizares, y que su monómero sólo puede visualizarse tras hervir la muestra 
antes de someterla a electroforesis desnaturalizante en gel de acrilamida. Análisis 
bioquímicos y biofísicos adicionales indicaron que la proteína podría formar agregados y 
oligómeros de orden superior. Los datos de cribado de glicanos mostraron que LH3 no tiene 
afinidad por carbohidratos; sin embargo, debido a su localización en la cápside viral, no 
puede descartarse que esté involucrado en el reconocimiento de la célula hospedadora. 
 La proteína LH3, junto con otra denominada p32k, forma el conjunto de proteínas 
minoritarias de la cápsida específicas de Atadenovirus. Estas proteínas podrían conferirles 
distintas funciones que no se han observado previamente en otros adenovirus. Además, LH3 
por su posición externa en la cápsida, podría estar involucrada en funciones de 
reconocimiento del receptor, associándose con otras proteínas bien establecidas. En cualquier 
caso, una caracterización más profunda de estas proteínas ayudará a revelar nuevas facetas de 
estos virus. 
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6.5 Conclusiones 
1. La proteína de la fibra del SnAdV-1 consta de 345 aminoácidos en lugar de los 415 
registrados en la base de datos. 
2. La estructura de la cabeza de la fibra del adenovirus de serpiente 1, resuelta a 1.35 Å de 
resolución, es la primera descrita dentro del género Atadenovirus y conserva la topología 
de otras cabezas de fibra de adenovirus, pero es mucho más compacta. 
3. La estructura del dominio de cabeza de la fibra corta del adenovirus de lagarto, resuelta a 
2.0 Å de resolución, es muy similar a la del adenovirus de serpiente. 
4. La estructura del dominio cabeza del adenovirus de pavo 3 resuelta a 2.2 Å es la primera 
resuelta dentro del género Siadenovirus. Posee una superficie cargada positivamente, lo 
que probablemente es importante para la interacción con la célula hospedadora. Una 
inserción en forma de horquilla beta que contacta con un monómero vecino es una 
característica única de la estructura de cabeza de la fibra del adenovirus de pavo 3. Sus 
homólogos estructurales más próximos han sido identificados como proteínas de unión al 
receptor de reovirus. 
5. El dominio de cabeza de la fibra del adenovirus de pavo une 2,3'- y 2,6'-sialillactosa. El 
sitio de unión se compone de los residuos Glu392, Thr419, Val420, Lys421, Asn422, y 
Gly423. 
6. La estructura del dominio de cabeza de la fibra del adenovirus de ratón 2 resuelta a 1.8 Å, 
reveló una estructura en sandwich beta muy similar a la de otros Mastadenovirus. El 
dominio asta de la estructura resuelta está compuesto de dos repeticiones en espiral beta de 
tipo glicina. 
7. In vitro, el dominio carboxi-terminal de la fibra del adenovirus de ratón une N-
acetilglucosamina. 
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Table AI: List of glycoproteins and neoglycoconjugates used in glycan array screenings 
Abbreviation 
Fetuin 
ASF 
PBS 
Ov 
RB 
Xferrin 
4APHSA 
a-C 
M3BSA 
GlcNAcBSA 
LacNAcBSA 
3SLNBSA 
3SLacHSA 
6SLacHSA 
2FLBSA 
3SFLBSA 
H2BSA 
BGABSA 
BGBBSA 
GGGNHSA 
Ga3GBSA 
Gb4GBSA 
Ga2GBSA 
4APBSA 
LNFPIBSA 
LNFPIIBSA 
LNFPIIIBSA 
LNDHIBSA 
LebBSA 
LexBSA 
DiLexBSA 
DiLexHSA 
3LexHSA 
3SLexBSA3 
Neoglycoconjugate 
Fetuin 
Asialofetuin 
Phosphate buffered saline 
Ovalbumin 
RNAse B 
Transferrin 
4AP-HAS 
a-Crystallin from bovine lens 
Mana1,3(Mana1,6)Man-BSA 
GlcNAc-BSA 
LacNAc-BSA 
3'SialylLacNAc-BSA 
3'-Sialyllactose-APD-HSA 
6'-Sialyllactose-APD-HSA 
2'Fucosyllactose-BSA 
3'Sialyl-3-fucosyllactose-BSA 
H Type II-APE-BSA 
Blood Group A-BSA 
Blood Group B-BSA 
Gala1,3Galb1,4GlcNAc-HSA 
Gala1,3Gal-BSA 
Galb1,4GalBSA 
Gala1,2GalBSA 
4AP-BSA 
Lacto-N-fucopentaose I-BSA 
Lacto-N-fucopentaose II-BSA 
Lacto-N-fucopentaose III-BSA 
Lacto-N-difucohexaose I-BSA 
LNDI-BSA/ Lewis b-BSA 
Lewis x-BSA 
Di-Lex-APE-BSA 
Di-Lewisx-APE-HSA 
Tri-Lex-APE-HSA 
3'Sialyl Lewis x-BSA 
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SLexBSA14 
6SuLexBSA 
6SuLeaBSA 
3SuLeaBSA 
3SuLexBSA 
DFPLNHHSA 
LeyHSA 
3FLeyHSA 
LNnTHSA 
LNTHSA 
SLNFVHSA 
MMLNnHHSA 
SLNnTHSA 
GM1HSA 
aGM1HSA 
GlobNTHSA 
GlobTHSA 
Inv 
Fibrin 
A1AT 
Cerulo 
AGP 
LacNAcaBSA 
LacNAcb4APBSA 
H2HSA 
Ovomuc 
RhaBSA 
XManaBSA 
XLacbBSA 
XGalbBSA 
XylbBSA 
XylaBSA 
XGlcbBSA 
FucaBSA 
FucbBSA 
GlcbITCBSA 
3'Sialyl Lewis x-BSA 
6-Sulfo Lewis x-BSA 
6-Sulfo Lewis a-BSA 
3-Sulfo Lewis a-BSA 
3-Sulfo Lewis x-BSA 
Difucosyl-para-lacto-N-hexaose-APD-HSA 
Lewis y-tetrasaccharide-APE-HSA 
Tri-fucosyl-Ley-heptasaccharide-APE-HSA 
Lacto-N-neotetraose-APD-HSA 
Lacto-N-tetraose-APD-HSA 
Sialyl-LNF V-APD-HSA 
Monofucosyl, monosialyllacto-N-neohexaose-APD-HSA 
Sialyl-LNnT-penta-APD-HSA 
GM1-pentasaccharide-APD-HSA 
Asialo-GM1-tetrasaccharide-APD-HSA 
Globo-N-tetraose-APD-HSA 
Globotriose-APD-HSA 
Invertase 
Fibrinogen 
alpha-1-antitrypsin 
Ceruloplasmin 
alpha-1-acid glycoprotein 
LacNAc-a-4AP-BSA 
LacNAc-b-4AP-BSA 
H-Type 2-APE-HSA 
Ovomucoid 
L-Rhamnose-Sp14-BSA 
Man-a-ITC-BSA 
Lac-b-4AP-BSA 
Gal-b-ITC-BSA 
Xyl-b-4AP-BSA 
Xyl-a-4AP-BSA 
Glc-b-4AP-BSA 
Fuc-a-4AP-BSA 
Fuc-b-4AP-BSA 
Glc-b-ITC-BSA 
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Galb4APBSA 
Neu5GcBSA 
CollagenIV 
D-GlobTHSA 
Gal-b-4AP-BSA 
Neu5Gc-a-4AP-BSA 
Collagen type IV 
Globotriose-HSA 
 
 
